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Summary 
The role of dietary intake in understanding the relationship between diet, health and disease has 
become crucial over the past several years. The valid estimation of habitual dietary intake in 
nutritional epidemiology is still challenging to this day. Identifying new habitual dietary 
biomarkers based on “omics” data in observational studies is a relatively new concept, which 
could improve the characterization of nutritional status in study participants and offer a deeper 
understanding of the effects of food components and diet on the human body, independent of 
dietary assessment measurement errors. The aim of this dissertation is to emphasize the need to 
identify new habitual dietary biomarkers in different biosamples in observational studies and to 
highlight the emerging field of nutritional metabolomics and relevant analytical methods. 
This dissertation comprises three manuscripts. As there are several sampling techniques used in 
identifying dietary biomarkers, the first manuscript gives an overview and suggestions for 
using alternative sampling techniques to improve the quality of nutritional research in large 
epidemiological studies. In the second manuscript, associations between habitual meat 
consumption and plasma concentrations of anserine, carnosine, pi-methylhistidine (Π-MH), 
tau-methylhistidine (T-MH) and the ratio of tau-methylhistidine to pi-methylhistidine are 
identified in a cross-sectional study (BVS II). Principally, red meat intake was associated with 
carnosine, whereas poultry and chicken consumption were related to Π-MH. Plasma anserine 
concentrations significantly increased with higher processed meat and turkey intake. 
The associations in the third manuscript between usual food intake and fecal sterols and bile 
acids are assessed and analyzed by means of a metabolomics technique in the KORA FF4 
study. It has revealed an effect of habitual diet on fecal concentrations of animal sterols but the 
influence of diet on bile acids was limited in this population study. 
In conclusion, this dissertation provides results with novel information as it has shown the 
association between usual dietary meat intake and plasma concentration of a cross-sectional 
study and has analyzed fecal concentrations of sterols in feces in a population-based study and 
related it to habitual dietary intake. However, it may be also important to further investigate the 
use of combinations of biomarkers of meat intake to specify particular types of meat 
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consumed, since plasma anserine, carnosine, and Π-MH seem to be markers for overall meat 
intake rather than specific markers of a certain type of meat. Additional future intervention 
studies are needed to reveal if the metabolites found in plasma are characteristic for a specific 
type of meat or not. Further studies are essential for assessing fecal animal sterol levels as 
biomarkers of diet and to confirm the findings in other populations with different dietary 
habits. Finally, the findings of this dissertation in combination with findings from the previous 
literature (and future studies) on associations between dietary intake and dietary biomarkers 
should be used in identifying dietary patterns (or food items, etc.) related to chronic diseases 
over the long term in the general population. 
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Zusammenfassung 
 
In den letzten Jahren ist die Rolle der Ernährung im Verständnis der Beziehung zwischen 
Ernährung, Gesundheit und Erkrankungen immer wichtiger geworden. Eine valide Schätzung 
des gewöhnlichen Verzehrs in der Ernährungsepidemiologie ist noch immer eine 
Herausforderung. Im Rahmen von Beobachtungsstudien ist die Identifizierung neuer 
Biomarker, die gewöhnlichen Verzehr beschreiben und auf “omics” Daten basieren ein relativ 
neues Konzept. Dieses könnte die Charakterisierung des Ernährungsstatus der 
Studienteilnehmer verbessern und gleichzeitig ein tieferes Verständnis der Einflüsse von 
Ernährungsbestandteilen und Ernährungsgewohnheiten auf den Menschen ermöglichen, 
unabhängig von Messfehlern bei der Erhebung der Nahrungsmittelzufuhr. Das Ziel dieser 
Dissertation ist, die Notwendigkeit der Identifizierung solcher Biomarker des gewöhnlichen 
Verzehrs in verschiedenen Bioproben aus Beobachtungsstudien zu unterstreichen und dieses 
aufstrebende Gebiet der Ernährungs-Metabolomics und deren analytische Methoden 
hervorzuheben. 
Die Dissertation umfasst drei Manuskripte. Das erste Manuskript gibt einen Überblick zur 
Identifizierung von Biomarkern der Ernährung in verschiedenen Bioproben sowie Vorschläge 
für alternative Bioproben, die die Qualität der Ernährungserhebung in großen 
epidemiologischen Studien verbessern können. Das zweite Manuskript untersucht die 
Assoziation von üblichem Fleischverzehr und den Plasmakonzentrationen von Anserine, 
Carnosine, Pi-Methylhistidine (Π-MH), Tau-Methylhistidine (T-MH) und dem Quotienten von 
Tau-Methylhistidine zu Pi-Methylhistidine in einer Querschnittsstudie (BVS II). Der übliche 
Verzehr von rotem Fleisch war mit der Carnosinekonzentration assoziiert, wohingegen der 
übliche Geflügel- und Hähnchenverzehr mit Π-MH assoziiert war. Die Konzentration von 
Anserine im Plasma stiegen mit vermehrter gewöhnlicher Aufnahmemenge von verarbeitetem 
Fleisch und Truthahn signifikant an. Im dritten Manuskript werden Assoziationen zwischen 
dem gewöhnlichen Verzehr und Metaboliten (genauer: Sterolen und Gallensäuren) im Stuhl 
von Probanden der KORA FF4 Studie untersucht. Es zeigte sich ein Einfluss des üblichen 
Verzehrs auf die Metabolit-Konzentrationen der tierischen Sterole im Stuhl, wohingegen der 
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Einfluss auf die Metabolite der Gallensäuren in dieser populationsbasierten Studie begrenzt 
war. 
Zusammengefasst kann man festhalten, dass diese Dissertation im Ergebnis neue Erkenntnisse 
liefert, da sie zum einen die Assoziation zwischen gewöhnlichem Fleischverzehr und der 
Biomarker-Konzentration im Plasma in einer Querschnittsstudie und zum anderen die 
Sterolkonzentrationen im Stuhl in einer populationsbasierten Studie analysiert und jeweils mit 
dem gewöhnlichen Verzehr in Zusammenhang gebracht hat. Trotzdem ist es von Interesse, 
auch eine Kombination verschiedener Biomarker für Fleischverzehr zu untersuchen, um zu 
identifizieren, welche Art von Fleisch verzehrt wurde. Anserine, Carnosine, und Π-MH im 
Plasma stellen generell Biomarker für Fleischkonsum dar und erlauben keine Rückschlüsse auf 
die Art des verzehrten Fleisches. Außerdem sind zukünftig Interventionsstudien nötig, die 
aufdecken könnten, ob bestimmte Metabolite die im Plasma nachgewiesen wurden für den 
Verzehr von bestimmten Fleischarten charakteristisch sind. Weitere Studien müssten zudem 
durchgeführt werden, um die Eignung von tierischen Sterolen im Stuhl als Biomarker für 
üblichen Verzehr zu untersuchen und um die gefundenen Resultate in anderen 
Bevölkerungsgruppen mit unterschiedlichen Ernährungsgewohnheiten zu bestätigen. 
Schließlich sollten die Ergebnisse dieser Dissertation und Resultate aus der Literatur und auch 
zukünftige Studien zur Assoziation von Ernährungszufuhr und Biomarkern der Ernährung als 
Grundlage dienen um Ernährungsmuster zu identifizieren, die über einen langen Zeitraum mit 
chronischen Erkrankungen in einer allgemeinen Bevölkerung assoziiert sind. 
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1. Introduction 
 
Assessment methods of habitual dietary intake 
The role of dietary intake has been investigated over several years in the context of 
understanding the relationship between diet, health and disease [1]. To this day, valid 
estimation of habitual dietary intake in nutritional epidemiology remains a challenge [2]. 
Each dietary assessment tool, even the most appropriate ones, has its own limitation in 
assessing dietary intake at the individual level in large cohort studies. Although dietary 
questionnaires such as food frequency questionnaires (FFQs) and 24 hours dietary recalls (24h-
DRs) have been utilized to collect food and nutrient intake data, they are very subjective and 
liable to different biases, affecting the accurate estimation of dietary intake [3]. These methods 
rely on memorizing or monitoring dietary intake from the participants leading to under- and 
over-reporting of certain foods [4]. To increase precision and validity of the currently available 
dietary assessment methods, a blended dietary assessment approach has been developed that 
combines the use of two different assessment instruments in one study. Combining the two 
methods improves the accuracy of the nutritional assessment [2,5,6]. Finding biomarkers that 
are independent of dietary assessment measurement errors would be advantageous in getting 
and assessing further information on dietary intake and nutritional status [7]. Dietary intake 
biomarkers may afford a more proximal measure of nutrient status for disease outcomes and 
for population-wide nutritional status measures [8]. Furthermore, they may overcome the 
problem of intra-individual diet variability [9]. However, it must be noted that biomarkers are 
not a gold standard to validate dietary questionnaires. They are more useful in comparing 
dietary assessment methods against each other [8]. On the contrary, questionnaires for dietary 
intake assessment are essential for biomarker evaluation, particularly when dietary 
supplements are administered, which can lead to an alteration in the correlation between 
dietary intake and a biological biomarker of a nutrient.  
Overall, identification of novel biomarkers is essential to improve nutritional science as 
suggested in previous reviews of this area [10,11]. 
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Definition of dietary biomarkers 
There are several different definitions for the term “biomarker” in literature. One of the WHO 
definitions is “any substance, structure, or process that can be measured in the body or its 
products and influence or predict the incidence of an outcome or disease” [12]. Since this 
dissertation covers biomarkers of dietary intake or health effects, the most appropriate 
definition would be a “chemical or biological test results in an analyzed biological material 
related to a certain exposure, susceptibility, or biological effect” [13]. 
Additionally, there are several different classifications for dietary biomarkers. They can be 
categorized into short-term, medium-term and long-term markers, where short-term biomarkers 
indicate intake over past hours or days, and medium-term represent intake over weeks or 
months. Long-term biomarkers observed in epidemiologic studies are focused on the intake of 
nutrients over months or years to assess habitual dietary intake [7,8]. 
Jenab et al. [14] divided biomarkers into recovery (exposure), predictive, concentration and 
replacement biomarkers; these are described in more detail elsewhere [15]. However, Biesalski 
et al. [13] focused only on their use and categorized them into exposure, effect and 
susceptibility biomarkers. An exposure biomarker is an intake biomarker that indicates the 
level of exposure to a diet or food component, while an effect biomarker indicates the human 
body’s functional response to an exposure. A susceptibility biomarker is a measurable indicator 
such as genetic or acquired host factors that affects the response of an individual to a dietary 
exposure [11]. Nevertheless, a biomarker can be classified into several different classifications 
contingent upon the aim of use. 
An ideal biomarker should assess nutritional intake more accurately than self-reported methods 
by being more specific and sensitive for the food it is supposed to monitor. It should validate 
and evaluate self-reported intake of food items [8]. Additionally, it should not be altered by 
diseases, by metabolic conditions or lifestyle, or other genetic or environmental factors. It 
should also be able to detect dietary intake alterations over time. Moreover, it should be 
inexpensive, non-invasive and applicable across different populations [7,16].
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Methods to identify dietary biomarkers 
Dietary biomarkers can be discovered by hypothesis-driven or data-driven approaches. In the 
past, most dietary biomarkers have been identified by hypothesis-driven methods, but today 
numerous new biomarkers of diet-related health effects are being explored by rapid data-driven 
approaches in the context of the development of “omics” technologies [10]. Metabolomics 
offers opportunities in the identification of the relationship between human nutrition and health 
status. Identifying dietary intake patterns by the use of metabolomics to find molecules that 
alter between different diets may lead to determining potential diet-disease risk biomarkers 
[17] and food-specific novel biomarkers [7,18]. Furthermore, identification of new dietary 
biomarkers of food-specific intake will correspond to the new trend of personalized nutrition 
and will help in distinguishing individuals and populations according to their different diets, 
lifestyles and environments [10,11]. 
Limitations of biomarkers 
It should be noted that biomarkers represent many more biological processes than just dietary 
intake. Unlike dietary questionnaires, biomarker concentrations are altered by many 
physiological, genetic and environmental factors like digestion, absorption, metabolism, and 
elimination as well as by physical activity, microbiota composition, drug use and diseases [7].  
Furthermore, food is a complex mixture and the absorption and metabolism of each single 
nutrient may depend on other food components, which makes it difficult to assess the nutrient-
metabolism interactions by dietary assessment methods [15].  
Identifying nutritional status by biomarkers is also affected by the method of bio-specimen 
collection, storage, laboratory variability and the study design in general [19]. There are only 
limited types of noninvasive, easily obtainable biospecimens for dietary intake assessment 
[11]. 
This dissertation addresses dietary biomarkers of habitual meat intake in plasma samples and 
the associations between habitual dietary intake and fecal animal and plant sterols, and bile 
acids. 
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Biomarkers of meat intake 
Meat intake offers a good source of protein in omnivorous populations and has a possible 
influence on an individual’s nutritional and health status. Defining total protein intake or 
categorizing individuals according to their meat intake is one of the main interests of 
epidemiological studies. The WHO has provided recommendation for red meat and processed 
meat intake, as it has been widely proposed in many studies that processed meat consumption 
increases the risk of colorectal cancer and probably other cancers [20]. Yet significant evidence 
is still needed to directly link the type of meat consumed to colorectal cancer and other chronic 
diseases such as diabetes, cardiovascular diseases and total mortality [21-23]. As dietary 
questionnaires are imprecise and subjective to measurement errors as mentioned above, finding 
valid and reliable biomarkers of different types of meat intake in biosamples would be helpful 
in supporting and evaluating existing dietary intake data and dietary recommendations. 
Biomarkers can be utilized to classify an individual’s dietary consumption to improve the 
assessment of the relationship between diet and chronic disease.  
Carnosine [24], anserine [24], pi-methylhistidine (Π-MH) [12], tau-methylhistidine (T-MH) 
[12], urea [24], creatine [24], creatinine [24], carnitine [24], ophidine [24]and sulphate [24] 
have been proposed as biomarkers of meat intake in different studies and various biospecimens 
[24]. They are found in different concentrations in all types of meat [24]; however, some of 
these biomarkers are catabolites of meat intake that resemble human catabolites of heme and 
protein. In this case, an ideal meat intake biomarker should specify the mean intake over a 
longer period of time and should also classify individuals in line with the type and amount of 
meat consumed in large, population-based studies. 
Thus, the association between dietary meat intake and plasma concentrations of anserine, 
carnosine, Π-MH, T-MH and the ratio of T-MH to Π-MH was assessed in this thesis. 
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Figure 1: Overview of the metabolism of carnosine (Adapted from Boldyrev et al., 2013) 
[Boldyrev A.A, Aldini G and Derave W. Physiology and pathophysiology of carnosine. Physiol Rev, 2013. 
93(4): p. 1803-45. Copyright 2013 “the American Physiological Society”. Adapted with permission.] [25] 
 
Carnosine (beta-alanyl-histidine) is a dipeptide synthesized by carnosine synthase from L-
histidine and ß-alanine. It has several naturally occurring derivatives such as anserine (β-
alanyl-Nπ-methyl-histidine), ophidine (β-alanyl-Nτ-methyl-histidine), homocarnosine and 
acetylcarnosine. Anserine and ophidine are the methylated analogs of carnosine. The metabolic 
pathways linking the related compounds to carnosine are depicted in Figure 1 (Adapted from 
Boldyrev et al., 2013) [25]. Π-MH is a degradation product of anserine, whereas T-MH is 
degraded from actin and myosin, the main proteins found in the striated muscle filaments [24]. 
Over many years, the distribution of carnosine, anserine and ophidine in various animals 
species has been studied [25]. Nearly all mammals have carnosine and one of the methylated 
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carnosine analogs except Homo sapiens. Homo sapiens possess only carnosine. Anserine is 
found more frequently than ophidine in mammals, whereas ophidine is only observed in high 
amounts in marine mammals. As this study is concerned with finding dietary biomarkers of 
meat intake, the focus was placed on anserine, carnosine, T-MH and Π-MH. 
Fecal sterols and bile acids as biomarkers of habitual dietary intake 
In the third manuscript, animal sterols [26], plant sterols [26,27] and bile acids [28] were 
assessed in relation to their excreted concentrations in feces, since they are found in different 
amounts in various foods. They have been proposed as dietary intake biomarkers by several 
studies [26-30] and have been analyzed in fecal samples to assess their associations with 
dietary intake and disease. Yet it is still not known if these biomarkers can also indicate 
habitual dietary intake or not. 
Metabolic pathway of cholesterol and bile acids 
Generally, cholesterol is excreted either as part of a sterol or in the form of bile acids in feces. 
Cholesterol is mainly metabolized in the liver into primary bile acids such as cholic- and 
chenodeoxycholic acids. These are conjugated with taurine and/or glycine, which are 
eliminated with bile into the intestine, where 95% are reabsorbed and enter the enterohepatic 
cycle. The other 5% are not absorbed and pass to the large intestine. Unabsorbed bile acids are 
deamidated or dehydroxylated by colonic microbiota to produce secondary bile acids e.g., 
deoxycholic acid and lithocholic acid. These compounds are finally excreted in feces [31,32] 
(See Figure 2). 
Thus, 9.5% of fecal neutral sterols are excreted as cholesterol itself, whereas coprostanol, a 
metabolite product of cholesterol, makes up 65% of fecal neutral sterols [33]. A thorough 
description of the fecal metabolic pathway of cholesterol and bile acids is outlined elsewhere 
[32]. 
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Figure 2: Overview of the metabolic pathway of cholesterol (from Mitry et al., 2019) 
 
[Mitry P, Wawro N, Sharma S et al. (2019) Associations between usual food intake and fecal sterols and bile 
acids: results from the KORA FF4 study. Br J Nutr, 2019: p. 1-26. Copyright Clearance Center. Reproduced 
with permission.] [34] 
Metabolic pathway of phytosterols 
Phytosterols like stigmasterol or ß-sitosterol are naturally occurring compounds that are 
derived by humans only through dietary intake of plant foods. They are similar to cholesterol 
in both structure and biological function except that they contain an additional ethyl- or methyl 
group at the C24 position on the sterol side chain [35]. It is necessary to mention that habitual 
dietary consumption of plant sterols is influenced by population and sex [36-38]. Vegetable 
oils are very rich in phytosterols, but their serving sizes are small in comparison with the 
serving sizes of seeds and nuts, grain products, vegetables, and fruits [27]. 
Dietary intake of plant sterols is mostly rich in campesterol and sitosterol, which are 
metabolized into methyl- or ethyl- coprostanol and methyl- or ethyl- coprostanone. Less than 
5% of dietary levels of phytosterols are absorbed in healthy humans; the remaining 95% enter 
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the colon [39]. Intestinally-absorbed phytosterols are excreted quicker than cholesterol via the 
biliary route, which results in a small pool of phytosterols in contrast to cholesterol [40]. The 
amount of dietary plant sterol intake is proportional to the total amount of plant sterols and 
plant sterol derivatives excreted in feces [41]. Additionally, plant sterol intake enhances fecal 
animal sterols excretion. 
 
Aim of this dissertation 
 
Identifying new habitual dietary biomarkers based on “omics” data in observational studies is a 
relatively new concept, which could improve the characterization of nutritional status in study 
participants and offer a deeper understanding of the effects of food components and diets on 
the human body. This concept may be useful for nutritional epidemiology since it aims to 
observe, independent of measurement errors, biomarkers of dietary intake and nutritional status 
[11]. It is the aim of this dissertation to emphasize the need to identify new habitual dietary 
intake biomarkers in different biosamples available from observational studies. Furthermore, it 
highlights the emerging field of nutritional metabolomics and potential analytical methods. 
Several meat, animal and plant sterol, and bile acid biomarkers of habitual intake are not well 
explored or validated in the present literature [7,10,11,24] and may be identified as useful upon 
better assessment in cross-sectional studies.  
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Accordingly, the main objectives of this dissertation are:  
1. To emphasize the need to identify biomarkers of nutrient intake using alternative 
sampling techniques to improve the quality of nutritional research in large 
epidemiological studies; e.g. utilizing fecal samples as a potential matrix for dietary 
biomarkers. It highlights the emerging field of nutritional metabolomics and the relevant 
analytical methods. 
 
2. To identify associations between habitual meat consumption and plasma concentrations 
of anserine, carnosine, pi-methylhistidine (Π-MH), tau-methylhistidine (T-MH) and the 
ratio of tau-methylhistidine to pi-methylhistidine in a cross-sectional study (BVS II). 
 
3.  To assess associations between usual food intake and fecal sterols and bile acids, 
analyzed by means of a metabolomics technique, in the KORA FF4 study. 
 
 
Objective 1 resulted in a manuscript with the doctoral candidate as the fourth author. 
Objectives 2 and 3 resulted in two manuscripts with the doctoral candidate as the first author. 
All three manuscripts are published in international, peer-reviewed journals ([42], [34] and 
[16]). 
This dissertation is based on these three manuscripts. The term ‘manuscript’ is used in the 
following for published manuscripts for reasons of simplification. 
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2. Methods 
 
2.1 Literature research 
The first manuscript gives an overview of different sampling techniques to facilitate 
identifying biomarkers of nutrient intake or nutrients status. For the chapter “feces— a 
potential matrix for dietary biomarkers”, a literature search was conducted mainly based on 
original research papers available in PubMed, Google, and Science Direct (ELSEVIER) up to 
November 2015.  
The search strategy addressed the subject of finding biomarkers of dietary intake in fecal 
samples by metabolite profiling and to what extent the gut microbiota composition is subject to 
dietary control. Different combinations of the following keywords were used to search for 
studies that were related to biomarkers of dietary intake in feces and metabolite profiling: 
“dietary intake”, “nutrient intake”, “short-chain fatty acids”, “branched-chain fatty acids”, 
“sterols”, “prebiotic”, “dietary polyphenols, “carotenoids”, “diet and stool metabolites” “bile 
acids”, “fecal metabolites”, “dietary intake and stool metabolites”. 
Additionally, an extended search was performed on this topic including information on 
metabolite profiling in fecal samples and the analytical methods used. To this end, the search 
terms “metabolite profiling in fecal samples” and “metabolomics techniques for stool 
metabolites” were included in addition to the above-mentioned keywords. Finally, the search 
was limited to human studies written in the English language. 
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2.2 Study population and data collection 
 
The analysis in the second manuscript is based on data from the second Bavarian food 
consumption survey (BVS II), which was conducted between September 2002 and June 2003 
and included a random sample of German-speaking participants of the Bavarian population 
[43]. 
The total participation rate was 71% after following a three-step random routine sampling. 
Participants were selected from 42 communities that were stratified by county and community 
characteristics. The aim of this cross-sectional study was to investigate the dietary and lifestyle 
habits of the included 1050 participants aged 13 to 82 years. 
Participants who completed at least one 24h-DR within six weeks of recruitment and were at 
least 18 years of age (n=879) were invited for standardized anthropometric measurements and 
blood sampling at their closest health office. Sixty-five percent (n=568) of those invited chose 
to participate.  
The second manuscript is based on the results of 294 participants whose plasma sample volume 
was adequate for lab analysis. A flow diagram of the study population used in the second 
manuscript is shown in Figure 3. 
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Figure 3: Flow diagram of the BVS II study population used in the second manuscript 
The Ethics Committeeof the Bavarian Medical Association (Bayerische Landesärztekammer) 
approved the BVS II study. The study was in agreement with the criteria laid down in the 
declaration of Helsinki and written informed consent was obtained from all study participants. 
The analysis in the third manuscript is based on data from the Cooperative Health Research in 
the Region Augsburg (KORA) research platform. It was established in the region of Augsburg 
to perform population-based surveys and subsequent follow-up studies in the fields of 
epidemiology, health economics and health care research. It originated as the World Health 
Organization (WHO) MONICA Project (monitoring trends and determinants in cardiovascular 
disease) and continued as the KORA cohort since 1996.  
BVS II 
participants 
2002-2003 
n = 1050 
Invitation to the study center, if 
- completed at least one 24h-DR
within six weeks after recruitment
- at least 18 years of age
Second manuscript  
Meatbolomics analysis of dipeptides and 
methylhistidines of dietary meat intake 
Collected blood samples 
n = 568  
Subsample for 
 LC-MS/MS analysis 
n = 294   
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The KORA cohort comprised four independent cross-sectional studies (S1-S4). A sum of 6,640 
community-dwelling adults aged 25 - 74 years and living in Augsburg were randomly chosen 
from the local population registries, adopting the same sampling technique used in MONICA 
[44], and were enrolled in the final KORA S4 health survey. In the final KORA S4 health 
survey (1999-2001), 4,216 out of 6,640 individuals participated, a 67% participation rate.  
The KORA FF4 cohort study (2013/2014) is a second follow-up examination, where 2,279 
individuals from the original S4 study participated. One of the main objectives of this study is 
to determine changes in health status and lifestyle habits that occurred over the follow-up 
period [45]. Further details on the participation response is given elsewhere [46].  
 
The third manuscript included 1,008 participants, for whom habitual food intake estimates were 
available and the metabolomics analysis was successfully completed. 
Stool samples were collected in the KORA FF4 study from 2,279 participants. For the 
metabolomics analysis, 864 samples were excluded and the remaining 1,415 stool samples were 
analyzed. Samples were included if participants had not been on antibiotics within the last two 
months prior to sample collection and the lab ID number was obtainable. Additionally, only stool 
samples that were not exposed to room temperature for longer than 3 hours overall and which 
were cooled for less than 48 hours before they were deep-frozen were included. A flow chart of 
the study population used in the second manuscript is shown in Figure 4.  
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Figure 4: Flow chart of the KORA FF4 study population used in the third manuscript. 
(Adapted from Mitry et al., 2019) 
[Mitry P, Wawro N, Sharma S et al. (2019) Associations between usual food intake and fecal sterols and bile 
acids: results from the KORA FF4 study. Br J Nutr, 2019: p. 1-26. Copyright Clearance Center. Reproduced 
with permission.] [34]  
In the third manuscript in the KORA FF4 study, baseline information on sociodemographic 
variables, lifestyle factors, medical history and medication use was collected in an extensive 
standardized face-to-face interview at the Augsburg study center. Additionally, all participants 
underwent standardized examinations such as anthropometric measurements that included 
blood examination, weight and height measurement and the collection of bio-specimens.  
KORA studies were approved by the Ethics Committee of the Bavarian Medical Association 
(Bayerische Landesärztekammer). Written informed consent was obtained from each 
participant in accordance with institutional requirements and the Declaration of Helsinki 
principles. 
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2.3 Biospecimen collection and laboratory analysis 
In the second manuscript, plasma samples of the BVS II study were analyzed to identify meat 
intake biomarkers whereas, in the third manuscript, fecal samples were analyzed to identify 
sterols and bile acids.  
In the second manuscript venous blood was drawn, chilled at 4 °C and stabilized with sodium 
ethylenediamine tetra-acetic acid (EDTA) (1 g/L). Plasma was separated from red blood cells 
by centrifugation before being divided in aliquots and stored at -80 °C until lab analyses.  
For the quantitative amino acids analyses in plasma, targeted LC-MS/MS measurements were 
performed based on the method described by Harder et al. [47]. Plasma samples were diluted 
51-fold in ice-cold methanol and an internal standard mixture of 16 deuterated amino acids was 
included, which was obtained from ChromSystems (Gräfelfing, Germany), Cambridge Isotope 
Laboratories (Tewksbury, MA, USA), and Sigma-Aldrich (Taufkirchen, Germany). After 
centrifugation of the samples and evaporation of supernatants containing the extracts, amino 
acids contained in the dried samples were derivatized to their butyl esters, as outlined by 
Gucciardi et al. [48]. The dried, derivatized samples were reconstituted in a 300 µl 
methanol/water/formic acid mixture. 
  
Mass spectrometric detection was performed using the QTRAP5500 LC-MS/MS system 
functioning in positive ESI mode (AB Sciex, Framingham, MA), supplied with a 1200 series 
binary pump (Agilent, Santa Clara, CA) and attached to an HTC pal autosampler (CTC 
Analytics, Zwingen, Switzerland). The mass spectrometric detection is described in more detail 
in the second manuscript [42]. Peak integration and data analysis were obtained utilizing 
Analyst 1.51 ® software (AB Sciex). 
 
In the KORA FF4 study (third manuscript), participants collected stool samples according to 
the instructions provided with the equipment on the day of the study center visit or the evening 
before. Participants were asked to collect probes of different areas of the fecal sample into two 
sterile plastic collection tubes (one of which already contained a stabilizing agent) that were to 
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be packed into the provided sterile plastic bag. Subjects were instructed to refrigerate the tubes 
(4-8 °C) after placing them in a storage box. Participants were requested to complete a 
questionnaire regarding the time and method of stool collection to confirm that fecal collection 
was obtained based on the SOP guidelines. Upon the participants’ arrival at the study center, 
fecal samples were directly deep-frozen initially at -20 °C and afterward at -80 °C until further 
processing. 
 
136 to 143 mg frozen fecal samples were administered into 2 ml homogenization tubes 
containing ceramic beads with a diameter of 1.4 mm (Precellys Ceramic Kit 1.4 mm, 50x 2,0 
ml tubes, Peqlab). Samples were re-suspended at a 12.5:1 (12.µl H2O for every 1 mg of feces 
weight) ratio and homogenized in a Precellys 24 homogenizer (PEQLAB Biotechnology 
GmbH, Germany) equipped with an integrated cooling unit 3 times for 20 s at 6,500 rpm, with 
15 s intervals between the homogenization steps. For the non-targeted metabolomics analysis, 
100 µl of the homogenate were pipetted onto a 2 ml 96- deep well plate. 
 
A Waters ACQUITY ultra-performance liquid chromatography (UPLC) and a Thermo 
Scientific Q-Exactive high resolution/accurate mass spectrometer interfaced with a heated 
electrospray ionization (HESI-II) source and Orbitrap mass analyzer operated at 35,000 mass 
resolution was applied for all analytical methods. The applied untargeted UPLC-MS/MS 
analysis method is described in detail in the third manuscript in the Supplementary Material 
[34]. 
Metabolon’s hardware and software (Metabolon, Inc., North Carolina, USA) was utilized for 
raw data extraction, peak identification and quality control processing. Compounds were 
identified by relating to library entries of purified standards or recurrent unknown entities. 
Identification of the biochemical metabolites were based on three criteria: retention index (RI) 
within a narrow RI window of the proposed identification, accurate mass match to the library 
+/- 10 ppm, and the MS/MS forward and reverse scores between the experimental data and 
authentic standards. The MS/MS scores are derived from a comparison of the ions present in 
the experimental spectrum to the ions present in the library spectrum. 
 
17 
 
 
The flow diagram in Figure 5 illustrates the number of metabolites which were assessed by 
metabolon and were included for further analysis in the third manuscript.  
  
Figure 5: Flow diagram of the KORA FF4 analyzed metabolites  
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Primary and secondary bile acids and sterol metabolites were chosen from 807 metabolites for 
the analysis in the third manuscript. Thirty metabolites measured in 1413 subjects were 
selected for the preprocessed data set and missing values were imputed based on the minimum 
value per metabolite as we supposed they were below the limit of detection. The sum of all 
primary bile acids, secondary bile acids, plant sterols and animal sterols was calculated from 
the imputed data set and included as two additional variables in the analysis.  
Furthermore, five individual metabolites with more than 25% of missing values (cholate 
sulfate, 7-ketolithocholate, glycocholenate sulfate, taurodeoxycholate and ursodeoxycholate 
sulfate) were omitted from individual analysis. In all, 27 metabolites were available to be 
analyzed in the third manuscript. 
 
2.4 Assessment of Anthropometric measures  
The anthropometric measure BMI was used as a covariable in the analysis of associations 
between dietary intake and fecal sterol/bile acids excretion (third manuscript). In the second 
manuscript, BMI was used as a continuous variable in the descriptive statistics of the 
population and as an adjustment variable in the analysis of associations between meat intake 
and plasma metabolites.  
Weight (kg) in KORA FF4 and BVS II was measured with an electronic scale and standing 
height (cm) with a stadiometer. These measures were obtained during the physical examination 
at the study center by trained investigators; participants wore light clothing without shoes. BMI 
was calculated as weight/height² (kg/m²) and subjects were classified as underweight (BMI < 
18.5 kg/m²), normal (18.5 kg/m² <=BMI < 25 kg/m²), preobese (25 kg/m² <=BMI < 30 kg/m²) 
or obese (BMI >= 30 kg/m²) according to WHO thresholds (2000) (third publication). 
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2.5 Assessment of sociodemographic and lifestyle variables 
Sociodemographic and lifestyle information of participants was used for the characterization of 
participants in BVS II (second manuscript) and KORA FF4 (third manuscript). Further, they 
were utilized as adjustment variables in the second manuscript and as covariables in the analysis 
of associations between diet intake and sterol/bile acids fecal excretion (third manuscript). 
The sociodemographic and lifestyle information was determined in the KORA FF4 study 
through questionnaires and the computer-assisted personal interview, whereas in the BVS II 
study it was assessed through computer-assisted personal interview and computer-assisted 
telephone interview.  
The second and third manuscripts included sex (men, women), age of participants (years), 
smoking status (smoker, ex-smoker and never-smoker), physical activity (active, inactive) and 
education (years) or socioeconomic status (classified based on the educational level, household 
net income and career position of the principal earner) as sociodemographic and lifestyle 
variables. 
 
The third manuscript additionally included alcohol consumption for the adjustment of the 
associations between dietary intake and fecal sterol excretion. Participants were classified into 
no or low alcohol consumption ( < 5 g/d for men and < 2 g/d for women), moderate alcohol 
consumption ( ≥ 5 to < 20 g/d for men and ≥ 2 to < 10 g/d for women) and heavy alcohol 
consumption ( ≥ 20 g/d for men and ≥ 10 g/d for women) based on the usual alcohol intake per 
day following the recommendations given by the German Nutrition Society[49]. The years of 
education reported were classified as up to 12 years of education and more than 12 years of 
education. 
 
The physical activity assessment in KORA FF4 (third manuscript) was categorized into four 
levels according to the amount of regular leisure-time exercise per week during summer and 
winter. The four levels are (i) more than 2 h/week regularly, (ii) about 1 h/week regularly, (iii) 
and about 1h/week irregularly and (iv) almost no or no physical activity. In the second 
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manuscript, participants recalled their physical activity in the last 24 hours via telephone 
interview. 
 
2.6 Assessment of chronic metabolic diseases  
 
In the third manuscript, hypertension status (hypertensive or not) and diabetic status (type 2 
diabetes or no type 2 diabetes) of the participants was assessed via questionnaire, personal 
interview or in the physical examination at the study center. These were used in the descriptive 
analysis of KORA FF4 participants. 
The systolic and diastolic blood pressure were measured with an oscillometric digital blood 
pressure monitor three times at intervals of at least 3 minutes at the right arm of the sitting 
subject. Participants with a mean blood pressure ≥ 140 mmHg or diastolic ≥ 90 mmHg and/or 
use of antihypertensive medication (given that they were aware of having hypertension) were 
specified as hypertensive. 
Diabetes was measured by a standard 75 g oral glucose tolerance test (OGTT) performed in the 
morning (7:00-11:00 a.m) in all subjects who were not previously diagnosed with diabetes and 
who were fasting overnight for at least eight hours. Diabetes was then specified as a fasting 
plasma glucose level ≥ 126 mg/dl or a plasma glucose level 2h after intake of 75 g of ≥ 200 
mg/dl. For participants with a self-reported diabetes history, the diagnosis was verified by 
intake of antidiabetic medication and/or by consulting the respective treating physician. 
Furthermore, the use of lipid-lowering drugs and anti-diabetic drugs was comprised. These 
were identified by ATC codes C10 and A10. The intake of medications was documented in the 
study center through a database-supported computer software called IDOM [50]. These 
medications were used as adjustment variables in the main analysis of the third manuscript. 
2.7 Assessment of dietary intake 
In the second manuscript, dietary intake data, which were assessed in BVS II participants, were 
investigated for their association with plasma biomarkers of meat intake in 294 individuals, 
stratified by age, sex and BMI. 
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The dietary intake of BVS II participants was estimated by three 24-hour dietary recalls (24h-
DR), where two of the 24h-DRs were to be completed on a working day (Monday-Friday) and 
the third on a weekend day (Saturday or Sunday). Trained study personnel conducted these 
telephone interviews and participants had to recall their dietary intake from the previous day. 
The 24h-DR results were grouped to 16 food groups and 21 subgroups according to the EPIC-
Soft classification scheme [51]. Dietary intake data were weighted correspondingly to weekday 
or weekend day to calculate a mean value for every food group or subgroup to present a usual 
daily intake in g/day. A mean value for every food group or subgroup was obtained from three 
24h-DRs. This represents the usual intake of the particular item in g/day. The food groups and 
subgroups included in this analysis are listed in Table 1.  
 
Table 1: Food groups and subgroups selected for the analysis of diet-plasma 
dipeptides/methylhistidines concentration associations (g/d)  
Main groups (g/d) Subgroups (g/d) 
All meat and meat 
products 
Red meat Beef  Pork Beef and Pork 
Poultry Chicken Turkey Processed meat 
Fish and Shellfish  
Egg and egg products 
Milk and dairy products 
 
In the third manuscript, 1008 participants of KORA FF4 were included who completed one 
FFQ and up to three web-based 24 hours food lists (24 HFL) by the end of November 2014, 
and for whom the metabolomics analysis was successfully completed. The 24HFL is a closed 
and structured list of 246 food items that assesses the participants’ food and drink consumption 
over the previous day [2], whereas the FFQ encompasses 148 items and reports the usual 
frequency of consumption and the usual portion size of the consumed food and drink items 
during the past 12 months. The FFQ is a validated assessment tool [52] based on the German 
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version of the multilingual European Food Propensity Questionnaire (EFPQ) [53], and it 
includes pictograms to help participants in estimating the portion sizes. 
Regarding the 24HFL, it does ask which meals were consumed, but it neither assesses which 
foods were consumed at each meal nor portion sizes. KORA FF4 participants were contacted 
on two randomly selected days within three months after their first study center visit to 
complete the 24HFL based on their diet on the previous day. Two 24HFLs were to be 
completed on a working day and the third one on a weekend day.  
To minimize the occurrence of errors in the dietary assessment [54,55], a blended approach 
that combines two assessment instruments was used to estimate usual dietary intake in the third 
manuscript. The blended approach is based on the National Cancer Institute (NCI) [56,57] and 
the Multiple Source Method (MSM) [58].  
It is a two-step model approach that separates consumption probability from consumption 
amount on a consumption day. Details are described elsewhere [6]. Briefly, the consumption 
probability was estimated first for each food item for each participant with a logistic mixed 
model including age, sex, BMI, smoking, physical activity, education level, and FFQ data as 
covariables. In the second step, the consumption amount on consumption days was estimated 
based on models having the same covariables to link both steps. Since the 24 HFLs do not 
assess portion sizes, these were calculated based on the data of the 24h-DR of the Bavarian 
Food Consumption Survey II (BVS II) (same study of the second manuscript). Using linear 
mixed models, the usual consumption amount of each food item on a consumption day was 
estimated with the BVS II data. These models were adjusted for age, sex, BMI, smoking, 
physical activity, and education level. Since consumption amounts were not normally 
distributed, they were transformed by Box-Cox transformations and predicted amounts were 
then back-transformed. At last, the usual intake was then derived by multiplying the estimated 
consumption probability of a certain food item by the estimated amount consumed on a 
consumption day. 
In the third manuscript, the usual dietary intake analysis focuses on 19 main food groups or 
subgroups, which are listed in Table 2.  
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Table 2: Food groups and subgroups for the analyses of diet-fecal sterol/bile acids 
excretion associations (g/d) 
- Potatoes  - Yogurt -Processed meat - Vegetable oil 
- Vegetables - Cheese (including cream cheese) -Fish and shellfish - Soy products 
- Fruits - Cereal and cereal products 
- Eggs and egg 
products - Non-alcoholic drinks 
- Nuts, seeds and nut 
spreads 
- Meat and meat 
products - Sugar - Alcoholic drinks 
- Milk and dairy 
products - Pork - Butter  
 
Total caloric intake [kcal/d] was used in the second and third manuscript as a covariable and 
was derived from the usual intake of the participants, taking into account all available food 
groups and subgroups. 
 
2.8 Statistical analysis 
 
All statistical analyses in the second manuscript were carried out using the SAS software, 
version 9.3 of the SAS system for Windows (Copyright © 2002-2010 SAS Institute Inc.), 
whereas in the third manuscript the statistical software R, version 3.3.2 (R Development Core 
Team, 2010, http://www.r-project.org) was used. P-values < 0.05 were considered statistically 
significant. 
 
Descriptive statistics 
In the second and third manuscript, the BVS II and KORA FF4 participants were stratified by 
sex and characterized depending on the respective study aim by socio-demographic and 
lifestyle variables, anthropometric and dietary intake characteristics, and clinical status. 
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Due to deviations from the normal distribution, descriptive statistics are presented in both 
manuscripts as median and interquartile ranges (for continuous data) or absolute numbers (n) 
and relative frequency (%) (for categorical variables) as appropriate. 
In the third manuscript, descriptive characteristics were stratified by sex and t-tests and the 
Chi2-test was used for sex-specific differences between characteristics of the population. The 
Kruskal-Wallis test was used to identify sex-specific differences in usual dietary intake, as 
intake distributions are typically not normal. 
Since the plasma concentrations of the metabolites in the second manuscript were non-
normally distributed, the differences of the metabolites across categories of BMI, sex, age, 
smoking, social class and physical activity were described by presenting the geometric means 
and 95% CI (confidence interval). Geometric means were obtained by fitting models with 
PROC GENMOD utilizing log-transformed plasma concentrations and transforming the 
estimates obtained from the model. BMI was categorized into quartiles and age into three 
groups (< 40 years, 40-60 years, ≥ 60 years). All bivariate models were adjusted for age, sex 
and BMI. The p-trend was obtained based on integer scores assigned to the categories of age, 
sex, BMI, smoking, social class, and physical activity. 
In the third manuscript, the percentage of missing values, median, 25%- and 75%-quantiles of 
all metabolites and metabolite groups was reported. The median and 25%- and 75%-quantiles 
or absolute numbers and percent of categories for the mentioned variables were provided for 
all 1,008 participants for which the fecal metabolite data and the habitual dietary intake data 
were available. Further analyses were completed with log-transformed metabolite data. 
T-tests or Kruskal-Wallis tests were used for the categorical variables and correlations were 
examined for continuous variables. In bivariate analyses, associations or differences in 
metabolite levels with the covariates were tested and related variables were chosen to be 
included as adjustment variables in additional regression analysis. 
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Analysis of dietary intake- biomarkers associations 
Different usual dietary intake variables (listed under section 2.7) were analyzed with respect to 
their association with biomarkers of meat intake in plasma in BVS II (second manuscript) or of 
animal- and plant sterols, and bile acids in feces in KORA FF4 (third manuscript). 
In the second and third manuscript, for each dietary intake variable, regression models with 
different sets of covariables were fitted. 
 
Geometric means for categories of food intake were obtained in the second manuscript by 
fitting linear models utilizing log-transformed plasma concentrations. The classification of the 
food items was done according to the intake data. Some food items were grouped into quartiles 
(“all meat and meat products”, “processed meat”, and “milk and dairy products”), but most 
other food groups could only be divided into no, low and high consumers (e.g. “red meat”, 
“pork”, “beef and pork”, and “eggs and egg products”) by their median value. For a small 
group of food items, only a distinction into consumers and non-consumers was possible 
(“beef”, “chicken” and “turkey”). Age, sex and BMI were included as adjustment variables. 
The p-trend was obtained based on integer scores assigned to the categories of food intake. 
Further non-parametric comparison of the consumption of “all meat and meat products”, “milk 
and dairy products”, “fish and shellfish”, and “eggs and egg products” across groups defined 
by the quartiles of biomarkers was carried out. Dunn’s post-hoc test was performed if the 
Kruskal-Wallis test showed significant differences (p < 0.05). 
For the third manuscript, the usual intake variables were obtainable only for 1,008 subjects for 
which the stool samples were analyzed. In the regression models described below, adjustment 
variables age, sex, BMI, smoking status, alcohol consumption, physical activity, years of 
education, medication, total caloric intake and usual intake of selected groups and subgroups 
were included. Smoking status, alcohol consumption, physical activity and education level of 
the participants were assessed and included as categorical variables. Further details are 
described elsewhere [42]. Further, BMI (kg/m2) and age of participants (years) were analyzed 
as continuous variables; as described in detail in (manuscript 3) [34]. 
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Differences in metabolite levels were investigated with respect to medication intake in order to 
select related variables to be included as adjustment variables in further regression analysis (p-
values < 0.05). Differences were tested for continuous variables and for categorical variables; 
t-tests or Kruskal-Wallis tests were completed.  
Regression models were fitted for all 27 metabolites and adjusted for age, sex, BMI, total 
caloric intake, smoking status, alcohol consumption, physical activity, years of education, 
diabetes medication, and lipid-lowering medication. The effect of the usual intake of a certain 
food group on metabolite levels was examined and the effect estimates and p-values were 
reported. Bonferroni adjustment of the p-values was done to correct for multiple testing by 
dividing 0.05 by the number of tests conducted (27*19=513, leading to 9.746589e-05). 
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3. Short description of publications  
 
3.1 Publication 1: Biomarkers for nutrient intake with focus on 
alternative sampling techniques 
Identifying new dietary biomarkers using alternative sampling techniques may help in 
understanding the relationship between food intake and nutritional status, leading to an 
improvement in the quality of nutritional status. Since most dietary intake data collected in 
large epidemiological studies rely on participants memorizing or monitoring food intake, these 
data are prone to over- and underreporting of certain foods. Utilizing new technology such as 
the dried blood spots (DBS) sampling technique is now cheaper and able to accurately measure 
several metabolites in very small biological samples. The DBS sampling technique is also 
easier to implement and more stable than classical blood sampling. The sample’s storage, 
transport and analysis is also cheaper and more practical. 
Diet has an essential role in maintaining the composition, metabolism, and function of the gut 
microbiota. Identifying dietary biomarkers in feces may help to understand how the 
composition of the gut microbiota is related to dietary intake. Metabolite profiling in feces 
allows for the discovery of new biomarkers of gut health and dietary intake. However, 
metabolite profiling in fecal samples is very difficult due to its physicochemical properties that 
have an impact on the level of reproducibility and full coverage of metabolite profiling that can 
be achieved. Additionally, different fecal sample collection methods and storage conditions 
may influence metabolite concentrations. Therefore, it is essential to utilize more than one 
analytical method to attain a comprehensive metabolite profile, since fecal metabolite levels 
can vary widely based on these factors. 
 
The doctoral candidate performed the literature research, drafting, writing and revising of the 
chapter “Feces— a potential matrix for dietary biomarkers”. 
 
[Holen T, Norheim F, Gundersen T E, Mitry P, Linseisen J, Iversen P O, Drevon C A. 
Biomarkers for nutrient intake with focus on alternative sampling techniques. Genes & 
Nutrition (2016) 11:12 DOI 10.1186/s12263-016-0527-1).] [16] 
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3.2 Publication 2: Plasma concentrations of anserine, carnosine and pi-
methylhistidine as biomarkers of habitual meat consumption  
 
Finding biomarkers of meat intake in plasma could deliver more valid intake estimates in 
observational epidemiological studies than dietary questionnaires, as the latter are prone to 
reporting bias. Since habitual dietary intake of meat has been shown to be correlated with 
human health and risk of chronic diseases, it was the aim of the study to investigate the 
relationship of habitual red and processed meat, poultry and fish consumption with plasma 
concentrations of anserine, carnosine, pi-methylhistidine (Π-MH), tau-methylhistidine (T-MH) 
and the ratio of T-MH to Π-MH in a cross-sectional study.  
The plasma metabolite concentrations were measured by applying the ion-pair LC-MS/MS 
technique. Three 24-h dietary recalls were administered per participant to assess habitual food 
consumption. For assessing the correlation between plasma metabolite concentrations and 
meat, fish, eggs and dairy product consumption, geometric means for food categories were 
obtained by fitting generalized linear models, adjusted for age, sex, and BMI. 
In the present study, we observed a correlation between habitual meat intake and plasma 
concentrations of anserine, carnosine, Π-MH and the ratio of T-MH to Π-MH. Red meat intake 
was associated with carnosine, whereas poultry and chicken consumption were related to Π-
MH. 
However, intervention studies are required to determine if the analyzed plasma metabolites are 
distinctive for a specific type of meat or not. 
 
The doctoral candidate conceived and conducted the literature research, drafting, writing and 
revising of the manuscript, correspondence to the journal and final approval of the publication.  
 
[Mitry P, Wawro N, Rohrmann S, Giesbertz P, Daniel H, Linseisen J: Plasma 
concentrations of anserine, carnosine and pi-methylhistidine as biomarkers of habitual 
meat consumption. European journal of clinical nutrition 2018.] [42] 
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3.3 Publication 3: Associations between usual food intake and fecal sterols 
and bile acids: results from the KORA FF4 study 
 
Sterols and bile acids in fecal samples have been proposed as biomarkers of dietary intake, but 
it is still unknown if these markers can be used to characterize long-term habitual dietary 
intake. The aim of this study was to examine whether habitual dietary intake is associated with 
fecal concentrations of animal sterols, plant sterols and bile acids in participants of an 
observational study. 
Only stool samples that met the quality criteria and were collected according to the standard 
protocol were analyzed. The fecal metabolite concentrations were measured by applying a non-
targeted UPLC-MS/MS technique. Repeated 24-h food lists and a food frequency 
questionnaire were administered for assessing the habitual food consumption per participant. 
Relationships between food intake and log-normalized metabolite concentrations were assessed 
in multivariable adjusted regression models. To adjust for multiple testing, the Bonferroni 
correction was utilized. A diet high in “fruits” and “nuts and seeds” was associated with a 
decreased total fecal cholesterol concentration, whereas a habitual diet high in “meat and meat 
products” was associated with an increase in animal fecal sterols concentrations. The 
associations between usual dietary intake and fecal concentrations of bile acids were limited; 
however, a positive association between glycocholate and fruit consumption was observed. 
Nevertheless, additional studies are needed to assess fecal animal sterols as biomarkers of diet, 
and most importantly, the results should be confirmed in other population-based studies with 
different dietary habits.  
 
The doctoral candidate performed the literature research, drafting, writing and revising of the 
manuscript, correspondence to the journal and final approval of the publication. 
 
[Mitry P, Wawro N, Sharma S, Kriebel J, Artati A, Heier M, Meisinger C, Thorand B, 
Rathmann W, Grallert H, Peters A, Linseisen J: Associations between usual food intake and 
fecal sterols and bile acids: results from the KORA FF4 study. British Journal of 
Nutrition.2019] [34] 
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4. Discussion 
 
Main findings 
The first manuscript gives an overview of different sampling techniques to identify 
biomarkers of nutrient intake. Obtaining accurate measures of exposure to different nutrients or 
food items on the individual level would help in understanding the relationship between diet, 
disease and health [59]. The high sensitivity and specificity of new technologies have 
facilitated the sampling and identification of dietary biomarkers in very small amounts of 
biosamples. Within the first manuscript, the use of fecal samples in identifying dietary 
biomarkers that could help in understanding to what extent diet can modify the gut microbial 
composition and affect human health and disease was outlined [60]. Identifying food 
metabolites that have been structurally modified by gut microbial activity in fecal samples may 
further reveal an individual’s dietary intake. The review included examples of metabolites 
identified in fecal samples that can be possibly utilized as dietary biomarkers, such as short-
chain fatty acids as metabolites of carbohydrate intake, metabolites of protein fermentation, 
and metabolites of fatty acids and sterols. Further, it briefly described the different 
methodological aspects of metabolite profiling in fecal samples using different analytical tools. 
Consequently, the aim of the second manuscript was to examine associations between usual 
dietary intake of meat intake and plasma concentrations of anserine, carnosine, Π-MH and T-
MH biomarkers in a cross-sectional study [42]. In brief, with higher total meat consumption, 
plasma anserine, carnosine, and Π-MH concentrations significantly increased. Plasma 
concentrations of carnosine and Π-MH also increased with higher red meat intake. 
Additonally, the intake of beef and pork were significantly related to anserine and carnosine 
plasma concentrations, whereas the plasma anserine concentrations significantly increased with 
higher processed meat and turkey intake. For Π-MH, a significant association with poultry and 
chicken consumption was observed. Yet no association between T-MH and any type of meat 
intake was observed. All analyses were adjusted for age, sex and BMI, as these factors were 
associated with the biomarkers of meat [42]. This is the first study that examined associations 
between habitual meat consumption and plasma concentrations of anserine, carnosine, T-MH 
or Π-MH in a cross-sectional format. 
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Associations between usual dietary intake and fecal metabolite concentrations of animal and 
plant sterols and bile acids were analyzed in the third manuscript. Before the Bonferroni 
correction was applied, a significant inverse correlation between the food groups “fruits”, 
“nuts, seeds and nuts spread”, “milk and dairy products”, “cheese” and “yogurt” and the fecal 
concentration of animal and plant sterols was determined. For the food groups “potatoes”, 
“meat and meat products”, “pork”, “processed meat”, “eggs and egg products” and “butter”, a 
positive correlation with animal sterol and plant sterol fecal concentrations was found. A 
statistically significant inverse association between “fruit” intake and fecal concentrations of 
campesterol, cholesterol, and sum of animal sterols was found after applying the Bonferroni 
correction. Further, a decline in fecal concentrations of these metabolites has been observed by 
a higher dietary intake of “nuts and seeds”. Additionally, a significant positive association 
between “meat and meat product” consumption and fecal cholesterol concentration was 
observed. After correction for multiple testing, only one significant association (a positive 
association between high fruit intake and glycocholate) could be observed with respect to bile 
acids. 
 
Biomarkers of meat intake 
Assessing plasma concentrations of objective meat biomarkers in observational studies would 
be useful in enhancing the characterization of nutritional status in participants and would 
provide a much deeper understanding of the effect of food constituents and diet on human 
health and disease. A meta-analysis of cohort studies observed an 18% and 22% higher risk of 
any disease compared to cardiovascular disease (CVD) mortality, respectively, based on intake 
of processed meat, whereas red meat consumption was associated with a 16% higher risk of 
CVD mortality. However, no association between white meat intake and CVD mortality was 
observed [61].  
As mentioned previously carnosine, anserine, pi-methylhistidine (Π-MH), tau-methylhistidine 
(T-MH), urea, creatine, creatinine, carnitine, ophidine and sulfate have already been identified 
as biomarkers of meat intake [12,24,62]. Trimethylamine-N-oxide (TMAO) has also been 
proposed as a biomarker of meat intake as trimethylamine, the precursor of TMAO is produced 
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by gut microbiota from carnitine, phosphatidylcholine (lecithin), choline, and betaine [63-65]. 
Carnitine and phosphatidylcholine are found in high concentrations in red meat, liver, fish, 
milk, cheese, and eggs [66]. One study assessed the associations between consumption of red 
meat, eggs, or dairy products and the concentrations of the circulating TMAO [66]. However, 
no significant associations between the plasma concentrations of TMAO and the intake of red, 
processed, or white meat; fish; or eggs have been observed. It should also be mentioned that 
identifying high concentrations of animal sterols in the stool could be another biomarker for 
high meat intake [34]. 
Histidine dipeptides are mainly found at very high concentrations in skeletal muscles, the heart 
and the central nervous system. Therefore, in humans, carnosine and its derivatives such as 
anserine are mainly derived from a diet comprised of animal protein such as meat, poultry 
and/or fish [67]. Yeum et al. indicated that 150 g of beef contains 343.4 mg carnosine and 42.9 
mg anserine, whereas 150 g of chicken contains 322 mg carnosine and 660 mg anserine [68]. 
Another study has reported that carnosine concentrations in pigs, beef, and turkey muscle is 
higher than in anserine, whereas anserine concentrations in rabbit, salmon, and chicken muscle 
are much higher than carnosine [69]. 
As mentioned above, carnosine is synthesized by carnosine synthase from β-alanine and 
histidine and degraded by carnosinase, also named dipeptidase [70]. There are two isoforms of 
carnosinase, one named serum carnosinase, which is a highly specific dependent homodynamic 
dipeptidase and the other a tissue carnosinase that acts as non-specific dipeptidase [70]. Tissue 
carnosinase hydrolyzes carnosine and anserine rapidly and their metabolites are eliminated in 
urine [71]. This could be a possible reason for finding very low plasma levels of these 
metabolites in the second manuscript [42].  
Unlike Park et al. [72], Mitry et al. [42] could not find any association between beef intake and 
carnosine plasma concentrations. This could be due to several reasons described thoroughly in 
Mitry et al.[42]. However, a study conducted by Yeum et al. is in good accordance with the 
findings of the second manuscript, stating that carnosine plasma levels were not significantly 
associated with beef or chicken consumption. Further, it indicated an increase in Π-MH plasma 
level after poultry and all meat consumption, as reported in other studies [73] [74]. 
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In one intervention study, meat protein intake was predicted by assessing carnosine, T-MH and 
Π-MH levels in urine. The authors reported that T-MH and Π-MH plasma levels were too low 
to be measured in plasma due to their rapid excretion in urine [75]. However, in the second 
manuscript we identified sufficient plasma levels of T-MH and Π-MH. Thus, no association 
between meat intake and T-MH was found, despite the results of the Cheung et al. study [73], 
that unlike Π-MH, T-MH does not reflect only meat intake, but also human muscle catabolism 
and muscle mass. Therefore, after consuming the same diet, a substantial difference in 
circulating T-MH concentrations was found among subjects [76]. 
Previously, some studies assessed the concentrations of T-MH and Π-MH eliminated in urine 
in intervention studies [62,71] or in a population-based study [77] to examine if they can serve 
as biomarkers of meat consumption. Other studies assessed meat intake biomarkers such as 
histidine dipeptides or TMAO in plasma or serum samples [66,72], whereas other studies 
attempted to identify carnosine, anserine, T-MH and /or Π-MH as meat biomarkers in plasma 
and urine samples as well [68,73,75]. Only two studies [68,73] had comparable analysis 
methods to the method utilized in the second manuscript; however, the biomarkers of meat 
intake in the second manuscript were assessed in a cross-sectional study and in plasma samples 
only. 
Fecal animal or plant or sterols or bile acids as biomarkers for dietary intake 
A high intake of cholesterol from animal origin, such as from meat and meat products, leads to 
high concentrations of animal sterols in feces [78,79]. Therefore, the sum of animal sterols in 
stool can be a promising biomarker of the intake of meat and meat products. Unlike 
cholesterol, the concentration of fecal bile acids did not increase with high meat intake, which 
is in line with Hentges et al’s study [80]. However, Reddy et al. observed an increase in 
secondary bile acids following high meat consumption [78]. A higher plant sterol intake may 
physiologically affect cholesterol absorption and excretion [81,82], and this may explain the 
inverse association of “fruits and nuts and seeds” intake with animal sterols fecal excretion 
found in the third manuscript. Plant sterols are known for their plasma cholesterol-lowering 
properties [26,83-87], as they reduce cholesterol absorption through competition with 
cholesterol for incorporation into micelles [26]. Several intervention studies observed an 
34 
 
 
increase in fecal excretion of cholesterol due to the intake of a phytosterol-enriched diet 
[81,82,88]. However, in the long term, it is still unknown if a diet high in plant sterols is 
associated with lower fecal animal sterols. Since the third manuscript is the first study that 
analyzed fecal concentrations of sterols in a population study and related it to habitual dietary 
intake, the observations are not comparable with results from intervention studies and other 
studies dealing with the effects of phytosterol consumption. This could be because an average 
of 4.7 g/d of nuts and seeds were consumed in the KORA FF4 study, which is probably too 
small of a quantity to observe a phytosterol-based effect on cholesterol excretion. Further, high 
dietary fiber intake may cause an increased fecal bulk, and this may lead to a lower fecal 
concentration of sterols and bile acids per g of dry weight [89]. 
 
Identifying biomarkers in serum versus urine 
Different types of biosamples can be collected in order to assess the nutritional status of a 
subject or population.  
It is proposed that the collection of multiple 24-hour urine samples can reflect the total protein 
intake of individuals [7,90], although it is impractical in epidemiologic studies [8]. Dietary 
histidine-dipeptides are mainly eliminated in urine [24]. One study reported 82% of the 
anserine consumed is directly and quantitatively eliminated as Π-MH in urine [71]. In plasma, 
anserine and carnosine are quickly hydrolyzed by the enzyme carnosinase and eliminated in 
urine [68], yet several limitations exist. Comparing a 28-day feeding study with multiple 24-
hour urine nitrogen outputs, a correlation of 0.99 was found, whereas a correlation of 0.5 was 
observed when the time period was reduced to a single observation. However, an 18-day 
feeding study produced a correlation of 0.95 [90]. Therefore, it is more convenient to collect 
24-hour urine samples in intervention studies, as individuals should maintain a controlled 
constant daily diet, whereas this is not possible in epidemiological studies. Short-term 
biomarkers such as Π-MH and T-MH have been suggested for use with 24-hour recalls, as they 
have an elimination half-life of 11.7 and 12.6 hours [62]. Accordingly, a study observed 
urinary biomarkers of meat intake in 24-hour urine samples and indicated that their study 
design is not suitable for identifying biomarkers of long-term consumption [76]. It is important 
to point out that short-term biomarkers are only useful in populations that frequently and not 
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episodically consume these dietary sources [10]. This may explain why no associations were 
identified between meat intake and T-MH concentration in the second manuscript, as T-MH is 
rapidly eliminated and the food groups meat, beef and pork were sporadically consumed in 
BVS II study.  
Blood samples are assumed to be the specimen of choice in epidemiologic studies, as they are 
accessible and easily stored and handled. Having plasma and serum samples in biobanks 
facilitate conduction more metabolomics studies [10]. Yet several methods have now been 
developed to utilize urine spot samples in identifying metabolites of interest in large-scale 
population studies [8]. 
Playdon et al. [91] compared metabolite profiling of habitual diet in urine and serum and 
observed that biomarkers of habitual dietary intake were identifiable in serum as well as in 
urine. Consequently, it was concluded that the same habitual dietary intake biomarkers can be 
identified in different types of biosamples in epidemiological studies. Although urine sample 
collection is less invasive and less expensive to obtain, only water-soluble nutrients pass 
through urine [8], and samples may need acidification and cold storage promptly after sample 
collection to avoid the degradation of nutrients. Therefore, metabolite concentrations might 
vary greatly due to ionic strength, osmolarity, pH and dilution, which may cause urine analysis 
to result in lower quality data on habitual dietary biomarkers status [92]. It is also important to 
mention that few other studies compared urine and blood for either the identification of similar 
biomarkers using metabolomics techniques or to prove their stability and reliability as potential 
biomarkers of meat intake [68,73-75]. One study observed carnosine and anserine stability in 
human serum [68], where carnosine rapidly disappeared within 5 minutes with a hydrolysis 
rate of 170 nmoles ml-1 min-1and a 3 minute half-life. Although anserine disappeared rapidly, a 
quantifiable amount could be identified since it disappeared with a slower hydrolysis rate than 
carnosine (16nmoles ml-1 min-1, half-life 30 minutes). The same study did not observe any 
carnosine in plasma after consumption of beef, chicken, or chicken broth ingestion. Anserine 
was detectable (between the limit of detection (LOD) and limit of quantitation (LOQ)) after 
beef consumption. However, after chicken and chicken broth consumption, anserine plasma 
concentrations were higher than the LOQ. This is in line with the findings presented in the 
second manuscript. 
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Parameter selection of fecal samples for identification of biomarkers  
Feces is composed of undigested food, gut bacteria and other metabolites of the host’s cellular 
components. This makes it an optimal biospecimen for non-invasive assessment of the whole 
bowel environment [93]. Studies that obtain fecal samples are important in assessing 
nutritional issues, e.g., several studies collected fecal samples to assess sterols, bile acids and 
fiber to identify a correlation between their intake and relevant diseases such as colon cancer 
[8,94,95].  
However, metabolite profiling in feces is considered to be more complex than in any other 
biosample, since the physicochemical properties of the feces affect the reproducibility and full 
coverage of the obtained metabolite profile [96]. Nevertheless, lyophilization of fecal samples, 
extracted by water-methanol mixtures, facilitate the analysis of reproducible metabolite 
profiles that comprise a variety of compounds. Another limitation of fecal samples is that there 
are several different techniques of fecal sample collection and storage conditions that may alter 
the metabolite concentrations, such as instant freezing, freezing after cooling on ice or in 
refrigerator, or freezing after keeping it at room temperature [97]. For instance, in water 
extracts, the concentration of glucose and amino acids are higher in frozen samples than in 
fresh fecal samples [98].Alternatively, other studies immediately combine the collected fecal 
samples with a stabilizing agent such as RNAlater or Amis Transport Medium [99]. Loftfield 
et al., found that metabolomic measurements are stable and reproducible when fecal samples 
are collected with 95% ethanol or a fecal occult blood test (FOBT) [100]. However, standard 
fecal collection protocols are still required for the identification of dietary biomarkers in feces 
that can be obtained by optimizing and harmonizing sample collection, storage and processing 
procedures. Additionally, epidemiological studies also have to consider the day-to-day-
variation in fecal samples. Therefore, a study suggested that fecal samples should be collected 
from each subject on 3-5 different days in order to cover not only differences in food 
consumption, but also alterations in stool transit time, gut microbiota activity, etc. [101]. The 
analytical tools used for fecal metabolite profiling, such as NMR, GC-MS, LC-MS, and LC-
MS-MS should be chosen according to their coverage, dynamic range, selectivity, accuracy, 
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precision, and price per sample [102]. As fecal metabolites are highly diverse, more than one 
analytical method is needed to obtain a comprehensive metabolite profile [103].  
Role of gut microbiota and metabolism on stool-derived dietary biomarkers  
Epidemiology studies are interested in microbiome analysis in order to understand the 
interactions and relationships between dietary intake, host metabolism and gut microbiota 
[104]. 
The gut microbiota, one of the most densely populated microbial ecosystems in nature, is an 
extremely active metabolic “organ” that produces metabolites that influence physiological 
processes in the intestine and elsewhere. Furthermore, metabolites of the gut microbiota 
interact with the host’s metabolic phenotype and may have an impact on human health and 
disease [104]. Therefore, several studies have examined the bile acid-gut microbiome axis to 
understand its role in colon cancer risk [105-107]. Other studies were interested in 
understanding the concept of how the intake of prebiotic alters the composition, metabolism, 
and function of the gut microbiota in order to enhance the gut and host health [108]. Still, it 
should be considered that not only dietary intake affects the gut microbiota composition and its 
metabolic activity, but also the physicochemical properties of foods, nutrient availability, 
colonic transit time, and age of the host [60,109]. 
Dietary intake can be identified by the metabolites produced by bacterial energy metabolism 
[34]. Metabolites such as minor food constituents that have been structurally altered by 
microbial activity might be identified in fecal samples, and can indicate the consumption of 
specific foods such as animal sterols and plant sterols. Sterols, bile acids and their metabolites 
are mainly excreted in feces, and their content and proportions are highly affected by the gut 
microbial composition and several other factors [110]. Recently, Ridlon et al. reviewed that the 
host and gut microbiome modulate bile acids. After the host produces a large pool of 
conjugated hydrophilic bile acids, the microbiota convert bile acids and their conjugates into a 
smaller pool of unconjugated hydrophobic acids [105]. In contrast, bile acids seem to be a 
major regulator of the gut microbiota as well. This was observed in a study searching for the 
relationship between the liver health, gut microbiota composition and fecal bile acid 
concentrations [111]. Diet also appears to modulate both the gut microbiome and bile acid 
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levels. A high fat diet may not only increase bile acids concentrations, but also modulate gut 
microbiota activity, resulting in the production of tumor-promoting substances from bile acids 
[89,112]. On the contrary, a high fiber diet dilutes the carcinogens and promoters by increasing 
the bulk of stool [113]. Additionally, it alters the metabolism of carcinogenic compounds. 
 
Role of identification and application of dietary biomarkers in large epidemiological 
studies  
Several calibration and validation methods that apply different references of dietary and 
biological measurements have been generated to overcome the problem of measurement errors 
in dietary assessment methods [114-116]. Additionally, an increasing number of metabolomics 
studies have been conducted over the past few years in the nutrition field [117,118]. 
Metabolomic techniques help in screening differences in metabolic profiles of specific 
nutrients or food consumption in intervention studies [10]. However, the food metabolome is 
complicated and highly variable, as humans consume different foods, comprising more than 
25,000 compounds - most of which are then metabolized in the human body [119]. To achieve 
an accurate measurement of dietary exposure in epidemiologic studies, an accurate assessment 
method with minimized random and systematic errors is required. The conventional dietary 
assessment methods like dietary recalls or food frequency questionnaires used in population 
studies suffer from systematic and random errors as well as from recall bias and difficulty in 
measuring portion sizes [120]. Consequently, the misclassification of participants according to 
their dietary intake in epidemiological studies can affect the observed associations between 
dietary intake and disease outcomes, and may cause essential discrepancies in published 
findings in the field of nutritional epidemiology [121]. Therefore, the application of dietary 
biomarkers in nutritional epidemiology as an objective assessment of dietary intake is essential 
[14]. Few biomarkers of dietary intake have been utilized as surrogate biomarkers in 
population studies. For example, urinary polyphenols, plasma carotenoids and plasma vitamin 
C are proposed as biomarkers for fruit and vegetable intake [122,123]; fatty acids (e.g. plasma 
phythanic acid) and urinary and plasma amino acids are proposed for meat [77,124]; plasma 
alkylresorcinols for whole grain cereals [125]; and intake of fatty acids as plasma 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for fish and plasma phythanic 
acid for dairy products [124,126]. 
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Reliability of dietary biomarkers and its limitations 
As discussed before, dietary biomarkers also have their limitations. They not only provide 
objective data on nutrient intake or status, but they also act as markers of other biological 
processes in the human body. Biomarkers are prone to variation due to potential interactions 
with genetic factors, health status, or factors such as age, sex or BMI [127]. Other factors such 
as diet and lifestyle (i.e. smoking and alcohol) [128] may alter the biomarkers as well. 
Therefore, these covariables have to be taken into consideration during the analyses by 
adjustment. 
For short-term dietary biomarkers with a half-life of less than 24 hours, a higher intraindividual 
variability is presumed [129]. Habitual dietary intake measurement errors are likely to occur 
due to intraindividual variability when the habitual dietary intake in observational studies is to 
be assessed and small numbers of measurements across subjects are obtainable [10].  
Therefore, these short-term biomarkers such as polyphenols, alkylresorcinols and amino acids 
[130,131] can be beneficial only in populations who consistently and frequently consume these 
dietary sources. However, long-term biomarkers such as carotenoids [132] and fatty acids 
[133] have a longer half-life ranging from weeks to months, which makes them appropriate for 
cohort studies.  
Intervention studies are needed to measure the sensitivity and the concentration of dietary 
biomarkers upon consuming a specific diet. This information is needed before biomarkers can 
be utilized in population studies. Dietary biomarkers should have sufficient sensitivity and 
specificity to assess dietary intake. A very low or high concentration of dietary biomarkers is 
unreliable to assess a dietary intake of a specific food [10]. Further, some biomarkers can be 
highly specific to a certain food e.g., proline betaine for citrus fruits [134] and lycopene for 
tomatoes [135], or commonly found in several foods. Examples include vitamin C and 
carotenoids, which are found in several vegetables and fruits [135], or anserine or carnosine, 
which are characteristic of an entire food group (meat) [42]. 
Most biomarkers are still inadequate to meet the gold standard that reflects true intake. In these 
cases, concentrations of the biomarkers identified in biological samples vary between subjects 
despite identical dietary intake. Further, individual variations are present not only in 
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absorption, but also in rates of metabolism and excretion. Yet errors in biomarkers are 
independent of errors in other dietary assessment methods e.g., dietary questionnaires [136] . 
Accordingly, two properly selected biomarkers can be utilized to offer relatively unbiased 
estimates of correlations between dietary estimates and true intakes [137]. 
 
Strengths and limitations of the manuscripts 
The analytic approaches used in this dissertation are a targeted LC-MS/MS approach in the 
second manuscript and a non-targeted UPLC-MS/MS approach in the third manuscript. 
Because of the metabolite diversity and the range of concentrations in which they may appear, 
there is no single technique capable of measuring the entire metabolome. Therefore, a number 
of these technologies are employed, although these approaches all have their advantages and 
limitations [138]. Of the two methods mentioned above, the non-targeted approach provides a 
broader coverage of known metabolites and allows for the discovery of new target metabolites 
[139]. Nevertheless, this approach requires a lot of time to process the extensive amounts of 
raw data produced and faces difficulties in characterizing the bias towards high-abundance 
molecules [140,141]. 
Both analytic methods are state-of-the-art with a fairly low limit of detection. Recent studies 
administered the same analytic method applied in the second manuscript for amino acids 
quantitation [68,73]. 
The strength of the second and third manuscripts is that they are the first studies that examined 
the association between habitual dietary meat intake and plasma carnosine, anserine, Π-MH 
and T-MH, and between habitual dietary intake and fecal concentration of animal sterols, 
phytosterols and bile acids in cross-sectional studies administering targeted or untargeted 
metabolomic technique.  
The second manuscript included the results of only 294 participants who completed three 24-h 
dietary recalls and had a plasma sample volume that was sufficient for lab analysis. Differential 
bias is unlikely despite the fact that this study is not a random subsample. Due to its relatively 
good validity and measurement properties, the 24-h dietary recall is the favored assessment 
method of dietary intake at the population level [142-144]. This is why it was implemented in 
this study. Weighting factors were applied in order to account for consumption differences due 
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to the day of the week on which the questionnaire was completed. However, dietary intake as 
well as information on socio-demographics, lifestyle and disease status were assessed mainly 
in the second and third manuscript based on self-reports; therefore, misreporting cannot be 
excluded. Because certain food groups (such as pork and beef) are rarely consumed, the second 
manuscript was limited in its capacity to examine the effect of these meat subgroups on their 
related biomarkers. Further, it was not possible to assess short-term biomarkers of rarely 
consumed foods, as the food may not have been consumed on the day prior to blood collection. 
In the third manuscript, dietary intake was comprehensively assessed in KORA FF4 
participants using an advanced method combining the information of a FFQ and repeated 
24HFLs so that a full range of food items could be examined. Nevertheless, since only habitual 
intake of food groups is analyzed in observational studies, it was not possible to examine 
special diets (with specific dietary patterns), which may be high in a specific food item, e.g. 
plant sterols. 
Feces is the biospecimen of choice in identifying sterols, bile acids, and their metabolites, as 
they are mainly metabolized by the gut microbiota and excreted in feces [32,145]. Feces can 
also be easily obtained in a non-invasive manner. Yet the collection and storage of fecal 
samples has its limitations. As opposed to blood samples that are collected in the study center 
by trained personnel, fecal samples are usually collected by participants at home and kept 
cooled until their study center visit. Despite the fact that participants were well-instructed 
about the handling and storage of fecal samples, not all stool samples were correctly stored 
until being handed over in the study center. Therefore, all samples that were stored at room 
temperature for more than three hours were excluded. This cut-off was based on a study [100] 
that compared the concentrations of metabolites in fresh samples and samples stored under 
different conditions. Still, metabolite degeneration in the selected samples cannot be excluded. 
 
Conclusion and future perspectives 
The current Ph.D. project was designed to identify new biomarkers of habitual dietary intake in 
various biosamples in observational studies that can be used to find associations between 
dietary intake and chronic disease risk. It also aims to improve nutritional science by utilizing 
metabolite profiling to identify new dietary biomarkers. 
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The first manuscript provides an overview of the identification of dietary biomarkers utilizing 
different biosamples and techniques. Two different cross-sectional studies which differ in bio-
specimen collection and analysis method were carried out to specify dietary biomarkers of 
meat intake in relation to the specific type of meat consumed, and to identify associations 
between dietary intake and fecal animal and plant sterols and bile acids. Metabolite profiling of 
stool was performed by non-targeted UPLC-MS/MS analysis. Quantitative measures of 
carnosine levels and its derivatives were obtained using targeted LC-MS/MS analyses. The 
analytic methods applied in this dissertation to quantify or identify the biomarkers in plasma 
and feces are state-of-the-art with a fairly low limit of detection.  
This dissertation provides novel results, by demonstrating the association between usual meat 
intake and plasma concentrations in a cross-sectional study. Additionally, it related the 
concentrations of sterols in feces to habitual dietary intake in a population-based study. As 
plasma anserine, carnosine, and Π-MH are associated with meat intake, they seem to be 
markers for overall meat intake, rather than markers specific to a certain type of meat. 
Therefore, it may also be important to further investigate the use of combinations of 
biomarkers of meat intake to specify the particular type of meat consumed. Further, future 
intervention studies should reveal if the metabolites found in plasma are characteristic for a 
specific type of meat or not.  
The third manuscript results revealed an effect of habitual diet on fecal concentrations of 
animal sterols, but the influence of diet on bile acids was limited in this study.  
Further studies are essential for assessing fecal animal sterols as biomarkers of diet and to 
confirm the findings in other populations with different dietary habits. 
A further question that should be explored is the possible health benefits or risks of a higher or 
lower fecal animal sterol content in response to dietary habits. 
Finally, the findings of this dissertation in combination with findings from the existing 
literature and future studies should be used in identifying which dietary factors that are related 
to which diseases in the general population over the long-term. Biomarkers are essential to the 
objective measurement of nutrients status because the measurement error is a major limitation 
of conventional dietary assessment methods [7]. Dietary biomarkers require additional research 
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so that they can be better utilized and interpreted. High-quality dietary intake data, reliable 
dietary biomarkers, accurate metabolite profiling, and new statistical methods are urgently 
needed in epidemiological studies to uncover new diet-disease risk associations[14]. 
Biomarkers of dietary intake should be valid, reproducible, sensitive, and able to detect 
alterations in intake over time. Further, they should be applicable into the general population 
[7]. 
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Biomarkers of nutrient intake or nutrient status are important objective measures of foods/nutrients as one of the most
important environmental factors people are exposed to. It is very difficult to obtain accurate data on individual food
intake, and there is a large variation of nutrient composition of foods consumed in a population. Thus, it is difficult to
obtain precise measures of exposure to different nutrients and thereby be able to understand the relationship between
diet, health, and disease. This is the background for investing considerable resources in studying biomarkers of nutrients
believed to be important in our foods. Modern technology with high sensitivity and specificity concerning many nutrient
biomarkers has allowed an interesting development with analyses of very small amounts of blood or tissue material. In
combination with non-professional collection of blood by finger-pricking and collection on filters or sticks, this may make
collection of samples and analyses of biomarkers much more available for scientists as well as health professionals and
even lay people in particular in relation to the marked trend of self-monitoring of body functions linked to mobile phone
technology. Assuming standard operating procedures are used for collection, drying, transport, extraction, and analysis of
samples, it turns out that many analytes of nutritional interest can be measured like metabolites, drugs, lipids, vitamins,
minerals, and many types of peptides and proteins. The advantage of this alternative sampling technology is that
non-professionals can collect, dry, and mail the samples; the samples can often be stored under room temperature in a
dry atmosphere, requiring small amounts of blood. Another promising area is the potential relation between the
microbiome and biomarkers that may be measured in feces as well as in blood.
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Reliable knowledge about the relationship between food
intake and nutritional status is very important for im-
proving the quality of nutritional research. Most data
generated in large epidemiological studies in humans are
based on memorizing or monitoring food intake from
the participants [1, 2]. These methods are inaccurate
and represent challenges concerning under- as well as
over-reporting of certain foods [3]. Based on these facts,
there is an urgent need for biomarkers of objectively
describing both intake and nutritional status. Different
omics analyses can be applied on all types of tissues and
biological liquids to improve dietary assessments [4].
However, the use of objective biochemical variables is
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Holen et al. Genes & Nutrition  (2016) 11:12 Page 2 of 20for registration of food intake simply because the two
approaches intend to monitor different variables (food
intake with all its inaccuracies) and a resultant of many
biological processes (biomarker measurement).
Definition of biomarkers
In the current context, we will apply the concept of bio-
markers as a way to characterize objectively nutrient in-
take and or nutritional status. There is a distinction
between nutrient intake and nutritional status as exempli-
fied in the case of vitamin D. The best way to evaluate
vitamin D intake objectively would be to measure vitamin
D2 and D3 in blood. However, the concentration of these
vitamins is so low in blood that it is not feasible to meas-
ure these molecules by available technology. It turns out
that a hydroxylated derivative of vitamin D (25-hydroxy
vitamin D, formed in the liver) is a sensitive marker of
how much vitamin D is found in the body based on the
two main sources, diet and sun exposure over a period of
months [6]. Another example of the distinction between
intake and status can be polyunsaturated fatty acids
(PUFAs). The best way to evaluate intake of especially
PUFAs is to isolate the triglyceride-rich chylomicrons in
the time interval of 2–6 h after the meal. Although it is
difficult to monitor the amount of fatty acids consumed, it
is possible to have good estimates on the quality of fatty
acids by gas liquid chromatography (GLC) in combination
with flame ionization detection (FID) [7]. The status of
PUFA in the body is obtained best by having samples of
tissues with slower turnover than plasma lipoproteins, like
red blood cells, as can be obtained in whole blood samples
and thus on dried blood spots (DBS).
The ideal biomarker is:
a) Sensitive and specific for the nutrient or food it is
supposed to monitor.
b) Reflecting the period of interest concerning health
or disease. Often in biomedicine, the long-term
exposure is the most important.
c) Unaffected by diseases or conditions of importance
for metabolism of the actual nutrient. An example
is plasma concentration of LDL-cholesterol, which
is a risk factor for myocardial infarction, at the same
time as a myocardial infarct by itself will reduce
plasma LDL-cholesterol during the first days after
infarction [8].
d) Unaffected by other environmental or genetic factors.
Often this is impossible to avoid, but the actual
factors should be characterized and adjusted for.
e) Inexpensive and reproducible to measure.
Many variables influence biomarker concentrations
It is important to note that the concentrations of bio-
markers in body tissues are influenced by many factorslike digestion, absorption, distribution, transport, stor-
age, metabolism, and export, as well as dietary character-
istics like matrix differences, physical activity, the
microbiome, environmental temperature, the use of
drugs, and the presence of diseases. All these pheno-
typic, genetic, and environmental factors may give other
results than what are obtained in traditional dietary
studies based on 24 h recalls or food frequency ques-
tionnaires (FFQ). Thus, it is essential to be aware that in
addition to provide objective data on nutrient intake or
status, measurements of biomarkers represent many
more biological processes than just food intake.
Hypothesis-driven and data-driven search for biomarkers
The methods used to discover novel biomarkers can be
divided into two categories: hypothesis-driven and data-
driven [9]. Using the hypothesis-driven approach, prior
knowledge might be obtained from food composition
databases such as FooDB before methods are developed
to measure the biomarker candidates of interest [9]. An
example of the hypothesis-driven approach is the identi-
fication of pentadecanoic acid as a marker of dairy fat
intake. Pentadecanoic acid is a saturated fatty acid with
odd numbers of carbon atoms (15:0) and cannot be syn-
thesized in the human body. However, pentadecanoic
acid can be synthesized by the bacterial flora of the
rumen of ruminants. Wolk et al. showed that the level of
pentadecanoic acid in subcutaneous adipose tissue can
serve as a marker of long-term milk fat intake [10]. Re-
cently, the plasma phospholipid levels of pentadecanoic
acid have been shown to associate with consumption of
dairy fat and butter in adults [11]. The plasma or serum
level of pentadecanoic acid represents a short-term
marker for intake [12] and is inversely associated with
type 2 diabetes [13]. The finding of a relationship be-
tween the plasma phospholipid levels of the trans-fatty
acid elaidic acid (18:1, n-9) and intake of highly proc-
essed foods is another example of the hypothesis-driven
approach [14]. Elaidic acid is generated during partial
hydrogenation of vegetable oils and is used for the
formulation of processed foods.
In the data-driven approach, there is no prior know-
ledge of the biomarkers. This makes the investigators
measure as many lipids as possible, with the main limita-
tion being the capacity of the analytical procedure. The
recent study of Hanhineva et al. [15], studying the
Nordic diet, is a good example of a successful data-
driven approach. Using non-targeted LC-MS plasma me-
tabolite profiling, in a randomized controlled trial with
106 participants assigned to three dietary interventions
for 12 weeks, they identified several lipid species as po-
tential biomarkers for fatty fish intake. The suggested
biomarkers for fish intake included EPA, DHA, lyso-
phosphatidylcholine (22:6 and 20:5), lysophosphatidyl-
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3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid
(CMPF). CMPF was clearly changed and positively as-
sociated with increased consumption of fish, and
using a stepwise linear regression model, they ob-
served that plasma CMPF is an even stronger inde-
pendent marker of fish intake than plasma EPA [15].
DBS technology
With modern technology, it is possible to measure ac-
curately thousands of metabolites, as well as nutrients,
in small biological samples. It is also possible to monitor
hormones, peptides, and proteins to enhance the quality
of nutritional evaluation. We will describe the principles
for metabolomics, including lipidomics, in addition to
measurements of different nutrient-relevant proteins
and minerals.
With enhanced sensitivity for measurements of very
small amounts of nutrients and other molecules, it is ob-
vious that we do not need large biological samples but
can obtain high-quality measurements based on small
samples (microliters) collected by non-professional sub-
jects, who are able to follow simple instructions. This
will allow a marked reduction in costs and will make it
much easier to collect samples from thousands of sub-
jects, e.g., in remote study-fields.
DBS sampling has been used to screen newborn ba-
bies for metabolic diseases for more than 50 years [16].
A spot of blood from a heel stick is applied on a filter
paper and allowed to air dry. A circular punch (about
3 mm) is removed, eluted, and analyzed for metabolic
markers. More than 50 separate analytes can be mea-
sured from a quarter of a blood spot [17, 18], mainly
due to adoption within the last decades of the high sen-
sitivity of liquid chromatography (LC) combined with
mass spectrometry (MS) (http://vitas.no/services/dried-
blood-spots).
Advantages of DBS
As an important part of alternative sampling tech-
niques, we will focus on DBS and similar alternatives
because:
a) Sampling can be performed by non-professionals
following simple instructions.
b) Sampling can be performed anywhere: in the field,
classroom, gym, workplace, and before, during and
after sports competitions.
c) DBS is close to being non-invasive.
d) DBS requires much less material (uL compared to
mL) due to the improved sensitivity obtained with
modern chromatography in combination with use
of sensitive detectors like mass spectrometry,
fluorescence, and flame ionization [19–21].e) Sampling is much cheaper than classical blood
sampling and does not require participation of
health professionals.
f ) Sample stability is often very good for DBS but has
to be validated for each analyte.
g) Transport of samples is easier, is less expensive, and
represents minimum biohazard compared to
classical blood/plasma samples.
h) Samples are easy to store in tissue banks due to
stability and small volume.
i) There is often no need for laborious blood
processing before analyses.
Disadvantages of DBS
Due to the fact that the DBS technology is relatively
new, much less experience is accumulated than for clas-
sical measurements in plasma or serum:
a) Less information is available on metabolites,
nutrients, and proteins in the whole blood compared
to classical plasma/serum samples.
b) Measurements of every new analyte collected by
DBS have to be validated—i.e., accuracy, reference
values, pathological values, and reproducibility
should be established before the measurements can
be fully interpretable.
c) Whole blood is much more heterogeneous than
plasma/serum, including all components of plasma
in addition to platelets and several cell types.
d) Some analytes are differentially distributed between
plasma and blood cells. Potassium is a classical
example of an intracellular mineral with 15–50-fold
higher concentration in red blood cells than in
plasma [22].
e) Small volumes of blood are available making it
difficult to measure analytes with very low blood
concentrations.
f ) The quality of DBS can be poor because sample
donors do not follow instructions concerning
sampling, drying, and mailing.
g) Some donors are hesitant to perform their own
finger-prick sampling.
h) The exact volume of blood might be difficult to
obtain because the blood sample might be unevenly
distributed on the filter paper.
Applications of DBS
The DBS technology has been used for clinical and
pre-clinical pharmacokinetic studies, taking advantage of
smaller samples and simplified sample collection and
handling. DBS sampling has also been used for disease
surveillance in developing countries [23], at home, in the
pharmacy, in the gym, in sports competitions, and in
large epidemiological studies [24–28].
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The best way to obtain high-quality measurements is to
be aware of the pitfalls in the procedure and carefully
standardize all steps in the use of DBS technology [29].Blood sampling
Cleaning of the finger, earlobe, or heel can be done with
soap and clean water before the sampling place is dried.
The sampling place (finger or heel most often) should be
warmed in hot water (~40 °C) to enhance the capillary
blood-flow and make sampling easier. It is also import-
ant to increase the pulse pressure by standing up during
blood sampling. A safety lancet in the form of a needle
or blade is used to penetrate the skin with a depth of 1–
2 mm thereby cutting one or several capillary blood ves-
sel. The initial drop of blood is dried off with a clean
gauze pad because it may be contaminated with intersti-
tial fluid [30, 31]. The free dripping blood drops are ap-
plied on the filter paper and should not be squeezed out
blood by milking movements to avoid tissue fluid and
hemolysis. Clotting, layering, or supersaturating the filter
should be prevented. The predefined circle on the filter
should be homogenously and symmetrically filled and
both sides of the card/paper must show the same red
color. Samples indicating contamination or hemolysis
or with insufficient volume collected are not suitable
[18, 29, 32] depending on the type of analysis.
In every procedure, we depend on a device to cut into
the skin a few millimeters to get access to capillaries.
There are many protected types of lancets available,
which are released when pressure is applied on the
lancet resting on the skin, thus providing blood drops for
sticks or filter papers. Proper application of blood to the
filter paper requires care to reduce artifacts due to uneven
sample coverage; touching the paper, too large or too
small blood drop, or too much time between the
blood drops can make a sample unsuitable for ana-
lysis. These difficulties may limit the ability of non-
professionals to self-collect samples from home or a
remote location. However, in a large internet-based
dietary intervention study named Food4Me, it was
possible to collect thousands of samples by and fromFig. 1 Different devices for collecting capillary blood samples in small quannon-professionals with acceptable quality provided the
instructions were properly communicated [33].
Sampling matrix
The filter paper should be standardized in terms of par-
ticle retention, pore size, thickness, and weight (grams
per square meter). Most filter papers are cellulose filters,
and the recommended filters have a CE mark from the
European Union (EU). Typically a 1.2-cm-diameter cir-
cle holds 30–100 uL per spot. It is important to collect
enough blood to fill a circle in one go to obtain an even
distribution of blood with an even thickness. One of the
authors (TEG) has extensive experience with the stan-
dardized Whatman DBS filter paper 903 (Guthrie paper)
from General Electric (GE). Since the 1960s and until
recently, the only devices available have been different
versions of the Guthrie card, a cellulose-based paper
card with a clean and reproducible surface allowing even
distribution of the blood on the paper. However, in the
last 6–8 years, a number of new DBS devices have been
developed. Some of these devices are shown in Fig. 1.
The newly developed devices include different types of
material like strips, sticks, and pens.
The Mitra sticks (Fig. 1) seem to be especially promis-
ing because they have a clearly defined volume of blood
adsorbed on the gel matrix representing exactly 10.2 uL.
The whole collected sample is used in analyses, without
relying on punching out a representative area that could
contain an amount of blood that is not as expected from
the punched area. Another advantage is that it is easy to
load the Mitra sticks into a machine for robotic handling
of the whole analytical procedure. HemaSpot (Fig. 1) is a
cartridge containing an absorbent paper and desiccant.
Once blood drops are applied, the cartridge is closed
and the desiccant rapidly dries the sample. Thus, long
exposure to air during drying, with possible airborne
contamination, is avoided.
Strips (Fig. 1) are designed to overcome non-specific
binding limitations of classical dried blood spot cards;
special low retention absorbing material is used, which
in turn, readily releases proteins, enzymes, antibodies,
DNA, and nutrient biomarkers. Strips may have an ad-
vantage because less samples may be wasted, and dryingtities by non-professionals
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strips have been used for sampling of blood for glucose
measurements among subjects with diabetes [34]. Still,
strips have for some reason been less used in recent
times for new and more demanding analyses.
Pens can be used for finger-pricking, sample collection,
and processing, and be integrated with commercially avail-
able paper-based assays [35]. This approach ensures safety
and can be used by untrained end users in multiple settings.
The pen format may provide low cost, high degree of safety,
and robotization.
Sample drying
Drying the samples in air is quite important to improve the
stability of most metabolites, nutrients, and proteins. Most
biological molecules are often stable under dry conditions.
Required drying time is 1–4 h at room temperature of fil-
ters loaded with blood to make the analytes stable. Glucose
can be metabolized in wet samples for weeks after collec-
tion of samples, whereas dry samples keep a much more
stable glucose concentration. It is important to keep the
samples dry also during transport (see below). Current
methods require that the blood spotted onto filter papers
should be dried in open air for a few hours prior to ship-
ping or storage. This exposes the sample to potential
contamination from circulating air and from foreign sur-
faces. Dried DBS samples in this manner may be stored at
room temperature for many weeks, months, or years [36],
depending on the analyte stability. However, samples
containing unstable compounds should be stored at a lower
temperature (≤−80 °C); [37, 38] to enhance the stability.
Moreover, the drying rate can be variable based on ambient
humidity; a sample will dry much more quickly in an arid
atmosphere (e.g., Arizona) than a humid area (e.g.,
Amazon). Samples have greater stability with rapid drying
and storage in low humidity conditions [20].Packaging, transport, and stability
Once the samples have been dried (usually 2 h at room
temperature is sufficient), they should be placed in an
airtight small aluminum envelope, with a small amount
of dry silica to keep the humidity low during transporta-
tion. The small aluminum envelope can be placed in a
regular postal envelope and sent by regular mail to the
analytical laboratory for advanced analyses. Requirement
for all analytes is that the stability should be evaluated
during regular mailing/storage for up to 10 days, to
make sure that the analyses are performed on high-
quality samples.
Sample extraction
For water-soluble analytes, the most common solvent is
water, whereas different organic solvents like methanol,isopropanol, and chloroform are used for lipid extrac-
tion. For lipidomics of fatty acids, transmethylation is
often performed in parallel with the extraction [26]. For
extraction of peptides or proteins from DBS, enzyme-
linked immunosorbent assays (ELISA) are mostly used
with special buffers designed for optimal detection by
the actual antibody, whereas a lysis buffer is used as a
solvent when HbA1c is measured.
Quality control
Many studies show that DBS sampling is compatible
with, and equivalent to, current tests performed with
fresh blood samples [39–43]. The accuracy and precision
of a DBS LC-MS/MS method should be evaluated using
quality control samples prepared at least at three differ-
ent concentration levels (low, mid, and high), and ana-
lyzed along with a set of non-zero calibration standards
in three separate validation runs. The lower limit of
quantification (LLOQ) of samples must be assessed at
least in one of the three validation batches. The intra-
and inter-day accuracy, the bias (%) from the nominal
concentration values, should be within ±15 % for all
quality control samples except the LLOQs, for which a
bias of within ±20 % is acceptable. The intra- and inter-
day precision, assessed by the standard deviation divided
by the mean coefficient of variation (CV%) from the rep-
licate analyses, should be ≤15 % for the results of all
quality controls except the LLOQs, for which a ≤20 %
CV is considered acceptable [44].
Hematocrit is usually 0.41–0.51 for men and 0.37–
0.47 for women [45]. The percentage might be out of
the above ranges in certain populations, e.g., 0.28–0.67
for neonates (0–1 year old) and 0.35–0.42 for children
(2–12 years old). Capillary blood tends to have a higher
hematocrit (e.g., 0.61) than venous blood [46]. With high
hematocrit, the viscosity of blood is enhanced and the
diffusion of sample in the filter will be reduced, and the
layer of blood will be thicker and the concentration of
31 amino acids and acylcarnitines was higher in the sam-
ples with highest hematocrit [47]. However, other studies
do not show marked effect of hematocrit on 25-hydroxy
vitamin D [48] or cyclosporine A [45]. Alternatively, MS
signal for each lipid species can be standardized to the
summed intensities of selected signals, providing a
relative quantitation independent of blood volume
and hematocrit level, as demonstrated by DBS studies
of 3 months old infants compared with 12 months
old children [49, 50].
The volume of the blood spot may also influence ana-
lytical results [44]. For every new analyte, there should
be performed quality controls where the relationship be-
tween DBS area/weight and the amount of blood spotted
on the paper should be examined by spotting increasing
volumes of blood on the paper, and measuring the areas
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spots [52].
Chromatographic effects may also cause skewed distri-
bution of blood and/or analytes on the filter paper. This
is another factor that might cause significant differences
in the measured analyte concentrations between central
and peripheral areas within a spot. Different results have
been reported depending on the analytes [47, 53].
During assay method development, it should be assessed
whether the same analyte concentration could be
measured from punches in different locations of the
filter at different concentrations. Analyte classes with
successful recovery and analysis from DBS include many
metabolites (Table 1).
DBS differs from blood plasma or serum samples
mainly with respect to the presence of white and red
blood cells. White blood cells make up only 1 % of the
blood, whereas the red blood cells can vary between 30
and 70 % of the blood. The red color of blood is caused
by the heme-iron complex and will interfere with many
of the classical clinical chemistry methods using specific
reagents in colored reactions detected by colorimetry.
Thus, most analytical methods for DBS rely on separ-
ation of the analytes to be measured by means of
chromatography, mass spectrometry, or antibody-based
extraction. There is also a possibility of forming com-
plexes with color that do not interfere with the heme
complex or they may have fluorescent properties.
LC-MS/MS may be used for several types of analyses to
measure the concentration of many metabolites like
prostaglandins [28]. Solid-phase extraction (SPE) and
liquid chromatography/tandem mass spectrometry
(LC/MS/MS) may be used for the extraction, separ-
ation, and detection of 8-epi-PGF2α in DBS. Li and
Tse [44] reviewed several aspects of DBS sampling in
combination with LC-MS/MS, in particular focusing
on lipid analyses and several lipophilic drugs.
In sandwich ELISA, a primary antibody is immobilized
to the bottom of the sample container and the bio-
marker of interest is bound, whereas other constituents
including the red color of heme are washed out. ATable 1 Many types of metabolites, peptides, and proteins can
be measured using DBS technology [29]. Examples of analytes
measurable by the dried blood spot technique
Analytes class Typical analytes
Small molecules Amino acids, drugs, hormones, peptides, lipids,
vitamins, minerals
Nucleic acids DNA, miRNA, mRNA, RNA, virus
Proteins Hemoglobin, cytokines, adipokines, myokines,
thyroglobulin
Drugs Anitepileptics, chloroquine, cyclosporin,
gentamycin, paracetamolsecondary antibody is added that binds to the bio-
markers and provides a chromophore, which can be
measured by UV absorbance, fluorescence, or chemilu-
minescence. Many proteins, and some smaller mole-
cules, can be measured by ELISA, which exhibits better
specificity towards proteins than small metabolites like
amino acids or drugs [54, 55].
Once a DBS sample has arrived in the laboratory for
testing, a small punch (3–6-mm diameter) is taken from
the card, eluted in a relevant solvent, and analyzed by a
proper analytical method. The blood spot must be exam-
ined carefully to ensure that the sample punch is taken
from a representative area. Uneven sample coverage due
to poor application, variable hematocrit levels, or chro-
matographic effects may cause variable analytical results.
Although the vast majority of analytical methods can be
used with DBS, analyses requiring whole cells or volatile
analytes are incompatible with DBS.
Lipid profiling using classical lipidomics
Lipids include several classes of metabolites defined as
substances extracted by organic solvents. They have sev-
eral structural functions in cell membranes, lipid drop-
lets, and lipoproteins [56]. Moreover, functional roles of
lipids include membrane fluidity and microenvironment,
signaling via eicosanoids and lipokines, ligands for tran-
scription factors, and interaction with proteins based on
hydrophobic as well as covalent bonds, and they often
are important energy sources [5]. Whereas most lipids
can be synthesized in the body, some fat-soluble vita-
mins and polyunsaturated fatty acids are essential, such
as vitamin A, D, E, and K, and linoleic (omega-6) and
alpha-linoleic acids (omega-3). These nutrients have to
be obtained from the diet for mammals. One classifica-
tion system divides the lipids into eight classes: fatty
acyls, glycerolipids, glycerophospholipids, sphingolipids,
sterol lipids, prenol lipids, saccharolipids, and polyke-
tides [57]. Lipidomics represent the large-scale study of
lipids present in a given cell, tissue, or organism at a
defined time-point. It can be used to relate variation in
lipid composition in biological samples to consumption
of specific lipids, foods, or diets [4, 15, 58, 59].
Dietary lipid biomarkers in tissues, plasma, and sera
A variety of tissues and plasma/sera specimens have
been studied in search of biomarkers for intake of diet-
ary lipids [60–62]. Adipose tissue and plasma are the
most studied biological samples concerning biomarkers
for dietary fatty acid intake, and they are considered the
biological samples to choose for the study of relative
intake of PUFA [63]. The composition of fatty acids in
adipose tissue is to some extent determined by the habit-
ual fatty acid intake [64, 65]. This is due to the slow
turnover of fatty acids in the adipose tissue as well as in
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is estimated to be between 6 months and 2 years [66–68].
Direct measurement of lipid age in subcutaneous fat using
a 14C method, showed a mean lipid age of 1.6 years, which
is consistent with a half-life of approximately 400 days
[66–69]. Whereas the fatty acid composition of stored
triglycerides is influenced by diet, the structural lipids in
adipose tissue seem to be less influenced because of
special functional requirements [64]. The fatty acid pat-
tern of plasma phospholipids and cholesteryl esters is
mostly reflecting the dietary intake of the past few weeks
[70]. After 14 to 20 h of fasting, the plasma free fatty acids
(also called non-esterified fatty acids) composition is dom-
inated by the release of fatty acids from adipose tissue
[71]. Thus, the free fatty acid composition of plasma from
a fasting individual may serve as a surrogate for the fatty
acid composition in adipose tissue. As an example, Leaf
et al. [65] found correlation coefficients of 0.94 and 0.83
between adipose tissue and plasma phospholipid fractions
of eicosapentaenoic acid (EPA) and docosahexaeonic acid
(DHA), respectively. The red blood cells (RBC) may be a
useful long-term marker of fatty acid intake, as the RBC
turnover is 120 days [72]. Thus, when dietary information
is collected to be compared with lipid composition in bio-
logical samples, the time frame must be considered [59].
Exogenous fatty acids as biomarkers
Exogenous fatty acids (not de novo synthesized) serve as
the best candidates for dietary biomarkers. Although bio-
markers representing dietary intake of total fat and satu-
rated fatty acid (SFA) have demonstrated conflicting
results [73], PUFA and monounsaturated fatty acids
(MUFA) measured in adipose tissue and plasma appear to
be more valid [63]. The fact that the total pool of fatty
acids in circulation represents both de novo synthesized
(endogenous) and dietary (exogenous) fatty acids has
made it difficult to find biomarkers for total fat intake
[63]. However, one study showed that the combined
changes of a group of fatty acids in RBC, plasma phospho-
lipids, and cholesterol esters, in response to a low-fat or
moderate-fat diet almost perfectly discerned between the
total fat consumptions [72]. The same authors reported
systematic increase in many endogenous fatty acids in re-
sponse to a low-fat diet, despite reduced consumption of
these fatty acids [72]. It has also been shown that high
carbohydrate diets promote increased de novo synthesis
of palmitic acid [74]. A recent study showed that the level
of pentadeconic acid (15:0) in plasma and RBC reflected
saturated fatty acid intake within an 8 weeks period [75].
Interestingly, there was no change in pentadeconic acid
content in adipose tissue triglycerides [75]. Thus, future
studies investigating changes in dietary intake of saturated
fatty acids for up to 2 months might concentrate on
plasma or RBC, as can be obtained in DBS.Dietary interventions and observational studies
The pattern of dietary PUFAs correlates with the fatty
acid pattern in plasma and adipose tissue in dietary in-
terventions as well as observational studies [58, 65, 76].
Already in 1966, Dayton and colleagues showed in a
group of 393 institutionalized men, that increasing diet-
ary intake of linoleic acid from 11 % to almost 40 % of
total fatty acids, enhanced percentage of linoleic acid in
serum as well as adipose tissue [58]. The content of
linoleic acid in lipids from adipose tissue increased
from 11 to 32 % after 5 years with the diet high in lino-
leic acid [58]. Supplementing the diet with marine n-3
fatty acids for more than 12 months caused enhanced
incorporation of EPA and DHA into adipose tissue fatty
acids [65]. In a study comparing Greenland Inuits and
white Danes, it was shown that the Inuits had a higher
concentration of EPA in plasma, probably reflecting
their much higher consumption of very-long-chain n-3
[76]. Andersen and colleagues observed a correlation
coefficient of 0.51 and 0.49 between dietary intake of
EPA and DHA and corresponding plasma phospho-
lipids, respectively [4]. Finally, the sum of EPA and
DHA in RBC membranes is often called the Omega-3
Index. This index has been shown to discern between
different dietary intake of EPA and DHA [77]. How-
ever, the omega-3 index might not be better than
measuring EPA and DHA in plasma phospholipids or
whole blood [77].Fatty acid profiles based on DBS
The search for efficient biomarkers has been ham-
pered by the fact that most studies are relatively
small scale. For the last 10 years, the lipid profiling
assay developed by Marangoni and coworkers has
been extensively tested in field studies [78]. The
Marangoni-assay includes drying a blood drop on a
filter paper strip containing the antioxidant butylated
hydroxytoluene (BTH). The paper strip can be stored,
then subjected to transmethylation (HCl and metha-
nol) at high temperature, which will methylate fatty
acids for GLC-MS. Large-scale cross-sectional studies
with several thousand participants have been per-
formed [79, 80], as have studies under field condi-
tions in Cambodia and Tibet [81, 82] with several
supplement interventions and validations (Table 2).
Furthermore, method development has revealed and
resolved several methodological challenges [39–42],
providing a more robust method for future nutrient
analyses. Recently, a breakthrough paper described
DBS stabilization by chelators, which seemed to elim-
inate iron-promoted oxidation of PUFA, resulting in
an excellent correlation (r = 0.97) between venous
blood samples and DBS samples [43].
Table 2 Overview of studies measuring FA lipid profile by dried blood spot technique
Author Subjects Objective
Marangoni (2004) [78] 100 (46M, 54F) Founder paper establishing method
Agostoni (2005) [91] 39 (22M, 17F) + 95 controls Study infants of smoking mothers
Agostoni (2007) [81] 191 (100M, 91F) + 21 Italian controls Intervention Cambodian infants (12 months)
Marangoni (2007a) [83] 10 (5M, 5F) Walnut intervention (3 weeks)
Marangoni (2007b) [86] 108 (47M, 61F) - 10 (5M, 5F) Cross-sectional study PUFA intervention (21 days)
Agostoni (2008) [90] 106 + 53 controls Study infants of smoking mothers (follow-up of
Agostini (2005) [89])
Risé (2008) [82] 13 (13M, 0F) + 14 Italian controls Diet and FA profile study of Tibetians
Agostoni (2011) 16 pairs Study of whole blood FA in infant, cord and mother
Saga (2012) [80] 3476 (1463M, 2013F) Cross-sectional study of FA profile in Scandinavian
population
Risé (2013) [79] 1835 total Cross-sectional study of PUFA
- 81 infants
- 728 children
- 434 adults
- 592 elderly
Hinriksdottir (2015) [92] 52 (19M, 33F) + 25 controls PUFA enriched fish meal intervention
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Four walnuts per day, containing 1.2 g ALA and 4.4 g
LA, for 3 weeks, favorably affected the n-3 LC-PUFA
status of volunteers (n = 10) [83]. Time course of mea-
surements included 2 weeks run-in period and a 2 weeks
washout period. However, the high EPA values are in
contrast to two other studies with larger doses of
walnuts [84, 85].
A cross-sectional study investigated the fatty acid
profiles in a drop of blood from a fingertip and correlated
with physiological, dietary, and lifestyle parameters in
volunteers. A total of 108 healthy volunteers (47 males, 61
females), including 8 pregnant women, were questioned
for dietary and lifestyle habits for the last 3 days and blood
collected. In addition, 10 volunteers ingested either cap-
sules (350 mg EPA, 300 mg DHA) or 200 g/week of
smoked salmon, for 3 weeks [86]. These early studies
indicated that the DBS method was suitable for cross-
sectional studies as well as supplementation studies.Population screening by DBS
The Marangoni DBS technology was early used for
screening fatty acid profiles under field conditions in
less developed countries like Cambodia [81] and Tibet
[82]. The effects of supplementation of two micro-
nutrient powders on fatty acid status in Cambodian
infants (n = 204) were compared in a 12 months
intervention [81]. The fatty acid profiles of blood in a
Tibetanian population (n = 13, Italian controls n = 14)were significantly correlated with dietary fatty acid
patterns from the same population [82].
In a large cross-sectional study on blood from Italian
infants, children, adults, and elderly, different patterns of
n-6 and n-3 PUFA levels were observed. Data from four
cohorts of Italians (n = 1835) were pooled in four age
groups: 4 days old, 2–9 years old, adults (40–59 years),
and elderly (60–79 ears) [79]. This study showed that
the Marangoni-assay could be used in a large cross-
sectional study. The study also showed that the DBS
assay may allow detection of distinct PUFA profiles in
new born infants. Large cross-sectional population stud-
ies in Norway and Sweden (n = 3476) have shown that
food supplements like cod liver oil are in common use
especially in middle-aged and older subjects, with
marked influence on the fatty acid profiles [80].
Ethics and lipid profiling of children
Samples of relatively small DBS from finger- or heel-
pricks represent an important development due to the
increased range of experiments that can be performed in
an ethical way, like screening of infants [79, 87], very old
patients [88] or disadvantaged, and cognitively challenged
small school children [89]. Agostoni and coworkers re-
ported a 24 % reduction in DHA (22:6) in children with
mothers smoking throughout pregnancy (n = 159) [90].
The study was a follow-up of a smaller study observing
the same effects (n = 19 smokers + 20 first trimester
smokers + 95 reference controls) [91]. In a recent cross-
sectional study 493 school children, aged 7–9 years,
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ples; the results showed that low blood n-3 PUFAs was as-
sociated with poor cognitive performance and behavior
[89].
Commercial applications of DBS
The ease and flexibility of sampling blood using DBS
technology have revealed new commercial applications,
such as demonstrating the bioavailability of long-chain
n-3 PUFAs in fish oils. To fortify foods with PUFA from
marine sources has remained problematic, due to the
strong odor and taste. Hinriksdottir et al. added flavor-
neutral microencapsulated marine fish oil to meals and
compared with meals fortified with liquid fish oil and
placebo control meals. Icelandic individuals (n = 99)
were studied in a 4-week double-blinded dietary inter-
vention in three groups [92], demonstrating that bio-
availability of PUFA in encapsulated powder is very
similar to meals enriched with liquid fish oil.
The supplement industry has also used DBS technol-
ogy to demonstrate bioequivalence of different n-3 sup-
plements [40, 93]. In the latter study, the n-3 fatty acid
status of 50 young men was determined. In 10 individ-
uals, the effect of supplements was investigated with
time course from 2 to 24 h [93]. In times of increased
competition for consumers and increased demands for
new products, the demonstration of supplement efficacy
might be an important competitive advantage.
Cardiac disease studies using DBS
In a 3 g per day, PUFA supplement study of cardiac
patients, using DBS technology, no effect on atrial
fibrillation was seen after 6 months. The study was a
randomized, double-blind, multicenter study including
204 Italian patients [94].
In another Italian study of patients with a recent
myocardial infarction, matched case and control pairs
(n = 112) showed that whole blood n-6 and n-3 PUFA
levels were reduced. Using food frequency questionnaire
(FFQ) demonstrated for 86 cases and 72 controls signifi-
cant correlations between reported fatty acid intake and
measured fatty acid pattern from DBS [95]. In contrast,
another study applying DBS-based analyses showed no
difference between fatty acid profiles of patients with
arrhythmia without or with myocardial infarction and
controls at hospital admission [96].
Methodological challenges and refinement in
lipid profiling using DBS technology
High-throughput DBS analyses
DBS technology was originally used for screening of
genetic diseases and mailing the samples to core labora-
tories [97, 98]. Stabilization of PUFAs by butyl hydroxyl
toluene (BHT) has been successfully used [99]. Severalresearchers have increased the throughput of the fatty
acid analyses using microwave oven transmethylation
[100, 101]. Improved methodology allowed more fre-
quent sampling and time series of fatty acid profiles in a
fish oil supplementation study (n = 16) over 4 weeks and
a washout period over 8 weeks [101]. In a study of sol-
diers (n = 287), fatty acid profiles were reported to be
available 1 h after finger-prick sample collection [102].
DBS method challenges and refinement
Some scientists have advocated BF3 use for transmethyla-
tion, but clear superior results using BF3 have not been
demonstrated [100]. The less strict necessity of fasting
blood samples is an important issue in self-administrated
tests. Stark and coworkers [103] reported excellent stabil-
ity of blood samples on paper immersed with BHT over
8 weeks at room temperature, although other scientists
observed lower stability, in particular for DHA [41].
The importance of chelators
Interestingly, Stark and coworkers [104] demonstrated a
striking difference between DBS samples stored with or
without BHT at −20 °C. In contrast, storage at room
temperature, 4 and −78 °C showed little or no effect,
which may suggest that ice crystal damage to membranes
and release of chemicals within cells has important conse-
quence for fatty acid stability. Metherel et al. in a follow-
up study demonstrated that loss of PUFA probably was
due to release of iron from heme in erythrocytes and advo-
cated glycerol addition for freeze-protection of RBC [42].
A recent study reported that adding chelators (such as
EDTA) to the DBS papers increased correlations be-
tween stored DBS samples and venous blood control
samples markedly (r > 0.97) [43]. Similar improvement
was also observed when ascorbic acid was added to DBS
filters and during extraction, to improve the stability of
vitamin A [105].
DBS profiling of vitamins A and D
Vitamin A deficiency has long been recognized as a
major cause for blindness among children in developing
countries and to increased risk of infectious diseases
[106, 107]. The use of DBS technology for population
screening and monitoring of vitamin A status is often
used in developing countries. The National Facility for
DBS Technology for Vitamin A Estimation (Hyderabad,
India) has carried out a vitamin A symptom study of
8777 pre-school children. A sub-group of 407 children
with symptoms had DBS samples analyzed, finding
vitamin A deficiency, particularly among rural children
3–5 years of age, and of lower socioeconomic class
[108]. In a study in West Bengal, of 9228 children, 590
children had vitamin A deficiency, with higher incidence
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age [109].
A study in Guinea-Bissau of 1102 children (6–24 months
of age), using DBS combined with ELISA for retinol-
binding protein, observed a high prevalence of “vitamin A
deficiency” (defined as RBP concentration equivalent to
plasma retinol below 0.7 μmol/L) varying with season,
ethnicity, and vaccination status [110]. A higher preva-
lence of vitamin A deficiency was found in children with
infection, which is consistent with a study in Uganda of
661 children (6–59 months of age), demonstrating that
infection status (measured by C reactive protein (CRP))
influenced the ELISA values for retinol-binding protein.
Another interpretation is that dietary vitamin A deficiency
causes reduced immune function.
Commercial offers for measuring vitamin A status are
available [111–113]. However, there exists some contro-
versy on the efficacy of sampling and extraction tech-
niques [114]. A recent paper obtained a high correlation
(r = 0.97) between venous blood and DBS samples from
healthy subjects (n = 24) using acidic extraction [105].
Similar results were demonstrated 30 years ago, where
the loss of vitamin A in serum samples was eliminated
when adding ascorbic acid before extraction [115].
Vitamin D is linked to rickets, skeletal deformities,
and bone disease. More recently vitamin D deficiency
has been suggested to increase risk of many chronic
diseases such as certain types of cancer, autoimmune
diseases, cardiovascular diseases, and diabetes [116, 117],
although intervention studies do not support the results
based on observational, epidemiological studies [6].
An early study to optimize DBS technology for neo-
natal 25-hydroxy vitamin D status was performed by
Eyles et al. [118, 119]. In a study of 118 archive samples
stored up to 22 years, clear seasonal variations were de-
tected but no annual variation, suggesting that DBS
technology is reliable and promising for investigation
of archive material [118]. In a follow-up study, neo-
natal cord serum and matched DBS samples (n = 100)
were compared, finding them to be highly correlated
(r = 0.85) [119].
Validity and reliability of the DBS technique was further
investigated in plasma and matching DBS samples (n = 62)
[120]. Commercial kits for DBS for vitamin D are available
[121]. The feasibility of self-sampling of blood and saliva
on filters was studied in a Norwegian breast cancer
screening program (n = 381), reporting that postal service
transport was efficient and low cost [24].
There are rather few studies using DBS in studies of
older individuals [17]. Vitamin D status of seniors (>
60 years old, average age 72 years) was studied in 224
subjects in the ethnically diverse Older Adult Centre in
Toronto [122]. No major differences between ethnic
groups were found, although women had higher vitaminD status than men. Supplements were identified as the
major factors responsible for the uniformly high vitamin
D status. The concentration of 25-hydroxy vitamin D in
blood has also been found to correlate negatively with
cortical thinning in the brain during normal aging [26].
The vitamin D status in older adults in Toronto [122]
contrasted starkly with a study of vitamin D status in
young adults (n = 351), which showed that subjects with
South Asian and East Asian ancestry had substantially
lower 25-hydroxy vitamin D concentrations than sub-
jects with European ancestry [123]. However, vitamin D
status in 185 pairs of adolescent twins (average age
16 years) was found to be highly heritable (0.86) [124].
In a global perspective, the socioeconomic factors of
vitamin D status evaluated by DBS sampling was em-
phasized in a cross-sectional study in rural Nepal,
where 280 healthy children (12–60 months of age)
were screened, reporting widespread (> 90 %) vitamin
D deficiency [25].
Water-soluble vitamins
B-vitamins
DBS has been used quite successfully for measurements
of folate [125], 5-methyltetrahydrofolic acid [126], as
well as a sensitive marker of vitamin B12 deficiency, me-
thyl malonic acid (MMA) [127]. Scolamiero et al. [128]
screened 35,000 newborns over 6 years using DBS.
Those showing altered propionyl carnitine (C3), 10 % of
the subjects, underwent second-tier testing of MMA,
finding 7 cases of acquired vitamin B12 deficiency.
Algorithms, combining input for several analytes and
genetic disease models, from very large data sets, have
been developed. For example, Weisfeld-Adams et al.
[129] reported on screening of 1,006,325 infants in New
York from 2005 to 2008, in which 10 cases of confirmed
cblC mutations causing vitamin B12 metabolism disorder
were found. DBS data were retrospectively studied to
validate the algorithm [129].
C-vitamin
Vitamin C, or a range of carotenoids and flavonoids, has
been widely used as general biomarkers of intake of fruit
and vegetables [9, 130]. We have not found any studies
using DBS to measure vitamin C.
Amino acids, proteins, minerals, and trace
elements
Biomarkers of protein intake
An assessment of protein intake has been used exten-
sively to determine nutritional status in subjects at risk
of undernutrition, as well as among various patient
groups, e.g., those with chronic renal disease, obesity, or
in need of energy restrictions [131, 132]. The classical
way to evaluate protein status has been to study nitrogen
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Bingham [133] reviewed the use of urine nitrogen as a
biomarker for dietary protein intake and concluded that
the method was reliable and inexpensive. However, it is
a tedious and inaccurate procedure as it involves at least
one, but preferably several, 24 h samplings of urine, and
the study subjects should be in nitrogen balance. More-
over, measurement of urinary nitrogen tends to under-
estimate protein intake at high levels and overestimate
at low protein intakes.
Measurements of single protein molecules have been
used to assay whole protein intake and protein status.
Among the most widely studied are prealbumin and al-
bumin, which are produced endogenously by the liver.
Recent data have discredited the use of albumin, in
particular, as biomarker for protein intake, as it seems
to be markedly affected by coexistent morbidities,
especially in cancer and inflammatory disorders, as
reviewed by Lee et al. [134]. Creatinine, creatine, and
transferrin are other candidate biomarkers for protein
intake, but clinical studies have not shown reprodu-
cible results [135, 136].
Meat is among the protein rich foods, and several bio-
markers have been used to determine protein intake fol-
lowing meat consumption. Cross et al. [135] performed
a randomized crossover study feeding 17 adults with
various types of red meat for 15 days. Based on urinary
excretion, they concluded that 1-methylhistidine and 3-
methylhistidine were good biomarkers, which is in line
with the reviews provided by Dragsted [136] and
Scalbert et al. [9].
Petzke and Lemke [137] used a different approach to
estimate protein intake, namely by determining hair iso-
tope compositions. They studied if additional meat in-
take (200 g pork fillet/day) or omission of meat and
meat products had an impact on 15N and 13C within
4 weeks in hair and plasma of young women. They con-
cluded that hair protein 15N and 13C abundances take
more than 4 weeks to show animal protein intake, in
these women with a habitual daily protein consumption
of more than 1 g per kg body weight. Stable isotope ratio
analysis at natural abundance in human hair protein
offers a non-invasive method to reveal information about
long-term nutritional exposure to specific nutrients,
including proteins [137]. However, the use of isotopes in
hair as biomarkers of protein intake requires more
testing, in particular in randomized intervention studies.
Biomarkers of amino acid intake
Among the about 100 amino acids found in nature, 20
of them serve as building blocks and metabolites used
for energy and in signaling pathways in humans, 8 of
which are essential and have to be supplied in the diet.
Traditionally blood and urinary concentrations of aminoacids have been used as biomarkers of their intake. Re-
cent methodological advances have also made it possible
to assess local amino acid contents in hair [138] and lo-
cally in various organs, e.g., in neuronal tissues [139].
The advent of DBS to collect and store blood samples
has opened opportunities to assess biomarkers in vulner-
able populations, like premature infants and in popula-
tions in developing countries where access to freezers is
limited. High-performance liquid chromatography and
tandem mass spectrometry can be used to assess the
amino acid concentrations from DBS and with satisfac-
tory results [140].
Historically, the importance of amino acids has mostly
been related to disorders due to deficiencies in amino
acid metabolism such as maple syrup disease and
phenylketonuria. However, there is increased focus on
the use of amino acids including the claimed benefit of
branched amino acids (leucine and isoleucine) to en-
hance physical performance [141], as a risk factor for
cardiovascular disease (L-arginine) [142], and to improve
cognitive function (tyrosine) [143]. Given the multi-
tude of functions amino acids, more studies are war-
ranted to delineate how well blood concentrations of
amino acids and urine reflect subcellular levels of dif-
ferent amino acids.
Iron
Iron is part of the heme molecule, which is an integral
component of hemoglobin. In addition, iron is an im-
portant constituent of enzymes such as in the mitochon-
drial respiratory chain (cytochromes). According to the
World Health Organization iron deficiency anemia still
ranks among the top 5 causes of years lost to disability
globally (http://www.who.int/maternal_child_adolescent/
epidemiology/adolescence/en/) and continues to be a
problem among adolescent girls living in developed
regions [144].
The body stores of iron can be used as a proxy of
long-term iron intake and can be determined in various
ways. The classical way of estimating body iron content
is the assessment of iron in bone marrow using light
microscopy, although this approach yields only semi-
quantitative estimates. To evaluate iron overloading, in
particular in patients receiving frequent blood transfu-
sions, imaging techniques like magnetic resonance im-
aging (MRI) have been used [145]. However, these are
tedious procedures, and hence blood biomarkers are
much more frequently used. Serum levels of ferritin are
in most cases a reliable estimate of body iron stores,
although it is affected by a range of concomitant disor-
ders, in particular inflammations. Serum levels of ferritin
also increase with age. Complementary to ferritin is the
ratio between serum levels of iron and its transport pro-
tein transferrin, denoted iron-, or transferrin saturation.
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nancy. It is debated whether serum ferritin levels and
transferrin saturation levels correlate [146]. To circum-
vent these pitfalls, the use of serum levels of soluble
transferrin receptor has gained increasing attention, as
this is mostly independent of coexistent disease. Cook
et al. [147] found excellent correlation between whole
body iron content (measured according to known
ferritin and hemoglobin levels after phlebotomy in
healthy subjects), and the ratio of soluble transferrin
receptor to ferritin; the latter two biomarkers being mea-
sured by ELISA.
Ferritin as well as transferrin receptor can also be
measured using DBS with accuracy comparable to whole
plasma values [148]; this facilitates measurements of iron
status in remote areas where anemia is frequent. For
example, the use of DBS to measure soluble transferrin
receptor and hemoglobin was successfully applied
among pastoral women of fertile age residing in rural
North-Kenya [149].
Selenium
This trace element is mostly found in enzymes involved
in the human antioxidant defense system. Deficiency of
selenium has been linked to many conditions including
cardiovascular diseases and different forms of cancer.
Many grain-based foods contain selenium, although its
availability depends on the concentration of selenium in
the soil. Vacchina et al. [150] recently described a
method to assess selenium using mass spectrometry fol-
lowing acidic digestion of the DBS. In addition to plasma
selenium, selenoprotein 1 and glutathione peroxidase ac-
tivity are responsive to changes in selenium intake. How-
ever, their use as biomarkers for selenium intake is
limited by inconsistent response to selenium intake
[151] and might be explained in part by ethnic differ-
ences [152]. Moreover, Ashton et al. [151] concluded
that there was insufficient evidence to assess the useful-
ness of other biomarkers of selenium status, including
urinary selenium, plasma triiodothyroxine/thyroxine ra-
tio, plasma thyroxine, plasma total homocysteine, hair
and toenail selenium, erythrocyte, and muscle glutathi-
one peroxidase activity. Currently, no biomarker is avail-
able reliably mirroring (i) variable selenium intake and
(ii) selenium intake in different subpopulations.
Zinc
Zinc exerts several functions, including stabilization of
membranes, co-factor of transcription proteins, and as
part of metalloproteinases. The plasma/serum levels of
zinc and the erythrocyte zinc content have traditionally
been the most common ways to evaluate zinc intake.
The WHO report from 2007 on intake required to pre-
vent zinc deficiency recommend serum levels of zinc asa biochemical marker of zinc status [153]. However, re-
sults are conflicting regarding their sensitivity to low
and high zinc intake [154]; thus, new biomarkers for
zinc intake are needed. Recently, Reed et al. [155] used a
chicken model (Gallus gallus) to propose the erythrocyte
linoleic acid/dihomo-γ-linolenic acid ratio as a sensitive
biomarker of alterations in zinc intake. This was based
on previous findings that this broiler chicken is sensitive
to dietary intake of zinc [156]. In addition, a similar
membrane fatty acid composition has been reported in
mammals, which makes it possible to take advantage of
a link between the ratio of these two essential fatty acids
and mineral intake to evaluate zinc status [157]. The
DBS method developed by Vacchina et al. [150] can also
be used to assess zinc.
Magnesium
Magnesium is an important component of bone and
plays a role in energy metabolism and protein and nu-
cleic acid synthesis and is a co-factor for many proteins
and hormones. Magnesium is mostly located intracellu-
larly in spite of the fact that measurements of serum and
urine levels of magnesium are usually performed to
evaluate magnesium intake. Notably, ethnic variations
and concomitant intake of other trace elements like so-
dium and calcium may affect these measurements [158].
Another less studied biomarker of magnesium intake is
the content of magnesium in erythrocytes [159].
Witkowski et al. [160] performed a systematic review of
analyses of 20 biomarkers of magnesium intake and con-
cluded that the serum or plasma magnesium concentra-
tions, erythrocyte concentration, and urinary magnesium
excretion responded to dietary manipulation and could
be used as biomarkers. We have not been able to find
any scientific articles published concerning measure-
ment of magnesium applying DBS technology although
preliminary data show that whole blood analyses are
feasible.
Chromium
Chromium is important for the metabolism of glucose,
protein, and lipid by virtue of its action as co-factor for
several enzymes. To evaluate exposure to chromium in
foods and liquid intakes, measurements of both plasma
and hair have been used. Sazakli et al. [161] performed a
population-based cross-sectional study of chromium
exposure and intake in Greece, a country with higher
than WHO-recommended levels of chromium in the
drinking water. Both the plasma concentrations and the
hair levels of chromium were associated with intake in
different Greek regions. Urinary chromium may not be a
valid biomarker for chromium intake [162]. There is a
need for better biomarkers of chromium intake [163].
We have not been able to find any scientific articles
Holen et al. Genes & Nutrition  (2016) 11:12 Page 13 of 20published concerning measurement of chromium apply-
ing DBS technology although it should be feasible.
Fluoride
Fluoride is associated with dental enamel and bone
density. Little is known about useful biomarkers of
assessing fluoride intake. Rugg-Gunn et al. [164] con-
cluded in their review that: “While fluoride concentra-
tions in plasma, saliva, and urine have some ability to
predict fluoride exposure, present data are insufficient to
recommend utilizing fluoride concentrations in these
body fluids as biomarkers of contemporary fluoride ex-
posure for individuals. Daily fluoride excretion in urine
can be considered a useful biomarker of contemporary
fluoride exposure for groups of people.” We have not
been able to find any scientific articles published con-
cerning measurement of fluoride applying DBS technol-
ogy although it should be feasible.
Mercury
Measuring mercury intake is important to control for
the toxic effects of this trace element, in particular con-
cerning the developing nervous system. The concentra-
tion of mercury in plasma as well as its content in hair
has been used as biomarkers for mercury exposure, and
they are apparently well inter-correlated [165]. Blood
samples can be assayed using DBS [166]. The urinary ex-
cretion of mercury offers some promise as a biomarker
of mercury intake [167].
Cadmium
Similar to mercury, undesirably high intakes of cadmium
may lead to toxic effects. Often the plasma concentration
(e.g., as in DBS) is used as a biomarker of cadmium intake
[150, 166]. Interestingly, Piasek et al. [168] reported a po-
tential usefulness of cadmium content in the placenta for
evaluating cadmium exposure during pregnancy.
Iodine
Iodine is essential for adequate thyroid function. To
assess iodine intake, direct measurements of urine iodine
as well as of iodine incorporated into thyroid-derived
molecules (e.g., thyroxine, thyroid-stimulating-hormone
and thyroglobulin) have been used as functional markers
[169]. The systematic meta-analysis by Ristic-Medic
et al. [169] supported the use of all of these biomarkers
for evaluating iodine intake, although to a varying
degree, urine excretion being the better [170]. Moreover,
the analysis of thyroglobulin in DBS has emerged as a
putative biomarker alternative for iodine intake [171].
Feces—a potential matrix for dietary biomarkers
It has been generally acknowledged that the gut micro-
bial ecosystem may influence human physiology andhealth [172]. The understanding to what extent the in-
testinal microbic composition is subject to dietary con-
trol, and to integrate these data with functional
metabolic signatures and biomarkers is of utmost inter-
est [173]. The gut microbiota can be recognized as a
highly active metabolic organ because it affords metabo-
lites affecting physiological processes in the intestine
and beyond. Thus, gut microbiome metabolites interfere
with the metabolic phenotype of the host and conse-
quently may affect health and disease risk [174].
Diet and stool metabolites
Diet plays a pivotal role in shaping the human gut
microbiota (composition and metabolism), one of the
most densely populated microbial ecosystems in nature.
As a prominent example, prebiotics are used to modu-
late composition, metabolism, and function of the gut
microbiota to improve the gut and host health [175].
However, a number of additional factors, such as physi-
cochemical food properties, nutrient availability, colonic
transit time, and age of the host, may modulate the ef-
fect of diet on the composition and metabolic activity of
the colonic microbiota [172, 173]. Metabolites due to
bacterial energy metabolism may reflect dietary intake,
such as short chain fatty acids (SCFA) as a result of
carbohydrate metabolism, metabolites of fatty acids and
lipid bioconversion, and metabolites of protein fermen-
tation. Minor food constituents structurally modified by
microbial activity might be detectable in feces and could
be a characteristic for the consumption of certain foods,
especially plant foods (bioconversion of secondary plant
products). Thus, the hypothesis that metabolites detect-
able in fecal samples may reflect dietary intake is valid,
although not well elaborated yet.
Short chain fatty acids
Carbohydrates that are not digested in the small intes-
tine are fermented by colonic microbiota and produce
SCFA, e.g., butyrate, propionate, acetate, and longer-
chain fatty acids [176, 177]. The SCFA fecal concentra-
tion alters in different stages of life; e.g., the change from
breast-feeding to solid food or a higher butyrate produc-
tion at higher age as a consequence of an increase in
bacteroides [178]. Furthermore, the relative proportions
of SCFA differ from one person to another and they
are specifically sensitive to the type of fermented
carbohydrate [179, 180]. However, the current evi-
dence for a distinct dietary substrate identification
based on SCFA analyses in feces is not conclusive
[172]. Also, lactate and succinate are intermediate
metabolites of bacterial carbohydrate metabolism.
However, a direct link to specific dietary carbohy-
drates has not been established; rather, they may be
useful markers of gut health [172, 181].
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Many studies administering prebiotics as inulin, oligo-
fructose, and fructooligosaccharides (FOS) have reached
a significant increase in fecal bifidobacteria counts [182].
A double-blind placebo-controlled crossover study has
shown that the numbers of fecal bifidobacteria and
lactobacilli have significantly increased after administer-
ing very-long-chain inulin (VLI), derived from globe
artichoke, as compared to placebo [183]. Also oral ad-
ministration of a similar dose (similar to inulin dose) of
acacia gum increased bifidobacteria and lactobacilli pro-
duction [184]. Thus, an increase in fecal bifidobacteria
and lactobacilli excretion reflect prebiotics intake.
Another study has shown that administering 10, 15, or
20 g/day of a sugar-free digestion-resistant dextrin for
20 days led to increased number in the fecal lactobacilli
and bifidobacteria and a decrease in clostridium perfrin-
gens [185]. However, it should be considered that there
are different methods and no standard protocols for
assessing microbial proportions or numbers or activity
in fecal samples [186].
Branched chain fatty acids
Branched chain fatty acids (BCFA), ammonia, amines,
phenols, cresols, indoles, hydrogen sulfides (highly vola-
tile), etc. are metabolites arising from protein fermentation
[187]. There is a considerable inter-individual variation in
the urinary excretion of p-cresol and phenols probably
reflecting its production in colon [172]. In addition, fecal
concentrations of isobutyrate, 2-methylbutyrate and isova-
lerate, metabolites of the bacterial fermentation of valine,
isoleucine, and leucine [188] decreased after intake of pre-
biotics [189–191]. Thus, such metabolites could be evalu-
ated for its use as biomarkers of dietary intake. So far, they
are used only as more general markers for bacterial pro-
tein fermentation [192].
Dietary polyphenols
Most dietary polyphenols (e.g., flavonoids, anthocyanins,
phenolic acids, stilbenes, lignans, tannins) pass the small
intestine without absorption. Polyphenols have been de-
scribed to modulate composition of the gut microbiome
and probably contribute to gut and host health [193, 194].
In addition, polyphenols are bio-transformed into deriva-
tives that may become bioavailable for the host. Studies
using metabolomics techniques have shown that numer-
ous microbial metabolites of polyphenols can be detected
in feces and hence may be key markers for colonic bacter-
ial composition and activity [195]. They may also be valid
markers of food intake. As an example, serum concentra-
tions of enterolactone and equol are measured as markers
of plant lignan intake and microbial metabolism of daid-
zein (mainly derived from soy food), respectively. Using
feces as the analytic matrix, the chances to get moreinformation about diet (and microbial activity) would
be high.
Sterols
Secretions from the gastrointestinal tract constitute a
substantial portion of feces, and the bile is a major con-
tributor. Bile acids, cholesterol, coprostanol, and their
metabolites are subject to the enterohepatic circulation.
Their content and proportions (e.g., primary versus sec-
ondary bile acids) are strongly influenced by dietary fat
(saturated fat) intake, concomitant carbohydrate intake
and the gut microbial composition [196].
Fiber and resistant starch supplementation or chan-
ging to a lacto-vegetarian diet resulted in decreased fecal
bile acid concentrations, particularly secondary bile acids
[197, 198]. Cholesterol is transformed to coprostanol,
which represents about 60 % of the sterol content and is
considered the major 5ß-stanol in human feces [199].
Plant phytosterols, e.g., campesterol and sitosterol, are
reduced by enteric bacteria into 5ß-stigmastanol and 5-ß
campestanol. Hence, 5ß-stigmastanol and 5-ß campes-
tanol may be used as fecal biomarkers for dietary
phytosterol intake [200]. The relative proportions of
animal- and plant-derived stanols in feces may reflect
dietary preferences [200, 201]. Thus, the possibility of
applying various metabolites of bile acids and steroids
in feces as biomarkers of current diet should be
further explored.
Provitamin A carotenoids
Non-absorbed provitamin A carotenoids are mainly ex-
creted in feces. In addition, absorbed provitamin A caroten-
oids are partially excreted through bile and pancreatic
secretions in feces. Thus, carotenoids can be used as fecal
biomarkers for provitamin A (e.g., ß-carotene) intake or for
estimating ß-carotene bioavailability or for establishing ß-
carotene net balance in the body [202]; e.g., Van Lieshout
et al. [202] estimated the difference in the bioavailability of
ß-carotene between pumpkin and spinach based on meas-
uring carotenoids concentration in feces and serum.
Future prospect
The use of metabolomics techniques for analyses of fecal
samples allows identification of new biomarkers of gut
health, as well as understanding the interrelationship be-
tween the human gut microbiome activity and host
metabolism [203]. Moreover, it provides the possibility
to establish new markers of dietary (food) intake. A suc-
cessful strategy might be to utilize valid and reprodu-
cible metabolomics data to discover metabolite patterns
in feces that are associated with diet (rather than looking
for single compounds only). Thus, dietary intervention
studies may allow identification of fecal metabolite pat-
tern, which might be reproduced in population-based
Holen et al. Genes & Nutrition  (2016) 11:12 Page 15 of 20studies (e.g., cross-sectional and cohort studies). Up to
now, only some intervention studies have used metabo-
lomics techniques to evaluate the effect of synbiotics in
humans [204–206].
Methodological aspects
Metabolite profiling in fecal samples is much more com-
plicated as compared to other biospecimen. The physi-
cochemical properties of the feces influence the
reproducibility and full coverage of metabolite profiling
attained [206]. However, lyophilized feces samples ex-
tracted by water methanol mixtures, allow for the ana-
lysis of metabolite profiles that are reproducible and are
composed of various compounds. There are different
options for fecal sample collection and storage condi-
tions that may impact on the metabolite concentrations,
e.g., immediate freezing versus cooling on ice or in the
refrigerator before freezing versus storage at room
temperature before freezing [207]. For example, in water
extracts from frozen fecal samples, the concentration of
amino acids and glucose is higher than that in water ex-
tracts of fresh fecal samples [208]. Another option is
immediate mixing of the collected fecal sample with sta-
bilizing solutions such as RNAlater or Amis Transport
Medium [209]. A requirement for use of fecal samples
for dietary biomarker identification is a high sample
quality; however, optimization and harmonization of
sample collection, storage, and processing procedures
are yet to be established.
Analytical tools such as NMR, GC-MS, LC-MS, and
LC-MS-MS have been applied as metabolomics tech-
niques for the analyses of stool metabolites. Up till now,
mass spectrometry techniques have some advantages in
characterizing human metabolomes due to their high
sensitivity and selectivity [210]. NMR spectroscopy is
widely used in metabolite profiling due to its non-
destructive sample handling and its ability to quantify
compounds at very low concentrations. Furthermore,
NMR spectroscopy gives information on the structure of
the compounds, which is useful when unknown com-
pounds have to be identified [211, 212]. The heterogen-
eity of dietary compounds and of their formed
metabolites after ingestion is still a big challenge, as
many of these compounds are not yet defined [213].
Due to the diversity of fecal metabolites, more than one
method is necessary to achieve a comprehensive metab-
olite profile [214]. Important measures for selecting an
appropriate analytical method have to be considered
such as coverage, dynamic range, selectivity, accuracy,
precision, and price per sample [210].
Conclusions
Biomarkers of nutrient intake or nutrient status are im-
portant objective measures of one of the most importantenvironmental factors people are exposed to, namely
food. It is very difficult to obtain accurate data on
individual food intake, and there is a large variation in
nutrient composition of foods. This is the background
for studying more objective biomarkers of nutrient
intake. Modern technology with high sensitivity and
specificity concerning many nutrient-relevant bio-
markers has allowed an interesting development of non-
professional collection of small amounts of blood by
finger-pricking and collection on filters or sticks. With
proper collection, drying, transport, extraction, and ana-
lysis of the samples, many analytes of nutritional interest
can be measured such as metabolites, lipids, vitamins,
minerals, and many types of peptides and proteins. The
advantage of this alternative sampling technology is that
non-professionals can collect, dry, and mail the samples;
the samples can often be stored at room temperature in
a dry atmosphere; small amounts of blood are required
for analyses in professional laboratories with modern
analytical methodology. However, it should be noticed
that chemical measurements of nutrient biomarkers are
hampered by many confounding factors like variation in
food matrices, difference in digestion, absorption, trans-
port, distribution, activation, and catabolism. These facts
make it obvious that we do not get comparable data
from personal registration and objective biomarker mea-
surements. Thus, food registration as well as biomarker
measurements will most likely complement each other
in future decades of nutritional sciences. Another prom-
ising area of potential biological interest is the biology of
the microbiome in association with biomarkers. Interest-
ing perspectives are also related to the marked trend of
self-monitoring of body functions linked to mobile
phone technology.
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Abstract
Background/Objectives Dietary intake of red and processed meat has been associated with disease risk. Since dietary intake
assessment methods are prone to measurement errors, identifying biomarkers of meat intake in bio-samples could provide
more valid intake estimates. We examined associations of habitual red and processed meat, poultry, fish, and dairy products
consumption with plasma concentrations of anserine, carnosine, pi-methylhistidine (Π-MH), tau-methylhistidine (T-MH),
and the ratio of T-MH to Π-MH in a cross-sectional study.
Subjects/Methods Plasma anserine, carnosine, Π-MH, and T-MH concentrations were measured using ion-pair LC–MS/MS
in 294 participants in the second Bavarian Food Consumption Survey (BVS II). Habitual food consumption was assessed
using three 24-h dietary recalls. Associations between plasma metabolites concentrations and meat, fish, eggs, and dairy
products consumption were assessed by fitting generalized linear model, adjusted for age, sex, and BMI.
Results Total meat intake was associated with plasma concentrations of anserine, carnosine, Π-MH and, the ratio of T-MH to
Π-MH. Red meat intake was related to carnosine (p-trend= 0.0028) and Π-MH plasma levels (p-trend= 0.0493). Poultry (p-
trend= 0.0006) and chicken (p-trend= 0.0003) intake were associated with Π-MH. The highest anserine concentrations were
observed in individuals consuming processed meat or turkey. For T-MH we did not observe any association with meat intake.
Conclusions Our results indicate an association between habitual meat consumption and plasma concentrations of anserine,
carnosine, Π-MH and the ratio of T-MH to Π-MH. Intervention studies should clarify whether the analyzed plasma
metabolites are indicative for a specific type of meat before proposing them as biomarkers of habitual meat intake in
epidemiologic studies.
Introduction
The consumption of total meat, red meat, processed meat,
poultry, and fish has been associated with human health and
disease [1, 2]. In many populations, meat is an important
source of dietary protein and substantially contributes to the
supply with several essential nutrients, such as iron or zinc
[3]. In the past decade a lot of evidence has been obtained
showing that effects on chronic disease risk depend on the
type of meat consumed. While a high consumption of red
meat and processed meat is associated with a higher risk of,
e.g., type-2 diabetes, cardiovascular diseases, some types of
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cancer, and even total mortality, people consuming pre-
dominantly poultry or fish are not at higher risk. In contrast
to that a high consumption of fish even decreases the risk of
several chronic diseases [4–7].
In observational epidemiological studies, dietary ques-
tionnaires such as food frequency questionnaires and dietary
recalls are utilized to estimate habitual daily intake of food
[8]. However, dietary questionnaires are prone to different
types of bias leading to inaccurate estimates of dietary
intake [9], resulting in misclassification of participants and
impairment of risk estimates of diet–disease relationships
[10]. Hence, identifying new biomarkers of meat intake in
bio-samples provides the chance to get additional dietary
intake information that is not affected by the same mea-
surement error [10–12]. Biomarkers can complement the
dietary intake information and help to evaluate critically the
available dietary intake data. They can be used to classify a
person’s dietary intake and in turn will enhance the
assessment of the relationship between diet and chronic
disease [13]. Ideally, such metabolites can aid in categor-
izing participants according to the type and amount of meat
consumed.
Several studies have analyzed many single compounds in
body fluid samples regarding their correlation with meat and
fish intake [3, 11]. Carnosine [3], anserine [3], pi-
methylhistidine (Π-MH) [12], tau-methylhistidine (T-MH)
[12], and several other metabolic compounds have been
suggested as candidate biomarkers of dietary meat intake, as
they are found in various amounts in all different types of
meat [3]. A recent short-term intervention study confirmed
that urinary concentrations of some of the above-mentioned
compounds are fairly good biomarkers of meat intake [14].
It remains unclear, however, whether these markers can also
be used to characterize an individual’s habitual dietary meat
intake, the information required in observational (cohort)
studies for testing diet–disease associations. Since epide-
miological studies usually collect blood samples but often
lack (24-h) urinary samples, biomarker measurement in
plasma or serum samples can be done in most existing
studies.
Thus, in the present study we investigate whether habi-
tual meat, fish, egg, and dairy products consumption is
associated with plasma concentrations of anserine, carno-
sine, Π-MH, T-MH or the ratio of T-MH to Π-MH in a
cross-sectional study. Instead of using the terms 1- and 3-
methylhistidine we used the terms tau-methylhistidine (T-
MH) and pi-methylhistidine (Π-MH), respectively, accord-
ing to NT and NΠ atoms in the imidazole ring, following the
most common IUPAC nomenclature [15] to avoid confu-
sion about the numbering of atoms in the imidazole ring of
histidine. The methylhistidine structure derived from
anserine metabolism is termed as Π-MH, whereas the other
methylhistidine structure is named as T-MH.
Methods
Study participants
The second Bavarian Food Consumption Survey (BVS II),
conducted between September 2002 and June 2003, included
1050 participants aged 13–82 years. The overall participation
rate was 70%. The study was designed as a representative
cross-sectional study of the German-speaking Bavarian
population to describe their dietary and lifestyle habits. In
face-to-face interviews, demographics, lifestyle factors, and
medical history of the participants were assessed [16]. The
BVS II study was approved by the Ethics Committee of the
Bavarian Medical Association (Bayerische Land-
esärztekammer). Written informed consent was obtained from
each participant in accordance with institutional requirements
and the declaration of Helsinki principles.
Dietary data assessment
The standardized PC-guided program EPIC-Soft [17, 18]
was utilized to assess three 24-h dietary recalls per subject.
Trained study personnel conducted telephone interviews to
complete two dietary recalls on weekdays and one recall on
a weekend for each participant. Intake data were weighted
for weekday and weekend to calculate the average daily
food intake. Food items were summarized into 16 food
groups and 21 subgroups according to the EPIC-Soft clas-
sification scheme [17].
Men and women who completed at least one 24-h dietary
recall and were at least 18 years of age, participated in blood
sampling and anthropometry assessment in the nearest
health office of each participant. Blood samples were sta-
bilized with sodium ethylenediamine tetra-acetic acid
(EDTA) (1 g/L), centrifuged and separated from blood cells,
as described elsewhere in detail [19]. Plasma aliquots were
stored at −80 °C until lab analysis.
Potential meat intake biomarkers were measured in 294
plasma samples as only for those participants sufficient
plasma volume for the lab analysis was available.
Targeted LC–MS/MS amino acid measurements
Quantitative amino acid analyses were performed using
targeted LC–MS/MS based on the method described by
Harder et al. [20]. Briefly, plasma samples (10 µl) were
dissolved in 500 µl ice-cold methanol containing an internal
standard mixture of 16 deuterated amino acids, derived
from ChromSystems (Gräfelfing, Germany), Cambridge
Isotope Laboratories (Tewksbury, MA, USA), and Sigma-
Aldrich (Taufkirchen, Germany). Samples were centrifuged
(10 min, 10 °C, 4000 × g) and supernatants containing the
extract were evaporated to dryness under nitrogen. In the
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second step, amino acids in the dried samples were deri-
vatized to their butyl esters, as described by Gucciardi et al.
[21]. Briefly, a mixture of 95% n-butanol and 5% acet-
ylchloride (v/v) was added to the dried samples. Subse-
quently, the samples were incubated at 60 °C for 15 min at
600 rpm (Eppendorf Thermomixer Comfort; Eppendorf,
Hamburg, Germany). The derivatized samples were dried
and reconstituted in a 300 µl mixture of methanol/water/
formic acid (70/30/0.1% v/v).
The analysis was performed on a triple quadrupole
QTRAP 5500 LC–MS/MS system operating in positive ESI
mode (AB Sciex, Framingham, MA) equipped with a
1200 series binary pump (Agilent, Santa Clara, CA) and
coupled to an HTC pal autosampler (CTC Analytics,
Zwingen, Switzerland). Chromatographic separation was
achieved using a Zorbax Eclipse XDB-C18 column (length
150 mm, internal diameter 3.0 mm, particle size 3.5 µm;
Agilent). Eluent A consisted of 0.1% formic acid, 2.5 mM
ammonium acetic acid, and 0.005% heptafluorobutyric acid
in water. Eluent B consisted of 0.1% formic acid, 2.5 mM
ammonium acetic acid, and 0.005% heptafluorobutyric acid
in acetonitrile. Analytes were measured in scheduled mul-
tiple reaction monitoring (sMRM). For absolute quantifi-
cation, a 10-point calibration was performed, using a
mixture containing all amino acids in the measurement
(A9906 amino acid standards, Sigma-Aldrich, Taufkirchen,
Germany). Data analysis was done using Analyst 1.5.1®
software (AB Sciex).
Intra-day and inter-day precisions for Π-MH and T-MH
were evaluated using ClinCheck® control plasma samples
(Recipe, München, Germany). Since these control plasma
samples do not contain measurable concentrations of
anserine and carnosine, we additionally obtained human
plasma samples from individuals collected within a time
frame of 24 h after meat intake, and evaluated the intra-day
and inter-day precision for anserine and carnosine in these
samples. Except for low levels of anserine, coefficients of
variation for the precision were within 20% for the analytes
studied here (Supplementary Table 1). Accuracies were
between 77 and 119% for low levels and between 87 and
104% for high levels. Except for low levels of anserine,
sample peaks showed signal-to-noise values above 9,
defined as lower limit of quantitation.
Statistical methods
From three 24-h dietary recalls a weighted (for weekday and
weekend day) mean value for every food group or subgroup
was derived representing the usual intake in g/day of the
respective item. The following food groups and subgroups
were used in the present study: “all meat and meat pro-
ducts”, “red meat” (sum of beef, pork, and other rarely
consumed fresh meat, as wild, lamb etc.), “beef”, “pork”,
“beef and pork”, “poultry” (sum of chicken, turkey, ducks,
goose, etc.), “chicken”, “turkey”, “processed meat”, “fish
and shellfish”, “egg and egg products”, “milk and dairy
products”.
For the descriptive analysis, BMI (kg/m2), age of parti-
cipants (years) and total energy intake (kcal/d) were ana-
lyzed as continuous variables. Smoking status was
described as “smoker”, “ex-smoker” and “non-smoker”.
Socioeconomic status was assessed by household net
income, educational level of the one who was interviewed
and career position of the principal earner. It was categor-
ized into low, low-medium, medium, medium-high, and
high, based on the sum score derived from the single
variables. The descriptive analysis of main characteristics of
the study population was conducted separately for men and
women. We report median and interquartile ranges or
absolute numbers and relative frequency as appropriate.
To describe differences of non-normally distributed
plasma concentrations of anserine, carnosine, Π-MH, T-
MH, and the ratio of T-MH to Π-MH across categories of
sex, age, BMI, smoking, social class and physical activity,
we report geometric means and 95% CI instead of arith-
metic means and standard deviations. Geometric means
were obtained by fitting models with PROC GENMOD
using log-transformed plasma concentrations and trans-
forming the estimates derived from the model. For this
purpose, BMI was categorized into quartiles and age into
three groups (“<40 years”, “40–60 years”, “≥60 years”). All
bivariate models were adjusted for (continuous) age and
sex. When examining BMI, we additionally adjusted for
total energy intake. When smoking was examined, (con-
tinuous) BMI was added as adjustment variable. Physical
activity was categorized as either “active” or “inactive” (no
regular sports activity). The p-trend was derived based on
integer scores assigned to the categories of sex, age, BMI,
smoking, social class, and physical activity.
Further, we examined the relationship of plasma con-
centrations of anserine, carnosine, Π-MH, T-MH, and the
ratio of T-MH to Π-MH with food intake: geometric means
for categories of food intake were derived by fitting linear
models using log-transformed plasma concentrations. The
categorization of the food items was done with respect to
the intake data. The food groups “all meat and meat pro-
ducts”, “processed meat”, and “milk and dairy products”
were each grouped in quartiles whereas”red meat”, “pork”,
“beef and pork”, “poultry”, “fish and shellfish”, and “eggs
and egg products” were grouped into three groups defined
by non-consumers and the consumers divided by their
median value. For a small group of food items (“beef”,
“chicken”, and “turkey”) only consumers and non-
consumers were discriminated. As adjustment variables,
only age, sex, and BMI were included, as for smoking,
social class and physical activity no significant associations
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were detected. The p-trend was derived based on integer
scores assigned to the categories of food intake.
In addition, we performed a non-parametric comparison
of the consumption of “all meat and meat products”, “milk
and dairy products”, “fish and shellfish”, and “eggs and egg
products” across groups defined by the quartiles of all
biomarkers. When the Kruskal-Wallis test indicated overall
significant differences (p < 0.05), Dunn’s post-hoc test was
subsequently carried out. These analyses were restricted to
the consumers of the respective food groups.
All statistical analyses were performed using SAS soft-
ware, Version 9.3 of the SAS System for Windows
(Copyright © 2002-2010 SAS Institute Inc.).
Results
The present study included 101 (34.4%) men and 193
(65.7%) women. The mean age of the participants was 54
years in men and 44 years in women. On average, men had
a higher BMI and a higher energy intake compared with
women. Further baseline characteristics of the study parti-
cipants are shown in Table 1, stratified by sex. Mean intake
of milk and dairy products was higher in women (170 g/d)
compared with men (106 g/d), whereas total meat intake in
men (157 g/d) was much higher as compared with women
(91 g/d). Descriptive data on all analyzed dietary intake of
food groups and subgroups in gram per day are presented in
Table 1. Plasma biomarker concentrations range from
0.0771 µM for anserine in men and 0.0544 µM in women to
15.90 µM for T-MH in men and 12.33 µM women,
respectively.
Anserine, Π-MH, and the ratio of T-MH to Π-MH
plasma concentrations did not differ by sex. In contrast,
carnosine and T-MH concentrations were higher in men as
compared to women (Table 2). Plasma concentrations of
anserine, T-MH and Π-MH were associated with BMI
whereas only T-MH was significantly associated with age.
Consequently, all following analyses were adjusted for sex,
age, and BMI. Smoking, social class and physical activity
were not associated with any potential meat intake marker,
and thus not further considered.
Plasma anserine, carnosine, and Π-MH concentrations
significantly increased with higher total meat intake whereas
the ratio of T-MH to Π-MH plasma concentrations decreased
(Table 3). Red meat intake was significantly positively related
to plasma concentration of carnosine andΠ-MH. Beef or pork
consumption did not show any significant association,
whereas the sum of beef and pork intake significantly affected
anserine and carnosine plasma concentrations. With higher
processed meat consumption, plasma anserine concentrations
significantly increased. Furthermore, Π-MH and the ratio of
T-MH to Π-MH plasma concentrations differed by intake of
total poultry and of chicken. In contrast, consumption of
turkey was positively associated with plasma anserine con-
centrations. The potential meat biomarkers were, in general,
Table 1 Dietary and lifestyle characteristics and plasma biomarker
concentrations by sex
Male Female
n (%) 101 (34.4) 193 (65.7)
Age (years) 54 (41, 63) 44 (36, 57)
Food consumption (g/d)
Milk and dairy
products
105.8 (57.8,
195.9)
170.1 (80.6,
289.7)
Milk 20.6 (0, 99.3) 57.8 (3.7,
144.3)
Cheese 27.3 (8.6, 48.6) 23.2 (9.8, 38.9)
Total meat 157.4 (97.1,
223.9)
91.1 (47, 135.6)
Red meat 31.7 (0, 89.2) 25.4 (0, 55.7)
Beef 0 (0, 0) 0 (0, 0)
Pork 0 (0, 66.1) 0 (0, 37.7)
Beef & pork 23.6 (0, 78) 13.9 (0, 48.9)
Poultry 0 (0, 15) 0 (0, 10.5)
Processed meat 79.4 (40.7,
120.7)
38.1 (14.9,
68.3)
Fish & shellfish, 0 (0, 23.8) 0 (0, 17.8)
Eggs & egg
products
0 (0, 17.4) 0 (0, 17.1)
Total energy
intake (kcal/d)
2298 (2003,
2643)
1798 (1499,
2073)
BMI (kg/m2) 26.4 (24.3,
28.8)
24.6 (22.4,
28.3)
Smoking status, n (%)
Never 41 (40.6) 124 (64.6)
Former 33 (32.7) 38 (19.8)
Current 27 (26.7) 30 (15.6)
Social class, n (%)
Lower 10 (9.9) 29 (15)
Lower-middle 23 (22.8) 48 (24.9)
Middle 32 (31.7) 63 (32.6)
Upper-middle 17 (16.8) 41 (21.2)
Upper 19 (18.8) 12 (6.2)
Plasma biomarker concentrations (µM)
Anserine 0.0771 (0.018,
0.295)
0.0544 (0.014,
0.254)
Carnosine 0.0153 (0.011,
0.022)
0.0103 (0.007,
0.015)
Π -MH 1.940 (1.090,
4.120)
1.540 (0.750,
3.990)
T-MH 15.90 (13.20,
18.37)
12.33 (10.13,
15.53)
T-MH to Π -MH 2.165 (1.315,
2.708)
2.230 (1.226,
2.822)
Values are n (%) or median (IQR)
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Plasma concentrations of anserine, carnosine and pi-methylhistidine as biomarkers of habitual meat. . .
not related to the intake of eggs, fish or dairy food. However,
there was a significant inverse association between plasma
anserine concentrations and dairy food consumption. Such an
inverse trend did not reach statistical significance in the case
of fish consumption.
The Kruskal-Wallis test revealed significant differences
of the consumption of “all meat and meat products” across
quartiles for all biomarkers investigated (Table 4). The post-
hoc test showed group differences among the lower and
higher quartile groups. The consumption of “milk and dairy
products” was only significantly different across carnosine
quartiles, whereas consumption of “eggs and egg products”
differed only across quartiles of the T-MH to Π-MH ratio.
These results give reassurance to the findings provided in
Table 3.
Discussion
In the present study, we examined associations of the usual
dietary intake and biomarkers measured in plasma. We
observed a statistically significant association between total
Table 4 Comparison of
consumption of all meat, milk
and dairy products, fish and
shellfish and eggs and egg
products by plasma biomarkers
(in quartiles, based on all
available measurements)
All meat Milk and dairy
products
Fish Eggs
N Mean rank N Mean rank N Mean rank N Mean rank
Anserine (μM)
Q1: <0.0152 72 108.22a 78 162.97 33 48.44 32 66.81
Q2: ≥0.0152 to <0.0598 70 159.64b 70 144.43 21 47.36 30 67.12
Q3: ≥0.0598 to <0.272 72 141.78a,b 69 127.81 19 53.29 36 61.24
Q4: ≥0.272 72 164.81b 72 142.56 21 40.93 29 61.10
p= 0.0001 p= 0.0861 p= 0.5489 p= 0.8523
Carnosine (μM)
Q1: <0.008 74 104.81a 78 158.03a 26 54.71 31 65.55
Q2: ≥0.008 to <0.012 68 141.60b 70 154.57a,b 22 46.05 35 65.97
Q3: ≥0.012 to <0.018 75 147.88b,c 69 145.13a,b 27 39.98 30 60.07
Q4: ≥0.018 69 182.11c 72 121.03b 19 50.00 31 64.03
p < 0.0001 p= 0.0380 p= 0.2517 p= 0.9189
Π-MH (μM)
Q1: <0.9 71 120.37a 75 159.77 25 41.74 30 56.30
Q2: ≥0.9 to <1.6 69 146.12a,b 70 141.34 22 48.00 37 61.38
Q3: ≥1.6 to <4.1 73 142.12a,b 73 140.04 21 50.93 32 74.73
Q4: ≥4.1 73 164.90b 71 138.11 26 49.85 28 63.45
p= 0.0145 p= 0.3595 p= 0.6489 p= 0.2360
T-MH (μM)
Q1: <10.8 70 117.78a 71 153.89 19 49.55 35 65.69
Q2: ≥10.8 to <13.6 69 129.33a,c 73 159.58 29 42.69 29 52.55
Q3: ≥13.6 to <16.9 74 154.85b,c 73 136.36 21 40.69 34 69.00
Q4: 1His≥16.9 73 170.05b 72 130.21 25 57.24 29 67.55
p= 0.0005 p= 0.1087 p= 0.1382 p= 0.2847
T-MH to Π-MH (μM)
Q1: <1.248 73 163.82a 71 141.89 27 49.57 30 60.02a,b
Q2: ≥1.248 to <2.166 72 135.97a,b 73 141.45 22 50.68 32 77.98a
Q3: ≥2.166 to <2.767 72 150.90a,b 72 145.29 23 44.74 38 64.97a,b
Q4: ≥2.767 69 122.14b 73 151.28 22 44.66 27 50.48b
p= 0.0171 p= 0.8866 p= 0.8182 p= 0.0339
Mean ranks and and p-value of Kruskal–Wallis test are reported. Letters indicate groups identified by Dunn’s
post-hoc test (alpha= 0.05). Only consumers are included in the respective analysis. All group sizes are
reported
Q Quartiles
Bold numbers indicate significant results (p-value < 0.05)
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meat intake and plasma concentrations of anserine, carno-
sine, Π-MH and the ratio of T-MH to Π-MH. Red meat
intake was significantly related to carnosine and Π-MH
plasma levels. Plasma concentrations of Π-MH were sig-
nificantly related to poultry and chicken intake. The highest
mean anserine concentrations were found in individuals
consuming processed meat or turkey. For T-MH, we did not
observe any association with meat intake.
Red meat, poultry, and fish contain significant amounts of
carnosine and its derivatives. Therefore, diet is the main
source of carnosine and its derivatives in men [22]. It has been
reported 150 g of beef contains 343.4mg carnosine and 150 g
of chicken contains 322mg carnosine [23]; however, infor-
mation about absorption and bioavailability of histidine-
dipeptides in human is still inadequate. The dietary
histidine–dipeptides carnosine and anserine are rapidly
hydrolyzed by carnosinase in plasma and excreted in urine. In
total 85–90% of dietary anserine intake is eliminated as Π-
MH in urine in human [24]. T-MH is a degradation product of
actin and myosin, which are the main proteins found in the
striated muscle filaments. T-MH is liberated from these pro-
teins in the gut after meat intake [3] and excreted mainly in
urine. T-MH reflects muscle catabolism and muscle mass. A
considerable variation in circulating T-MH was observed after
consuming the same diet between participants [25]. On the
other hand, Π-MH is a potential good biomarker for meat
intake because it is not affected by muscle mass and activity
[26]. To take this potential influence into account, we asses-
sed the bivariate associations of plasma concentrations of our
biomarkers with physical activity. No significant associations
were found in our study. All analysis were adjusted for BMI,
which can at least partly correct for muscle mass, as we found
significant associations with our biomarkers investigated.
Therefore, we believe that our detected association with meat
intake reveals that Π-MH is in fact a marker for meat intake.
Several studies attempted to identify objective bio-
markers of meat intake in urine [12, 24, 27, 28] and fewer
studies examined plasma or serum samples for meat bio-
markers [14, 23, 28–30]. Most studies were intervention
studies, e.g., [23, 28, 30] and had comparable analysis
methods [23, 28]. To the best of our knowledge, no study
has yet examined the association between usual dietary
meat intake and plasma carnosine, anserine, T-MH or Π-
MH concentrations in a cross-sectional study.
Both anserine and carnosine content is highly variable in
different types of meat [3]. Both compounds are likely to
serve as generic indicators of total meat intake rather than
specific quantitative biomarkers as they cannot differentiate
between the types of meat that have been consumed.
However, some studies suggest that anserine concentrations
in urine can be used as a specific biomarker for chicken
intake [28, 31]. Yeum et al. [23] analyzed serum anserine
concentrations and found anserine serum levels as a marker
for chicken intake rather than beef intake. They reported
that anserine concentrations in plasma were well detectable,
and concluded that the methyl group lowers the affinity of
the histidine dipeptides for the carnosinase enzyme,
enhancing its blood (serum) stability. However, we did not
find any association between chicken intake and anserine
plasma level. This could be due to the short elimination
half-life of dipeptides [14], as anserine should be a specific
biomarker for chicken consumption like Π-MH. The
reported half-life of anserine is 32 min [23], though others
indicate half-life of 4 h [3]. Further, our finding of an
inverse relationship of the consumption of milk and dairy
products and fish with anserine concentrations most likely
represents a substitution effect, i.e., a lower meat intake in
individuals with a high consumption of dairy food or fish.
We did not observe any association between carnosine
plasma concentration and beef consumption in contrast to
the findings of Park et al. [30]. The peak plasma con-
centration of carnosine was reached after 2.5 h of beef
consumption, and after 5.5 h of beef consumption carnosine
was not detectable anymore [30]. Since we aimed to capture
usual dietary intake habits, we did not measure carnosine
plasma concentration directly after beef consumption and
therefore, most likely, we missed the carnosine peak. Other
reasons that can lead to carnosine disappearance in blood are
the rapid uptake of dipeptides into tissues or hydrolysis of
carnosine by carnosinase [31]. Because the carnosine plasma
concentration depends on the amount of carnosine con-
sumed [30, 31], our sample is likely to show on average low
carnosine levels as beef is not regularly consumed in
Bavaria, compared with other types of meat [32]. Carnosine
has been detected in urine after fish consumption showing an
association between carnosine urine concentration and fish
intake [24]. However, we did not observe any significant
association of carnosine plasma levels and fish consumption.
In line with our results, Yeum et al. [23] reported that
carnosine plasma levels were not significantly associated
with beef or chicken consumption. They suppose that the
carnosine metabolic pathway differs according to the diet-
ary source in humans. For example, beef may have com-
pounds such as carnosine inhibitor or peptides that compete
with carnosine in the hydrolytic process, which may stabi-
lize carnosine in serum.
In plasma, Π-MH has been found to be the best marker
for chicken intake and Π-MH levels are increased as well
after consumption of red meat and processed meat [28, 33].
This is in good accordance with our findings since we
observed additional associations with poultry and all meat
food group, although no association with consumption of
processed meat was found. Associations of meat and
chicken consumptions and Π-MH levels have been found in
urine as well [25, 28]. Π-MH is a short-term biomarker
especially for chicken intake rather than describing the
Plasma concentrations of anserine, carnosine and pi-methylhistidine as biomarkers of habitual meat. . .
usual intake [28]. The use of T-MH as a biomarker for meat
intake has been investigated in urine as well as in plasma.
Cross et al. found a significant increase of T-MH levels in
urine after red meat consumption [25], however Dragsted
argued that T-MH is not a marker of a specific kind of meat
[3]. Furthermore, Cheung et al. did not observe any asso-
ciation neither in urine nor in plasma [28]. This is in line
with our result of no significant association of dietary intake
and T-MH plasma levels. One study reported that 1-MH
and 3-MH half-lives were 11.7 and 12.6 h [12].
Urine analyses are less accurate compared to analyses in
plasma samples because human muscle catabolism con-
sistently contributes to urinary excretion of T-MH [3].
Fasting T-MH plasma levels are low as after T-MH intake
from meat, dipeptides are rapidly excreted in urine [14].
Further, a reason for not obtaining any significant T-MH
plasma concentration could be that the frequency of red
meat, beef or pork consumption by participants in the BVS
II was possibly too low to show a stable association with
plasma concentrations of T-MH. The median intake of beef,
pork or even poultry was 0 g/day.
Strength and limitations
The analytic method used to quantify anserine, carnosine,
Π-MH and T-MH in plasma samples is state of the art with
a fairly low limit of detection, which has also been applied
in other recent studies [23, 28]. Our results are based on 294
plasma samples available of the BVS II study participants
who completed three 24-h dietary recalls. Although this is
not a random subsample of the BVS II study participants, a
differential bias seems unlikely.
Three 24-h dietary recalls are efficient to determine
dietary intake at the population level. The use of 24-h dietary
recalls is the preferred dietary assessment method, since
several studies reported its good relative validity and mea-
surement properties [34–36]. We applied weighting factors
to account for consumption differences depending on the
day of the week. Yet, some food subgroups such as pork and
beef are rarely consumed. For that reason, this study had a
limited capacity to assess statistically the particular effect of
specific meat subgroups consumption on the related meat
intake biomarkers in contrary to the food group of total meat
consumption. As we did not assess dietary intake on the day
or the day before blood collection, we cannot assess short-
term biomarkers of intake of rarely consumed foods.
Conclusion
In conclusion, results of this study indicate an association
between meat consumption and plasma concentration of
anserine, carnosine, Π-MH and the ratio of T-MH to Π-MH.
For epidemiologic studies that did not collect urine samples,
these could be valid biomarkers for meat intake. Further
investigations of the use of these biomarker combinations as
indicators of specific types of meat consumed are needed. In
addition, intervention studies should clarify whether the
analyzed plasma metabolites are indicative for a specific
type of meat.
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Abstract
Animal sterols, plant sterols and bile acids in stool samples have been suggested as biomarkers of dietary intake. It is still unknownwhether they
also reflect long-term habitual dietary intake and can be used in aetiological research. In a subgroup of the Cooperative Health Research in the
Augsburg Region (KORA FF4) study, habitual dietary intake was estimated based on repeated 24-h food list and a FFQ. Stool samples were
collected according to a standard operating procedure and those meeting the quality criteria were extracted and analysed by means of a metab-
olomics technique. The present study is based on data from 513men and 495womenwith amean age of 60 and 58 years, respectively, for which
faecal animal and plant sterols and bile acids concentrations and dietary intake data were available. In adjusted regression models, the asso-
ciations between food intake and log-normalisedmetabolite concentrations were analysed. Bonferroni correctionwas used to account for multi-
ple testing. In this population-based sample, associations between habitual dietary intake and faecal concentrations of animal sterols were
identified, while the impact of usual diet on bile acids was limited. A habitual diet high in ‘fruits’ and ‘nuts and seeds’ is associated with lower
animal faecal sterols concentrations, whereas a diet high in ‘meat and meat products’ is positively related to faecal concentrations of animal
sterols. A positive association between glycocholate and fruit consumption was found. Further studies are necessary for evaluation of faecal
animal sterols as biomarkers of diet. The findings need to be confirmed in other populations with diverse dietary habits.
Key words: Dietary intake: Faeces: Sterols: Bile acids: KORA FF4
Several studies have analysed individual compounds in faecal
samples regarding their association with dietary intake and
diseases(1–3). Faecal animal sterols(4), plant sterols(3,4) and bile
acids(2) have been suggested as biomarkers for dietary intake
as they can be modified by changes in actual diet(2,4–6).
However, it is still unknown whether they also reflect long-term
habitual dietary intake.
Exogenous or endogenous cholesterol is metabolised mainly
in the liver, and cholesterol and primary bile acids are released
via bile secretion into the gut, and undergo further metabolism
by the intestinal microbiota to form coprostanol and secondary
bile acids (Fig. 1, adapted from Kaddurah et al.(7)). Cholic and
chenodeoxycholic acids as the major primary bile acids are syn-
thesised in the liver from cholesterol by side chain oxidation and
Abbreviations: 24HFL, 24-h food list; KORA FF4, Cooperative Health Research in the Augsburg Region.
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Publication 3
hydroxylation, conjugated with taurine and/or glycine, and
secreted into the small intestine, where 95 % of them get
reabsorbed (enterohepatic cycle). The other 5 % reach the large
intestine and undergo metabolic transformation by the gut
microbiota, forming secondary bile acids, e.g. deoxycholic
acid and lithocholic acid and further metabolites of these acids
(see e.g. Gerard(8)).
Thus, cholesterol is excreted in faeces either directly or in the
form of bile acids. Ferezou et al.(6) described already in the late
1970s that 9·5 % of faecal neutral sterols is cholesterol itself.
Among the direct cholesterol metabolites produced in the gut,
coprostanol (next to cholestanol and coprostanone) contributes
65 % of faecal neutral sterols(6). From the 5 % of bile acids that
reaches the large intestine, metabolites formed by the activity
of the gut microbiota are finally excreted in faeces. A detailed
description of the metabolic pathway of cholesterol and bile
acids, its absorption and excretion in stool is given elsewhere(8).
Phytosterols, such as stigmasterol or β-sitosterol, are naturally
occurring compounds in plant foods and are similar to choles-
terol in both structure and biological function. They have an
additional ethyl or methyl group at the side chain(9), and in
humans they are obtained only through dietary sources. Thus,
dietary intake of plant sterols depends on food consumption
habits and differs by population and sex(10–12). Vegetable oils
are rich in phytosterols; however the serving size of oils is small
as compared to the serving sizes of seeds and nuts, grain prod-
ucts, vegetables and fruits(5). Campesterol and sitosterol are the
most abundant phytosterols in the human diet, unlike their satu-
rated counterparts, campestanol and sitostanol. About 95 % of
dietary phytosterols enter the colon(13), where coprostanol and
coprostanone are formed from cholesterol. Sitosterol and cam-
pesterol are metabolised to methyl or ethyl coprostanol and
methyl or ethyl coprostanone. Absorbed phytosterols from the
intestine are excreted faster than cholesterol via biliary secretion,
leading to a small pool size of phytosterols compared with ani-
mal sterols(14). According to Gylling & Miettinen(15), the sum of
plant sterols and its derivatives excreted in faeces is proportional
to dietary plant sterol intake. Furthermore, the amount of plant
sterols consumed does influence the faecal sterol concentra-
tions, since plant sterols enhance cholesterol excretion(5).
In the present study, we investigate whether habitual dietary
intake, meaning long-term intake, is associated with faecal con-
centrations of animal sterols, plant sterols and bile acids in par-
ticipants of the observational, population-based Cooperative
Health Research in the Augsburg Region (KORA FF4) study.
Such biomarkers of dietary intake would be very helpful in char-
acterising key features of a subject’s habitual diet as well as their
effects on metabolism and health.
Materials and methods
Study population and design
The KORA FF4 study (2013–2014) is the second follow-up of
KORA S4 (1999–2001), a population-based health survey con-
ducted in the region of Augsburg, Germany(16). Of the 4216 par-
ticipants aged 25–74 years in KORA S4, 2279 individuals
participated in the KORA FF4 survey. The KORA FF4 study
Fig. 1. Cholesterol metabolism pathway. Primary bile acids are produced in the liver by endogenous enzymes in the liver and metabolised into secondary bile acids by
intestinal microbiota. Cholesterol is also metabolised to coprostanol by intestinal bacteria with a microbial steroid 5β-reductase enzyme (adapted from Kaddurah-Daouk
et al. 2011(7)).
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was designed to determine changes in lifestyle habits and health
status that developed over the follow-up period of, on average,
14 years. This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all procedures
involving human subjects were approved by the Ethics
Committee of the Bavarian Medical Association (Bayerische
Landesärztekammer). Written informed consent was obtained
from all participants.
Study participants were invited to the study centre to com-
plete a face-to-face interview (including questions on medica-
tion), to undergo physical examinations and anthropometric
measurements and to collect bio-specimens.
The flow chart in Fig. 2 illustrates samples sizes and the inclu-
sion and exclusion criteria applied. Stool samples were collected
from all 2279 participants in the KORA FF4 study. From these,
1415 stool samples were analysed. Samples were excluded if
participants had been on antibiotics within the last two months
before sample collection, no laboratory ID number was avail-
able, or if storage conditions of the sample were unclear.
Furthermore, due to financial constraints, only samples with
the best storage conditions were chosen. The stool samples ana-
lysed were not exposed to room temperature longer than 3 h
overall and were cooled for less than 48 h before they were
deep-frozen. Finally, the metabolomics analysis was conducted.
The present analysis comprises a subset of 1008 participants (513
men and 495 women) of KORA FF4 for which in addition to the
metabolomics data, estimates of habitual food intake were avail-
able. Further details on the collection, preprocessing and analy-
sis of stool samples are described below.
Participants were encouraged to complete at least two web-
based 24-h food lists (24HFL) and a web-based FFQ. However,
paper-based questionnaires were available upon request. The
closed 24HFL encompassed 246 food items used to assess which
foods and drinks were consumed over the previous day. A
detailed description of the 24HFL has been given elsewhere(17).
Briefly, the 24HFL is a closed and structured list of food items
used to identify which food items and drinks were consumed
over the past day. It neither assesses meals nor portion sizes.
For each food item, either yes or no must be answered regarding
consumption during the past 24 h. Freese et al.(17) describe that
the 246 food items were chosen such that at least 75 % of the
variation in nutrient intake was covered. It is important to note
that in our study the 24HFLwas used in a blended approach. The
stand-alone use of the 24HFL was not validated.
The results of the combination of two assessment instruments
for usual intake estimation were compared with the isolated use
of these instruments. The results clearly demonstrated that the
combined use of at least two 24-h recalls and an FFQ gave more
valid results on food intake as compared with the use of 24-h
recalls or an FFQ alone(18).
The FFQ included 148 food items to record food consump-
tion frequencies and amounts over the past 12months. It is based
on the German version of the multilingual European Food
Propensity Questionnaire (EFPQ)(19) and has been validated(20).
Participants used pictograms to estimate portion size. The fre-
quency of food item consumption was assessed in specified cat-
egories (never, once a month or less, two or three times amonth,
one to two times a week, three to four times a week, five to six
Fig. 2. Flow diagram illustrating the sample sizes and exclusion criteria of metabolite measurements and usual dietary intake in the Cooperative Health Research in the
Augsburg Region (KORA FF4) study.
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times a week, one time per d, two times per d, three times per d,
and more than three times per d).
Information on sociodemographic variables and lifestyle fac-
tors was collected in an extensive, standardised, face-to-face
interview at the study centre. Furthermore, all participants
underwent anthropometric assessment that included weight
and height measurement.
Stool sample collection, preprocessing and non-targeted
metabolomics analysis
Together with the appointment letter, participants were pro-
vided with instructions and the necessary equipment to collect
faecal samples on the day of their study centre visit or the eve-
ning before. Patients were instructed that probes from different
areas of the stool samples should be filled directly into two sterile
plastic collection tubes. One of the tubes was prefilled with a sta-
bilising agent (for DNA or RNA analysis). The filled tubes should
be packed in a sterile plastic bag and put into a box for storage in
the refrigerator (4–8°C). A stool collection questionnaire had to
be filled out, providing information about the time of collection,
description of the stool sample and problems experienced (if
any). Participants handed over the stool box upon entry into
the study centre where the faecal samples were deep-frozen
at −20°C immediately and later stored at −80°C until processing.
Using the stool collection questionnaire, storage conditions of
the samples were assessed, as these have great impact on the
quality of the sample. For our analysis, the native samples with-
out stabilising agent were used. Details on the following labora-
tory measurements are given in the Supplementary material.
Sample weight correction was achieved by dividing the raw
measurement (area counts) by the sample weight. Each partici-
pant gave one stool sample from 1 d, so no intra-individual varia-
tion was captured. No further technical adjustment was
performed, as inspection of data showed consistent perfor-
mance across all run days. We term these preprocessed metabo-
lite data as metabolite concentrations throughout the paper.
From all finally available 807metabolites, primary and secon-
dary bile acids and sterols were selected for the analysis. The
final preprocessed data set included thirty metabolites measured
in 1413 participants. Missing values were imputed by the mini-
mum (preprocessed) value per metabolite, as we assumed that
they were not missing due to technical reason but rather being
below the limit of detection. Five individual metabolites with
more than 25 % of missing values (cholate sulphate, 7-ketolitho-
cholate, glycocholenate sulphate, taurodeoxycholate and urso-
deoxycholate sulphate) were excluded from the analysis.
Based on the imputed data set, for plant sterols and animal ste-
rols, the sum over all metabolite measurements of the respective
group was derived as a further variable to be analysed, generat-
ing two further metabolite variables. In total, this results in
30− 5 + 2 = 27 metabolites to be analysed.
Usual dietary intake
From each participant up to three 24HFL and a FFQ were avail-
able to estimate usual, meaning long-term, intake by combining
the results of these two instruments. From these two instruments,
the usual intake was derived as described in detail in the
Supplementary material. We restricted the analysis to the follow-
ing nineteen main food groups or subgroups: ‘potatoes’, ‘vege-
tables’, ‘fruits’, ‘nuts, seeds and nut spread’, ‘milk and dairy
products’, ‘yoghurt’, ‘cheese (including cream cheese)’, ‘cereal
and cereal products’, ‘meat and meat products’, ‘pork’, ‘proc-
essed meat’, ‘fish and shellfish’, ‘eggs and egg products’, ‘sugar’,
‘butter’, ‘vegetable oil’, ‘soya products’, ‘non-alcoholic drinks’
and ‘alcoholic drinks’. These variables describing the usual
intake were only available for a subsample of 1008 participants
for which the stool samples were analysed. When including
usual intake values in the regression models described below,
each food item was scaled by its standard deviation. The total
energy intake (kJ/d) was derived from the usual intake of the
participants, taking into account all available food groups and
subgroups.
Other covariables
Smoking status was assessed as ‘ex-smoker’, ‘never smoker’ and
‘current smoker’. Following the recommendations given by the
German Nutrition Society, alcohol consumption was categorised
as ‘noor lowalcohol consumption’ (<5 g/d formen and<2 g/d for
women), ‘moderate alcohol consumption’ (≥5–<20 g/d for men
and ≥2–<10 g/d for women) and ‘heavy alcohol consumption’
(≥20 g/d for men and ≥10 g/d for women) based on the usual
alcohol intake per d, estimated from the 24HFL and FFQ as
described before(21). Physical activity was assessed in four catego-
ries, describing high to no activity. In detail, these were ‘more
than 2 h/week regularly’, ‘about 1 h/week regularly’, ‘and about
1 h/week irregularly’ and ‘almost no or no physical activity’,
regarding physical activity during leisure time in summer andwin-
ter. The years of education reported were categorised as ‘up to
12 years of education’ and ‘more than 12 years of education’.
Use of lipid-lowering medication and antidiabetic medications
were included. These were identified by ATC codes C10 and A10.
For the descriptive analysis, BMI, computed as weight/
height2 (kg/m2), was additionally categorised as underweight
(BMI< 18·5 kg/m2), normal (18·5 kg/m2≤ BMI<25 kg/m2), pre-
obese (25≤ BMI< 30 kg/m2) or obese (BMI≥ 30 kg/m2); hyper-
tensive status (actual hypertensive or not) and diabetes status
(type 2 diabetes or no type 2 diabetes) have also been included.
Actual hypertension status was assessed by blood pressure mea-
surements (systolic ≥140 mmHg or diastolic ≥90 mmHg) and/or
use of antihypertensive medication, given that the subjects were
aware of having hypertension. Diabetic participants include per-
sons with known, validated diabetes as well as those who were
newly detected by an oral glucose tolerance test (OGTT) (fasting
plasma glucose level ≥126 mg/dl (6·99 mmol/l) or plasma glu-
cose level 2 h after intake of 75 g of glucose ≥200 mg/dl
(11·1 mmol/l)). For thirty-one participants, the diabetes status
wasmissing (OGTT informationmissing or no validation possible),
and for two participants, the hypertensive status was missing.
Statistical analysis
Variables included in the statistical analyses were age, sex, BMI,
smoking status, alcohol consumption, physical activity, years of
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education, medication, total energy intake and usual intake of
selected food groups and subgroups. Age (years) and BMI were
included as continuous variables in the analyses.
The descriptive analysis provided information about
percentage of missing values, medians, and 25 %- and 75 %-
quantiles of all metabolites and metabolite groups. Median
and 25%- and 75 %-quantiles or absolute numbers and percent-
age of categories, whatever appropriate for the variables age,
food consumption, total energy intake, BMI, smoking status,
physical activity, alcohol consumption, years of education, dia-
betes and hypertension were given for all n 1008 participants
that had metabolite measurements and dietary intake data
available. All further analyses were performed with log-trans-
formed metabolite data. Sex differences between characteris-
tics of the population were examined by t tests and χ2 tests.
To detect sex-specific differences in the usual dietary intake,
we chose the Kruskal–Wallis test due to typically skewed intake
distributions.
To select relevant variables to be included as adjustment var-
iables in further regression analysis, we examined associations
or differences inmetabolite levels with the covariates in bivariate
analyses. For continuous variables, correlations were examined;
for categorical variables, t tests or Kruskal–Wallis tests were
performed.
In themain analysis, regressionmodels were fitted for each of
the twenty-seven metabolite variables, investigating the effect of
the usual intake of a certain food group, adjusted for age, sex,
BMI, smoking status, alcohol consumption, physical activity,
years of education, diabetes medication, lipid-lowering medica-
tion and total energy intake. We report effect estimates and
P values. Bonferroni adjustment of the P values was done by
dividing 5 % by the number of tests conducted (27 × 19 = 513,
leading to 9·746589 × 10–5).
All statistical analyses were performed using the statistical
software R, version 3.3.2 (R Development Core Team, 2010,
http://www.r-project.org)
Table 1. Clinical and lifestyle characteristics of the study population, by sex (n 1008)
(Numbers and percentages; medians and 25%-quantiles, 75%-quantiles)
Male Female
P *n % n %
Sex 513 50·9 495 49·1
Age, years 0·018
Median 60 58
25 %-quantile, 75 %-quantile 50, 70 48, 66
BMI (kg/m2) 0·027
Median 27·32 26·24
25 %-quantile, 75 %-quantile 24·96, 30·41 23·49, 29·96
BMI† <0·001
Underweight 0 0 3 0·6
Normal 130 25·3 187 37·8
Preobese 242 47·2 181 36·6
Obese 141 37·5 124 25·0
Smoking status <0·001
Never 211 41·1 287 58·0
Former 225 43·9 145 29·3
Current 77 15·0 63 12·7
Physical activity‡ 0·013
Regular, >2 h/week 150 29·2 133 26·9
Regular, 1 h/week 149 29·0 189 38·2
Irregular, 1 h/week 72 14·0 67 13·5
Almost no/no physical activity 142 27·7 106 21·4
Alcohol consumption§ <0·001
No to low consumption 115 22·4 190 38·4
Moderate consumption 207 40·4 258 52·1
Heavy consumption 191 37·2 47 9·5
Years of education 0·008
≤12 years 297 57·9 328 66·3
>12 years 216 42·1 167 33·7
Type 2 diabetes <0·001
Yes 79 15·8 53 11·1
No 420 84·2 425 88·9
Missing 14 18
Hypertension <0·001
Yes 231 45·1 162 32·8
No 281 54·9 332 67·2
Missing 1 1
* t Test for continuous variables, χ2 test for categorical variables.
†Underweight, BMI< 18·5 kg/m2; normal-weight, BMI< 25 kg/m²; preobese, BMI 25–29·99 kg/m²; obese, BMI≥ 30 kg/m². For the χ2 test underweight participants were discarded.
‡Physical activity during leisure time in both seasons.
§ No or low alcohol consumption,<5 g/d for men and <2 g/d for women; moderate alcohol consumption, ≥5–<20 g/d for men and≥2–<10 g/d for women; heavy alcohol consumption
≥20 g/d for men and ≥10 g/d for women.
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Results
The present study was comprised of 513 men and 495 women
with a mean age of 60 years and 58 years, respectively. On aver-
age, men had a higher BMI and a higher energy intake as com-
pared with women. Most of the participants were non-smokers
at the time of assessment and physically active. Further baseline
characteristics of the study participants are given in Table 1,
stratified by sex.
Table 2 lists descriptive data on dietary intake, given as food
group and nutrient intake, and stratified by sex. As expected,
mean intake of vegetables, fruit and dairy products was higher
inwomen than inmen. In contrast, men had higher consumption
of cereals, meat and meat products and alcoholic beverages.
These differences in food intake are naturally reflected in the
nutrient intake. Higher amounts of alcohol, carbohydrate, fat
and protein in men are due to higher intake of alcoholic drinks,
cereal products and meat and meat products.
Faecal metabolite concentrations after minimum imputation
are described in Table 3. We report the medians, 25 %- and
75 %-quantiles of the data and the percentages of imputed
values.
Table 4 shows the correlations between metabolites. The top
10 % of correlations are highlighted, as are the 10 % of lowest
correlations. It is noteworthy that both sitostanol and coprosta-
nol consistently show the weakest correlations with most
bile acids.
Tables 5 and 6 show the significant findings when analysing
the association of food group intake with the log-transformed
concentrations of sterols and bile acids. In general, the food
groups ‘fruits’, ‘nuts, seeds and nuts spread’, ‘milk and dairy
products’, ‘cheese’ and ‘yogurt’ were inversely correlated with
the faecal concentration of animal and plant sterols, while
‘potatoes’, ‘meat and meat products’, ‘pork’, ‘processed meat’,
‘eggs and egg products’ and ‘butter’ were positively correlated
with animal sterol and plant sterols faecal concentrations. An
exception arises with ‘cereals and cereal products’ intake.
This food group intake was inversely correlated with choles-
terol faecal concentration, whereas positively associated with
sitostanol faecal concentration. After Bonferroni correction,
‘fruit’ intake was significantly inversely associated with the fae-
cal concentration of campesterol, cholesterol and the sum of
animal sterols. With higher ‘nuts and seeds’ consumption, fae-
cal total cholesterol concentration significantly decreased.
Furthermore, consumption of ‘meat and meat products’ was
significantly positively related to the faecal concentration of
cholesterol. Partial R2 values show, in general, a small contribu-
tion of the dietary intake in the models fitted. Nonetheless, the
Table 2. Dietary characteristics of the study population, by sex (n 1008)
(Medians and 25%-quantile, 75%-quantile)
Male Female
Median 25%-quantile, 75%-quantile Median 25%-quantile, 75%-quantile P*
Total energy intake (kJ/d) 8782·2 7849·2, 9790·6 6640 5974·8, 7539·6
Usual food consumption (g/d)
Potatoes 60·7 50·0, 76·1 50·8 41·0, 64·0 <0·001
Vegetables 148·7 121·3, 185·6 182·6 146·8, 224·4 <0·001
Fruits 138·5 80·7, 205·3 147·5 100·2, 208·3 0·026
Nuts, seeds, nut spread 4·7 3·3, 9·3 3·8 2·5, 9·05 <0·001
Milk and dairy products 149·6 99·2, 229·0 202·8 136·5, 274·7 <0·001
Yogurt 18·6 11·8, 54·0 39·3 17·9, 79·5 <0·001
Cheese (including cream cheese) 27·9 19·3, 38·5 25·7 18·3, 36·8 0·041
Cereals and cereal products 187·8 162·6, 219·4 137·9 120·4, 163·6 <0·001
Meat and meat products 140·2 116·9, 161·9 85·2 72·65, 99·75 <0·001
Pork 21·5 17·7, 30·1 13·9 11·25, 19·05 <0·001
Processed meat 60·1 43·7, 75·3 31·2 24·5, 40·45 <0·001
Fish and shellfish 18·5 13·2, 26·9 15 11·1, 22·2 <0·001
Eggs and egg products 14·8 10·7, 21·9 13·2 9·9, 17·7 <0·001
Sugar 39·5 27·7, 50·7 33·6 24·6, 42·9 <0·001
Butter 16·5 8·6, 21·9 12·5 7·15, 15·45 <0·001
Vegetable oil 5·7 3·8, 8·5 5·2 3·45,7·65 0·006
Soya products 0·1 0, 0·1 0·1 0, 0·2 0·626
Non-alcoholic drinks 1501 1312·0, 180·0 1582 1416·0, 1783·0 <0·001
Alcoholic drinks 283·6 100·7, 564·7 37·3 25·1, 82·7 <0·001
Usual nutrient intake (g/d)
Protein 76·59 69·46, 85·84 61·27 54·12, 68·31 <0·001
Carbohydrate 216·2 189·1, 248·6 173·2 149·8, 201·9 <0·001
Ethanol 13·53 5·53, 25·33 2·42 1·64, 5·28 <0·001
Fat 86·55 77·15, 97·91 67·49 60·0, 74·91 <0·001
SFA 38·95 34·24, 43·87 30·89 27·12, 34·45 <0·001
Unsaturated fatty acids 30·73 27·65, 34·99 23·33 20·89, 26·23 <0·001
PUFA 10·98 9·58, 12·9 8·61 7·69, 10·09 <0·001
n-3 fatty acids 1·63 1·42, 1·92 1··31 1·14, 1·52 <0·001
n-6 fatty acids 9·29 8·02, 10·99 7·25 6·47, 8·50 <0·001
Cholesterol 0·32 0·28, 0·37 0·25 0·22, 0·28 <0·001
* Kruskal–Wallis test (P value is 5 %).
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impact is highest for those associations with the smallest
P values.
To find out if our detected inverse association of fruit intake
and animal sterols is confounded by meat and meat products
intake, we adjusted the fruit intake models for this potential con-
founder. The sum of animal sterols was still significantly associ-
ated with fruit intake at the Bonferroni-corrected significant
level. The association of cholesterol and fruit intake was just
above the significant level (results not shown). Overall, the
intake of ‘fruits’, ‘nuts and seeds’, ‘yogurt’, ‘cheese’, ‘butter’,
and ‘soya products’ was mainly inversely associated with
selected faecal primary and secondary bile acid concentrations
(Table 6). However, some bile acids were also positively associ-
ated with ‘fruits’ and ‘yogurt’ consumption (e.g. glycocholate,
glycolithocholate sulphate). Additionally, glychochenodeoxy-
cholate was positively associated with ‘fruit’ intake. The dietary
intake of ‘potatoes’, ‘vegetables’, ‘meat and meat products’,
‘pork’, ‘processed meat’, ‘eggs and egg products’ and ‘vegetable
oils’ was positively related to faecal concentrations of bile acids.
Among the associations examined in primary and secondary bile
acids, only the secondary bile acid glycocholate showed signifi-
cant positive association with fruit consumption after Bonferroni
correction. No other primary and secondary bile acids were
significantly associated with habitual food consumption after
adjustment for multiple testing.
Discussion
In the present study, we examined associations between
habitual dietary intake and faecal concentrations of sterols and
bile acids measured by a metabolomics technique. After correc-
tion for multiple testing, we observed a statistically significant
inverse association between ‘fruit’ intake and faecal concentra-
tions of campesterol, cholesterol and sum of animal sterols.
A higher consumption of ‘nuts and seeds’was also associatedwith
lower faecal concentrations of these metabolites. Additionally, a
significant positive association between ‘meat andmeat products’
consumption and faecal cholesterol concentration was found.
Concerning the association of bile acids and habitual dietary
intake, only one result remained significant after Bonferroni cor-
rection: a high fruit consumption was associated with a high gly-
cocholate concentration in faeces. All other identified associations
were no longer significant after Bonferroni correction.
Due to the high cholesterol content in foods of animal origin,
especially in meat and meat products, the findings concerning
higher animal sterols in stool when following a high-meat diet
are not surprising(22,23). The identified relationship is strong
and thus the sum of animal sterols is a promising biomarker
of dietary intake of ‘meat and meat products’.
Concerning bile acids, it is reported in the literature that con-
suming a high-fat, high-beef diet does not alter the activity of fae-
cal bacterial enzymes, although faecal secondary bile acid
Table 3. Description of metabolite concentrations in faecal samples of the study participants (after imputation) (n 1008)
(Medians and 25%-quantiles, 75%-quantiles)
n imputed (%) Median 25%-quantile 75%-quantile
Primary bile acids
Cholate 3 0·0469 0·0134 0·1899
Glycochenodeoxycholate 6 0·0479 0·0188 0·1215
Glycocholate 1 0·0525 0·0195 0·1490
Secondary bile acids
12-Dehydrocholate 17 0·0320 0·0086 0·1532
3b-Hydroxy-5-cholenoic acid 12 0·0459 0·0215 0·0810
6-Oxolithocholate 15 0·0435 0·0175 0·0811
7,12-Diketolithocholate 22 0·0338 0·0070 0·0930
7-Ketodeoxycholate 12 0·0409 0·0127 0·1781
Dehydrolithocholate 1 0·0514 0·0241 0·0896
Deoxycholate 2 0·0504 0·0170 0·1067
Glycodoxycholate 9 0·0426 0·0165 0·1123
Glycolithocholate sulphate 7 0·0446 0·0163 0·1324
Glycoursodeoxycholate 19 0·0385 0·0117 0·1026
Hyocholate 10 0·0454 0·0215 0·0920
Isoursodeoxycholate 1 0·0491 0·0218 0·1300
Lithocholate 1 0·0504 0·0293 0·0813
Ursocholate 1 0·0495 0·0247 0·1786
Ursodeoxycholate 2 0·0466 0·0205 0·1172
Plant sterols
β-Sitosterol 1 0·0511 0·0306 0·1002
Campesterol 1 0·0500 0·0280 0·1006
Ergosterol 5 0·0508 0·0218 0·1189
Sitostanol 8 0·0490 0·0224 0·0742
Stigmasterol 4 0·0476 0·0308 0·0755
Sum of plant sterols 0·2989 0·1920 0·4786
Animal sterols
Cholesterol 0 0·0522 0·0241 0·1384
Coprostanol 5 0·0492 0·0249 0·0823
Sum of animal sterols 0·1320 0·0828 0·2159
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Table 4. Correlation matrix of metabolites (n 1008)
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β-Sitosterol 1·00* 0·88* 0·07 −0·03 0·75* 0·66* −0·17† 0·16 0·11 0·12 0·19 0·26 0·15 0·22 0·19 0·04 0·32 0·13 0·10 0·16 0·35 0·28 0·33 0·20 0·30
Campesterol 0·88* 1·00* 0·07 −0·04 0·66* 0·71* −0·05 0·15 0·09 0·10 0·18 0·28 0·15 0·22 0·19 0·06 0·40 0·13 0·10 0·14 0·39 0·30 0·40 0·20 0·32
Ergosterol 0·07 0·07 1·00* 0·02 0·03 0·06 0·01 0·00 0·12 0·03 0·01 0·04 0·02 0·00 0·00 0·07 0·01 0·11 0·08 0·03 0·02 0·01 0·04 0·01 0·01
Sitostanol −0·03 −0·04 0·02 1·00* 0·02 −0·33† 0·64* −0·18† −0·11† −0·11† −0·18† −0·07 0·14 −0·13† −0·15† 0·26 −0·08 −0·12† −0·13† −0·14† −0·19† −0·19† 0·05 −0·16† −0·20†
Stigmasterol 0·75* 0·66* 0·03 0·02 1·00* 0·51 0·02 0·08 0·07 0·09 0·11 0·16 0·10 0·17 0·12 0·11 0·21 0·10 0·03 0·14 0·23 0·18 0·25 0·11 0·18
Cholesterol 0·66* 0·71* 0·06 −0·33† 0·51 1·00* −0·26† 0·23 0·10 0·11 0·29 0·34 0·06 0·27 0·23 −0·01 0·40 0·15 0·14 0·17 0·48 0·38 0·36 0·25 0·41
Coprostanol −0·17† −0·05 0·01 0·64* 0·02 −0·26† 1·00* −0·16† −0·10† −0·09 −0·13† −0·03 0·17 −0·07 −0·13† 0·29 0·03 −0·08 −0·10† −0·11† −0·16† −0·16† 0·18 −0·14† −0·15†
Cholate 0·16 0·15 0·00 −0·18† 0·08 0·23 −0·16† 1·00* 0·31 0·24 0·57 0·25 −0·10 0·29 0·51 −0·15† 0·25 0·37 0·49 0·34 0·51 0·51 0·06 0·55 0·62*
Glycochenodeoxycholate 0·11 0·09 0·12 −0·11† 0·07 0·10 −0·10† 0·31 1·00* 0·58 0·13 0·07 −0·04 0·12 0·17 0·00 0·15 0·72* 0·57 0·50 0·18 0·21 0·12 0·15 0·20
Glycocholate 0·12 0·10 0·03 −0·11† 0·09 0·11 −0·09 0·24 0·58 1·00* 0·16 0·07 −0·06 0·12 0·18 −0·03 0·09 0·52 0·32 0·69* 0·16 0·21 0·03 0·17 0·22
12-Dehydrocholate 0·19 0·18 0·01 −0·18† 0·11 0·29 −0·13† 0·57 0·13 0·16 1·00* 0·36 0·01 0·66* 0·60 −0·09 0·22 0·23 0·18 0·23 0·48 0·52 0·12 0·45 0·59
3b-Hydroxy-5-cholenoic acid 0·26 0·28 0·04 −0·07 0·16 0·34 −0·03 0·25 0·07 0·07 0·36 1·00* 0·10 0·19 0·18 0·14 0·44 0·14 0·15 0·10 0·29 0·34 0·47 0·28 0·37
6-Oxolithocholate 0·15 0·15 0·02 0·14 0·10 0·06 0·17 −0·10 −0·04 −0·06 0·01 0·10 1·00* 0·08 −0·06 0·33 0·06 −0·04 −0·03 −0·05 0·06 −0·03 0·24 −0·07 −0·02
7,12-Diketolithocholate 0·22 0·22 0·00 −0·13† 0·17 0·27 −0·07 0·29 0·12 0·12 0·66* 0·19 0·08 1·00* 0·65* 0·04 0·15 0·14 0·07 0·26 0·40 0·46 0·13 0·31 0·43
7-Ketodeoxycholate 0·19 0·19 0·00 −0·15† 0·12 0·23 −0·13† 0·51 0·17 0·18 0·60 0·18 −0·06 0·65* 1·00* −0·10 0·15 0·13 0·10 0·26 0·38 0·67* 0·04 0·63* 0·58
Dehydrolithocholate 0·04 0·06 0·07 0·26 0·11 −0·01 0·29 −0·15† 0·00 −0·03 −0·09 0·14 0·33 0·04 −0·10 1·00* 0·02 0·01 −0·04 −0·06 −0·11† −0·12† 0·31 −0·12† −0·12†
Deoxycholate 0·32 0·40 0·01 −0·08 0·21 0·40 0·03 0·25 0·15 0·09 0·22 0·44 0·06 0·15 0·15 0·02 1·00* 0·27 0·22 0·15 0·34 0·39 0·78* 0·18 0·45
Glycodoxycholate 0·13 0·13 0·11 −0·12† 0·10 0·15 −0·08 0·37 0·72* 0·52 0·23 0·14 −0·04 0·14 0·3 0·01 0·27 1·00* 0·69* 0·51 0·23 0·19 0·16 0·11 0·27
Glycolithocholate sulphate 0·10 0·10 0·08 −0·13† 0·03 0·14 −0·10† 0·49 0·57 0·32 0·18 0·15 −0·03 0·07 0·10 −0·04 0·22 0·69* 1·00* 0·30 0·22 0·17 0·12 0·15 0·24
Glycoursodeoxycholate 0·16 0·14 0·03 −0·14† 0·14 0·17 −0·11† 0·34 0·50 0·69* 0·23 0·10 −0·05 0·26 0·26 −0·06 0·15 0·51 0·30 1·00* 0·32 0·38 0·07 0·20 0·35
Hyocholate 0·35 0·39 0·02 −0·19† 0·23 0·48 −0·16† 0·51 0·18 0·16 0·48 0·29 0·06 0·40 0·38 −0·11† 0·34 0·23 0·22 0·32 1·00* 0·61 0·21 0·48 0·69*
Isoursodeoxycholate 0·28 0·30 0·01 −0·19† 0·18 0·38 −0·16† 0·51 0·21 0·21 0·52 0·34 −0·03 0·46 0·67* −0·12† 0·39 0·19 0·17 0·38 0·61 1·00* 0·25 0·83* 0·89*
Lithocholate 0·33 0·40 0·04 0·05 0·25 0·36 0·18 0·06 0·12 0·03 0·12 0·47 0·24 0·13 0·04 0·31 0·78* 0·16 0·12 0·07 0·21 0·25 1·00* 0·09 0·30
Ursocholate 0·20 0·20 0·01 −0·16† 0·11 0·25 −0·14† 0·55 0·15 0·17 0·45 0·28 −0·07 0·31 0·63* −0·12† 0·18 0·11 0·15 0·20 0·48 0·83* 0·09 1·00* 0·75*
Ursodeoxycholate 0·30 0·32 0·01 −0·20† 0·18 0·41 −0·15† 0·62* 0·20 0·22 0·59 0·37 −0·02 0·43 0·58 −0·12† 0·45 0·27 0·24 0·35 0·69* 0·89* 0·30 0·75* 1·00*
* Highest 10 % of correlations.
† Lowest 10 % of correlations.
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excretion is increased(22). However, Hentges et al.(24) did not
observe increasing concentrations of bile acids in faeces of sub-
jects following a high-meat diet. This is in line with our findings
of a non-significant increase in bile acid excretion with relatively
high meat consumption.
The explanation for the findings of an inverse association of
‘fruits’ and ‘nuts and seeds’ intake with animal sterols in faeces is
not as straight forward. At least in part, it may be explainable by
the higher plant sterol intake and its physiological consequences
on cholesterol absorption and excretion(25,26), which shall be dis-
cussed in the following paragraph.
Plant sterols have a plasma cholesterol-lowering property as
described in numerous studies(3,27–31). It is commonly accepted
that this effect is mediated by reducing cholesterol absorption
through competition of plant sterols with cholesterol for incorpo-
ration into micelles(3). Further, the intestinal absorption rate of
cholesterol (40–60 %) is much higher than of plant sterols (15 %
or less)(13,32). Weststrate et al.(25) analysed faecal concentrations
of sterols and bile acids and found a significant increase in faecal
neutral sterols after consumption of phytosterol-enriched mar-
garine. Also Racette et al.(26) concluded that phytosterols act as
bioactive compounds that lead to increased cholesterol excretion
in faeces. In an intervention study, eighteen participants followed
a low-phytosterol diet and received beverages supplemented
with 0, 400 or 2000mg phytosterols/d for 4 weeks each, with 1
week washout period. They reported that consuming dietary
Table 5. Regression coefficient estimates, standard errors of estimates, P and partial R 2 modelling associations of faecal sterols with habitual intake (only
associations with P <5 % are reported†; n 1008)
Food group (g/d) Metabolite Estimate SE P Median of concentration Partial R 2
Potatoes Campesterol 0·120 0·040 0·002892 0·0500 0·0089
Potatoes Sum of plant sterols 0·085 0·033 0·009016 0·2989 0·0069
Potatoes Stigmasterol 0·089 0·038 0·018518 0·0476 0·0056
Potatoes β-Sitosterol 0·086 0·037 0·018881 0·0511 0·0056
Potatoes Cholesterol 0·108 0·048 0·023228 0·0522 0·0052
Fruits Sum of animal sterols −0·131 0·028 0·000003* 0·1320 0·0216
Fruits Campesterol −0·160 0·036 0·000007* 0·0500 0·0202
Fruits Cholesterol −0·180 0·042 0·000021* 0·0522 0·0181
Fruits Sum of plant sterols −0·111 0·029 0·000132 0·2989 0·0147
Fruits Stigmasterol −0·121 0·034 0·000336 0·0476 0·0129
Fruits Ergosterol −0·173 0·054 0·001509 0·0508 0·0101
Fruits β-Sitosterol −0·102 0·032 0·001618 0·0511 0·0100
Nuts, seed and nut spread Sum of animal sterols −0·112 0·026 0·000024* 0·1320 0·0179
Nuts, seed and nut spread Ergosterol −0·192 0·051 0·000179 0·0508 0·0141
Nuts, seed and nut spread Sum of plant sterols −0·090 0·027 0·000971 0·2989 0·0109
Nuts, seed and nut spread Campesterol −0·097 0·034 0·004115 0·0500 0·0083
Nuts, seed and nut spread Cholesterol −0·096 0·040 0·016798 0·0522 0·0058
Nuts, seed and nut spread Coprostanol −0·110 0·048 0·020992 0·0492 0·0054
Milk and dairy products Sum of animal sterols −0·065 0·028 0·021292 0·1320 0·0053
Milk and dairy products Sum of plant sterols −0·062 0·029 0·031410 0·2989 0·0047
Milk and dairy products Ergosterol −0·116 0·054 0·032991 0·0508 0·0046
Yogurt Sum of animal sterols −0·078 0·026 0·002554 0·1320 0·0092
Cheese Sum of animal sterols −0·094 0·027 0·000509 0·1320 0·0121
Cheese Cholesterol −0·129 0·040 0·001432 0·0522 0·0102
Cheese Stigmasterol −0·088 0·032 0·006093 0·0476 0·0076
Cheese β-Sitosterol −0·079 0·031 0·010856 0·0511 0·0065
Cheese Campesterol −0·079 0·034 0·020562 0·0500 0·0054
Cheese Sum of plant sterols −0·055 0·028 0·045793 0·2989 0·0040
Cereals and cereal products Cholesterol −0·134 0·062 0·031550 0·0522 0·0047
Cereals and cereal products Sitostanol 0·161 0·078 0·037869 0·0490 0·0043
Meat and meat products Cholesterol 0·244 0·062 0·000081* 0·0522 0·0156
Meat and meat products Campesterol 0·189 0·052 0·000301 0·0500 0·0131
Meat and meat products Sum of animal sterols 0·136 0·041 0·000949 0·1320 0·0110
Meat and meat products β-Sitosterol 0·122 0·047 0·010114 0·0511 0·0067
Meat and meat products Sum of plant sterols 0·100 0·042 0·018348 0·2989 0·0056
Pork Sum of animal sterols 0·084 0·031 0·005991 0·1320 0·0076
Pork Cholesterol 0·119 0·046 0·009913 0·0522 0·0067
Pork Campesterol 0·082 0·039 0·035595 0·0500 0·0045
Pork Sum of plant sterols 0·065 0·031 0·040136 0·2989 0·0042
Processed meat Cholesterol 0·173 0·052 0·001015 0·0522 0·0109
Processed meat Sum of animal sterols 0·102 0·035 0·003689 0·1320 0·0085
Processed meat Campesterol 0·125 0·044 0·004922 0·0500 0·0080
Eggs and egg products Sum of animal sterols 0·079 0·026 0·002129 0·1320 0·0095
Eggs and egg products Cholesterol 0·091 0·039 0·018491 0·0522 0·0056
Butter Ergosterol 0·147 0·054 0·006293 0·0508 0·0075
Butter Sum of animal sterols 0·061 0·028 0·029641 0·1320 0·0048
* P indicating significant associations after Bonferroni correction (P< 9·746589 × 10–5).
† Models were adjusted for age, sex, BMI, smoking status, alcohol consumption, physical activity, years of education, use of lipid-lowering and antidiabetic medication and total
energy intake.
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phytosterols in moderate or high doses could alter the cholesterol
metabolism in human body. The cholesterol excreted was mainly
from biliary cholesterol and a smaller proportion from dietary
cholesterol. Another intervention study has also observed an in-
crease in faecal excretion of cholesterol through the intake of a
phytosterol-rich diet(33).
In the long-term, however, it is not clear whether a diet rel-
atively high in plant sterols is associatedwith lower faecal animal
sterols. Jaceldo-Siegl et al.(34) examined dietary intake and
plasma concentration of plant sterols and cholesterol across five
different dietary patterns. Dietary phytosterols were highest in
the diet of vegan subjects and lowest among non-vegetarians,
whereas total cholesterol consumption was highest among
non-vegetarians and lowest in vegans. However, the plasma
concentrations of plant sterols and animal sterols did not vary
across different diets. In addition, an alteration in the intestinal
cholesterol absorption by consuming 0·7–0·9 g/plant sterols
per d was observed(35). However, the daily intake of plant
sterols following a regular diet ranges between 160 and
400 mg/d(34), which is lower than the required concentration
to achieve a higher excretion rate of sterols in faeces(26).
Our results provide novel information, since no other study
has analysed faecal concentrations of sterols in faeces in a
population-based study and related it to habitual dietary intake.
However, our observations are not consistent with results from
intervention studies or other previous projects dealing with the
effect of phytosterol intake, aswe reported an inverse correlation
between fruits and nuts consumption and faecal animal sterols.
In our study, on average 4·7 g/d of nuts and seeds were con-
sumed, which is a very small amount, and likely too small for
a phytosterol-based effect on cholesterol excretion.
Another aspect explaining the inverse association of fruit con-
sumption and sterols in our study is that fruit intake contributes to
the total dietary fibre intake. As high dietary fibre intake leads to
increased faecal bulk, and this may result in lower faecal concen-
tration of sterols and bile acids per g of dry weight(36).
Diets that are rich in fruits are linked to a decreased
colorectal cancer incidence. Regarding bile acids, it is notewor-
thy that dietary fibres from vegetables and fruits can bind to
the secondary bile acid lithocholate and enhance its faecal
excretion(37,38). This may explain our finding of a positive asso-
ciation between fruit consumption and glycocholate excretion,
Table 6. Regression coefficient estimates, standard errors of estimates, P and partial R 2 modelling associations of faecal bile acids with habitual dietary
intake (only associations with P <5 % are reported†; n 1008)
Food group (g/d) Metabolite Estimate SE P Median of concentration Partial R 2
Potatoes Deoxycholate 0·143 0·058 0·014425 0·0504 0·006031
Potatoes Lithocholate 0·082 0·037 0·024920 0·0504 0·005070
Vegetables 12-Dehydrocholate 0·223 0·091 0·014203 0·0320 0·006058
Fruits Glycocholate 0·237 0·059 0·000058* 0·0525 0·013907
Fruits Hyocholate −0·199 0·055 0·000326 0·0454 0·013128
Fruits 7,12-Diketolithocholate −0·189 0·071 0·007827 0·0338 0·005920
Fruits Ursocholate −0·153 0·061 0·012232 0·0495 0·007134
Fruits Glycolithocholate sulfate 0·152 0·061 0·013571 0·0446 0·006044
Fruits Isoursodeoxycholate −0·123 0·051 0·016015 0·0491 0·006119
Fruits Glycochenodeoxycholate 0·129 0·055 0·018184 0·0479 0·000002
Fruits Deoxycholate −0·117 0·052 0·024726 0·0504 0·004882
Nuts, seed and nut spread Hyocholate −0·144 0·052 0·005792 0·0454 0·006880
Nuts, seed and nut spread Lithocholate −0·080 0·031 0·008960 0·0504 0·005328
Nuts, seed and nut spread Dehydrolithocholate −0·093 0·040 0·021496 0·0514 0·004603
Nuts, seed and nut spread Ursodeoxycholate −0·108 0·050 0·032633 0·0466 0·007062
Milk and dairy products Glycocholate 0·156 0·059 0·008093 0·0525 0·004675
Milk and dairy products Dehydrolithocholate 0·093 0·043 0·031300 0·0514 0·008118
Yoghurt Glycocholate 0·154 0·054 0·004511 0·0525 0·004310
Yoghurt Ursocholate −0·116 0·056 0·038704 0·0495 0·004308
Yoghurt Isoursodeoxycholate −0·097 0·047 0·038749 0·0491 0·004252
Yoghurt Glycolithocholate sulphate 0·116 0·056 0·040044 0·0446 0··006643
Cheese Lithocholate −0·080 0·031 0·010226 0·0504 0·004301
Cheese Deoxycholate −0·103 0·050 0·038898 0·0504 0·004206
Cheese Ursodeoxycholate −0·105 0·051 0·041136 0·0466 0·004063
Meat and meat products Hyocholate 0·162 0·081 0·044747 0·0454 0·003970
Meat and meat products Ursocholate 0·177 0·089 0·047247 0·0495 0·010524
Pork 6-Oxolithocholate 0·193 0·059 0·001214 0·0435 0·009596
Pork Lithocholate 0·109 0·035 0·002009 0·0504 0·003984
Processed meat Hyocholate 0·137 0·069 0·046860 0·0454 0·012058
Eggs and egg products Deoxycholate 0·164 0·047 0·000531 0·0504 0·008699
Eggs and egg products Lithocholate 0·087 0·030 0·003280 0·0504 0·008213
Eggs and egg products Ursodeoxycholate 0·139 0·049 0·004283 0·0466 0·005262
Eggs and egg products Isoursodeoxycholate 0·106 0·046 0·022321 0·0491 0·004382
Eggs and egg products Hyocholate 0·105 0·050 0·037117 0·0454 0·008743
Butter Glycolithocholate sulfate −0·179 0·061 0·003202 0·0446 0·005174
Vegetable oil 7,12-Diketolithocholate 0·149 0·066 0·023479 0·0338 0·005802
Soya products Cholate −0·170 0·071 0·016418 0·0469 0·006031
* P indicating significant associations after Bonferroni correction (P< 9·746589 × 10–5).
† Models were adjusted for age, sex, BMI, smoking status, alcohol consumption, physical activity, years of education, medication use and total energy intake.
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although for all other bile acids we found (non-significant)
inverse associations.
Also, the amount of vegetable oils – rich in phytosterols – con-
sumed in our population sample (on average, 5·7 g/d) is likely
not high enough to result in a significant effect on faecal sterols.
However, intervention studies did observe an effect of replacing
butter consumption with vegetable oils and found a significant
increase in faecal excretion of sterols and bile acids(39). In
another study, the faecal sterols concentration increased from
30 mg/g to about 50 mg/g dry weight after enriching margarine
with 8·6 g vegetable oils(25). However, we only observed a cor-
relation between vegetable oils intake and faecal excretion of the
secondary bile acid 7,12-diketolithocholate.
Strengths and limitations
To the best of our knowledge, the present study provides, for the
first time, data on the association between habitual food intake
and faecal concentration of animal sterols, phytosterols and bile
acids in a cross-sectional study applying metabolomics tech-
niques. Several studies measured animal and plant sterols in
blood and faecal samples(26,33) or plasma only(34). Some studies
examined faecal samples only in (short- to medium-term) inter-
vention studies(1,25,26,33).
Our study is of observational nature and stool samples were
collected only once per subject. To consider day-to-day variation,
collecting faecal samples on 3–5 d from each participant was
recommended by Setchell et al.(40). This would allow integrating
not only day-to-day variation in food consumption, but also
differences in stool transit time, gut microbiota activity, etc.
Unlike blood, stool samples usually cannot be collected in the
study centre; rather, it is collected at home and thus has to be
stored until the study centre visit. Although correct handling
and storage was communicated to all participants, not all stool
samples were stored cooled until handed over in the study
centre. In a prestudy, comparisons were made concerning
metabolite concentrations in fresh samples and samples stored
under different conditions. Due to the results of this study and
in accordance with Loftfield et al.(41), samples with storage at
room temperature of more than 3 h were excluded from the
analysis. Nonetheless, we cannot rule out that metabolite degen-
eration took place in the selected samples.
Faeces can be easily accessed in a non-invasive manner and
make it possible to study the diet–gut microbiota–host interac-
tion via the analysis of unabsorbed metabolites(42). Further, ste-
rols and bile acids are mainly metabolised by the gut microbiota
and excreted in faeces(8). Therefore, it is more reasonable to esti-
mate especially sterol in faeces rather than in any other biospeci-
men. Several sterol metabolites have previously been identified
in human faeces(43). Phytosterols may be metabolised into C21-
bile acids in the liver and not to the common C24-bile acids in
mammals(13). Since only the common C24-bile acids were
detected in our study and not the C21-bile acids, we could not
observe the total metabolite excretion of plant sterols in faeces.
In our study, no extremely high amounts in the consumption
of certain food groups were observed. Unlike the procedures in
short-term intervention studies, we analysed estimates of usual
dietary intake of food groups and not a specific diet (high in a
specific food) on the day before stool sampling. Plant sterols
are derived only from diet, and if they are not consumed regu-
larly in high amounts, it is unlikely to find high concentration
of phytosterols in faeces. Daily intake of plant sterols ranges
from 160 to 400mg in different populations (see Jaceldo-Siegl
et al.(34)). However, to observe significant reduction of plasma
LDL-cholesterol concentrations and to obtain cardiovascular
health benefits, adults should consume 2 g/d(44), a dose not
attainable by habitual diet without supplementation.
In conclusion, the results of this study conducted inparticipants
from the general population indicate an effect of habitual diet on
faecal concentrations of animal sterols, while the impact of diet on
bile acids is limited. A diet high in ‘fruits’ and ‘nuts and seeds’ is
associated with lower concentrations of animal sterols in faeces.
Asexpected, a diet high in ‘meat andmeat products’ leads tohigher
concentrations of animal sterols in faeces. Further studies are nec-
essary for evaluation of faecal animal sterols as biomarkers of diet.
Our findings especially need to be confirmed in other populations
with diverse dietary habits. Also, the question of possible health
benefits or risks of a higher or lower faecal animal sterol content
in response to dietary habits needs further discussion.
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